Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,chloride channel activity (GO:0005254),-0.5711465943024616,-2.07856323821784,0.0,0.012837738904248814,0.009,21/59,13.96%,SLC26A7;CLIC4;GABRG3;ANO1;ANO4;CLCN3;GABRA2;GABRB3;GLRA1;GABRB1;GABRG2;TTYH2;GLRA2;CLIC1;GABRB2;CLCN5;GABRA3;ANO3;ANO2;CFTR;SLC1A4
prerank,metalloendopeptidase activity (GO:0004222),0.6538261490120088,1.9970342526963643,0.0,0.007323548259131549,0.008,19/76,8.79%,ADAMTS6;ADAMTS12;ADAMTSL3;TRABD2B;THSD4;ADAMTS10;ADAMTS5;ADAM33;ADAMTS2;ADAMTSL2;MMP2;MMP19;MMP11;MMEL1;ADAMTS9;SPRTN;PMPCB;ECE2;EEF1AKMT4-ECE2
prerank,anion channel activity (GO:0005253),-0.5308881218974766,-1.9533420731677824,0.0,0.04551561975142761,0.07,22/61,13.96%,SLC26A7;LRRC8C;CLIC4;GABRG3;ANO1;LRRC8D;ANO4;CLCN3;GABRA2;GABRB3;GLRA1;GABRB1;GABRG2;GLRA2;CLIC1;GABRB2;CLCN5;GABRA3;ANO3;ANO2;CFTR;SLC1A4
prerank,metallopeptidase activity (GO:0008237),0.6001767939557421,1.9263506249246298,0.0,0.031582801867504805,0.06,21/113,8.79%,PAPPA;ADAMTS6;ADAMTS12;ADAMTSL3;TRABD2B;THSD4;ADAMTS10;ADAMTS5;ADAM33;ADAMTS2;ADAMTSL2;MMP2;MMP19;MMP11;MMEL1;ADAMTS9;SPRTN;DPEP1;PMPCB;ECE2;EEF1AKMT4-ECE2
prerank,transmitter-gated ion channel activity (GO:0022824),-0.5968610068085167,-1.8683225455749317,0.0029498525073746312,0.11281649340097442,0.231,14/29,9.66%,GRID2;GRIA4;GABRG3;GRIK1;GRIK2;GABRA2;GABRB3;GABRB1;GABRG2;GLRA2;GABRB2;GRIA2;GABRA3;GRID1
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.697404262237331,-1.8609259351900798,0.0025575447570332483,0.07492571251388853,0.247,6/16,5.92%,PTPRB;PTPRG;PTPRE;PTPRD;PTPRK;PTPRT
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.697404262237331,-1.8609259351900798,0.0025575447570332483,0.07492571251388853,0.247,6/16,5.92%,PTPRB;PTPRG;PTPRE;PTPRD;PTPRK;PTPRT
prerank,retinoid binding (GO:0005501),0.7604157426022007,1.8483638919373673,0.0015748031496062992,0.11595618076958288,0.275,5/22,6.06%,RBP4;CYP26B1;NR2F2;RBP1;ALDH1A2
prerank,protease binding (GO:0002020),0.57929270711163,1.8262854170639231,0.0012422360248447205,0.12610234658692135,0.375,37/99,14.40%,CCBE1;COL1A2;COL1A1;TIMP3;SERPINE1;BCL2;ITGA3;CFLAR;ATP9A;STIM1;INSL3;RFFL;LDLR;BFAR;CST3;DERL1;BDKRB2;DERL3;CD28;POLG;TIMP2;RNF139;SLC2A13;PRKN;ITGB3;ITGAV;LONP2;ADAMTSL4;SELENOS;RIPK2;NOL3;TRIP4;PTEN;COL3A1;ADRM1;RIOK3;AMFR
prerank,chloride transmembrane transporter activity (GO:0015108),-0.6869769246975088,-1.8207703556356127,0.0,0.10659213514436894,0.387,7/16,14.00%,SLC26A7;SLC26A2;SLC1A1;SLC4A8;SLC26A6;CFTR;SLC12A5
prerank,platelet-derived growth factor binding (GO:0048407),0.848645422184102,1.8172387118906914,0.0,0.11827530438497452,0.422,5/11,3.56%,COL1A2;COL1A1;COL5A1;PDGFRA;PDGFRB
prerank,glutamate receptor activity (GO:0008066),-0.6572210038514461,-1.814927487787618,0.007042253521126761,0.09970088136027,0.418,10/19,10.97%,GRM7;GRID2;GRM3;GRIA4;GRIK1;GRIK2;GRM5;GRIA2;GRID1;GRM8
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.7851961080515665,1.7943513660743473,0.003179650238473768,0.1397577126117604,0.545,5/15,8.58%,ALDH1A1;ALDH1A2;ALDH1L1;ALDH7A1;ALDH2
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.8006241607769544,1.7753572185488495,0.0016207455429497568,0.15758706521881283,0.642,5/13,8.58%,ALDH1A1;ALDH1A2;ALDH1L1;ALDH7A1;ALDH2
prerank,ligand-gated ion channel activity (GO:0015276),-0.5581924211081137,-1.768049044156419,0.005847953216374269,0.1518646159013979,0.6,10/30,9.66%,GRID2;GRIA4;GRIK1;GRIK2;GRIN2A;GABRB1;GRIN2B;GRIN3A;GRIA2;GRID1
prerank,ligand-gated channel activity (GO:0022834),-0.5624063954898796,-1.76592226921028,0.005763688760806916,0.13797327468808826,0.61,10/29,9.66%,GRID2;GRIA4;GRIK1;GRIK2;GRIN2A;GABRB1;GRIN2B;GRIN3A;GRIA2;GRID1
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.737587609490219,1.7547039768065464,0.006309148264984227,0.18354642824448444,0.759,6/18,5.69%,LTBP1;TGFBR3;BMPR1A;TGFBR1;ACVR1;ENG
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.8068893241383095,1.7500841659068622,0.005154639175257732,0.1736291233102438,0.771,6/12,5.69%,LTBP1;TGFBR3;BMPR1A;TGFBR1;ACVR1;ENG
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.6557104205255793,-1.7472500078912063,0.0070921985815602835,0.15043495861433384,0.675,6/15,13.10%,SLC26A7;SLC26A2;SLC39A8;SLC4A8;SLC26A6;CFTR
prerank,insulin-like growth factor receptor binding (GO:0005159),0.7942925853346476,1.7418286097853757,0.005110732538330494,0.17933538799548382,0.81,4/12,3.29%,IGF1;IGF2;PIK3R1;GNAS
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.6686170181326054,-1.7381420768707376,0.0025974025974025974,0.15076385936312037,0.708,4/14,5.45%,KCNJ2;KCNJ3;KCND3;KCNQ1
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.6360119435517088,-1.7363399333644634,0.006726457399103139,0.1406315943601802,0.711,8/17,8.48%,GRIA4;PTK2B;GRIK1;GRIK2;GRIN2A;GRIN2B;GRIN3A;GRIA2
prerank,ligand-gated anion channel activity (GO:0099095),-0.6430468326240684,-1.7333431823483791,0.018617021276595744,0.13313543213287404,0.723,13/17,23.06%,GABRG3;GABRA2;GABRB3;GLRA1;GABRB1;GABRG2;GLRA2;GABRB2;GABRA3;CFTR;GABRA4;GABRG1;GLRA3
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.7059273807137845,-1.7309420215479097,0.016129032258064516,0.1268768741056279,0.729,4/11,11.84%,PPP1R1A;PPP1R14C;PPP1R14B;PPP1R14A
prerank,retinoic acid binding (GO:0001972),0.7965329496787659,1.7189365399587495,0.0034965034965034965,0.22536555324691177,0.908,2/12,1.88%,CYP26B1;NR2F2
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.6927370236994418,-1.709280945596918,0.01927710843373494,0.146972659334097,0.795,7/12,9.47%,GABRG3;GABRA2;GABRB3;GABRB1;GABRG2;GABRB2;GABRA3
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.7251578729270889,1.7040743920414518,0.015772870662460567,0.2278750208322086,0.936,4/17,2.61%,EPHA3;EPHA7;EPHA4;EPHA8
prerank,ephrin receptor activity (GO:0005003),0.7251578729270889,1.7040743920414518,0.015772870662460567,0.2278750208322086,0.936,4/17,2.61%,EPHA3;EPHA7;EPHA4;EPHA8
prerank,anion transmembrane transporter activity (GO:0008509),-0.6838330672389116,-1.7031191477221024,0.009324009324009324,0.14581045494087147,0.81,4/12,4.23%,ABCG2;SLCO2B1;SLC22A6;SLC39A8
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.5984699860858559,-1.6987790135819318,0.007712082262210797,0.14128377895692013,0.815,8/19,9.66%,GRID2;GABRG3;GRIK1;GRIK2;GABRA2;GABRG2;GABRA3;GRID1
prerank,amino acid binding (GO:0016597),-0.5421515963749843,-1.696745058897455,0.0029498525073746312,0.13609299979807202,0.817,9/31,7.48%,GRM7;NOS3;GLRA1;GLRA2;DDAH1;NOS1;DDAH2;GRIN2B;GRIN3A
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.7823978872127867,1.6825085643421815,0.015306122448979591,0.27260600618142344,0.973,3/11,4.72%,ITPR1;TRPA1;RASA3
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.6597855575802692,-1.6753732041513383,0.014962593516209476,0.1580454650747952,0.887,7/13,18.89%,SH3BP4;CCDC88A;GDI1;ARHGDIA;ARHGDIB;GPSM2;ITGB1BP1
prerank,endopeptidase inhibitor activity (GO:0004866),0.5403392462243686,1.672726530051432,0.006257822277847309,0.2838485246101737,0.978,16/82,7.13%,COL4A3;TIMP3;AHSG;SERPINE1;SERPING1;RECK;FETUB;CAST;SERPIND1;WFDC3;TFPI;SERPINF1;CST3;SERPINH1;CRB2;TIMP2
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.5791340692968902,1.6718462523408766,0.009296148738379814,0.26902596808153545,0.978,20/60,10.17%,EPHA3;NRP1;EPHA7;DDR2;FGFR1;EPHA4;EPHA8;FGFR2;KIT;FGFR4;PDGFRA;PDGFRB;AXL;MUSK;ROR1;NTRK3;EGFR;EPHB2;IGF2R;RYK
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.7491597958329073,1.6681874325140535,0.0156794425087108,0.262570744937687,0.979,2/14,0.18%,SLC7A11;SLC1A3
prerank,lipase activator activity (GO:0060229),0.7965866747643942,1.6676116480459586,0.019434628975265017,0.25042466408308156,0.98,3/10,6.31%,PDPK1;ARHGAP6;SRC
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.5343479754551668,-1.666441060069942,0.012461059190031152,0.1631559908012713,0.905,8/28,9.66%,GRID2;GABRG3;GRIK1;GRIK2;GABRA2;GABRG2;GABRA3;GRID1
prerank,phospholipase activator activity (GO:0016004),0.7968496702039223,1.6635238216183366,0.019230769230769232,0.24856700966355044,0.984,3/10,6.31%,PDPK1;ARHGAP6;SRC
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.6805876113243028,-1.6519446767567703,0.014814814814814815,0.17606041925826943,0.924,3/11,5.45%,KCNJ3;KCND3;KCNQ1
prerank,diacylglycerol kinase activity (GO:0004143),-0.6756367573073789,-1.6414442055712821,0.016203703703703703,0.18566977754078864,0.941,7/11,20.81%,DGKB;DGKH;DGKK;DGKG;DGKQ;DGKZ;DGKI
prerank,BMP binding (GO:0036122),0.7769810711613615,1.6404093135739057,0.018739352640545145,0.3016844160996003,0.994,2/11,5.69%,GREM2;ENG
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.7322464120625976,1.6377911529428193,0.008771929824561403,0.2955138907657903,0.995,6/13,15.57%,BMP6;CDH5;SRC;BMP2;BMP4;BMP5
prerank,calcium:sodium antiporter activity (GO:0005432),0.7758216808573866,1.6267611730551814,0.0341726618705036,0.3135810209137236,0.999,5/10,6.52%,SLC24A3;SLC8A1;SLC8A3;SLC24A1;SLC24A5
prerank,glycerophospholipid flippase activity (GO:0140333),-0.6691805838747246,-1.624365750886383,0.02771362586605081,0.2079409250182278,0.963,4/11,7.23%,ATP8A1;ATP8B1;ATP11C;ATP11A
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.705836947636149,1.623069360510889,0.01437699680511182,0.31081298019325143,0.999,6/18,9.92%,ALDH1A1;AKR1B1;ALDH1A2;ALDH2;ALDH18A1;AKR1B10
prerank,CoA-ligase activity (GO:0016405),0.7094687123084613,1.6147026276409984,0.015254237288135594,0.3221216929602393,0.999,6/14,15.44%,SLC27A5;ACSL1;ACSS3;ACSF3;ACSS2;AACS
prerank,acid-thiol ligase activity (GO:0016878),0.7290481363381794,1.6144674477299659,0.020905923344947737,0.3099691800677428,0.999,7/13,15.44%,SLC27A5;ACSL1;ACSS3;AASDH;ACSF3;ACSS2;AACS
prerank,metallocarboxypeptidase activity (GO:0004181),0.6370580130714681,1.6072496740505562,0.019548872180451128,0.3203348176037444,1.0,7/26,11.69%,CPXM2;AEBP1;VASH2;CPXM1;AGBL2;PEPD;CPA2
prerank,BMP receptor binding (GO:0070700),0.732256170962896,1.6029875202374773,0.012345679012345678,0.32176144897758524,1.0,6/12,15.57%,BMP6;CDH5;SRC;BMP2;BMP4;BMP5
prerank,cation:chloride symporter activity (GO:0015377),-0.6770300904631276,-1.5990898559669926,0.019313304721030045,0.2431389943986518,0.98,5/10,17.73%,SLC12A2;SLC12A7;SLC12A6;SLC12A5;SLC12A8
prerank,alanine transmembrane transporter activity (GO:0022858),-0.6437844685953193,-1.5972648715841393,0.02586206896551724,0.23696131882897084,0.98,5/12,13.96%,SLC6A6;SLC38A5;SLC36A4;SLC3A2;SLC1A4
prerank,mannose binding (GO:0005537),0.7206470085801746,1.5964527569540112,0.04006968641114982,0.3317828916681561,1.0,3/12,5.96%,LMAN2L;LMAN1;COLEC11
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.6010413254946996,-1.5938710517208847,0.030456852791878174,0.23471516339271692,0.983,8/15,12.99%,HS3ST1;HS3ST3A1;NDST3;HS3ST4;HS6ST3;HS3ST5;HS6ST2;HS3ST2
prerank,transforming growth factor beta binding (GO:0050431),0.6409560184732538,1.5886933695596437,0.017080745341614908,0.3417761077655917,1.0,7/23,6.88%,LTBP1;TGFBR3;TGFBR1;TWSG1;ACVR1;ENG;LTBP3
prerank,poly(U) RNA binding (GO:0008266),0.6506328401765538,1.588398153167831,0.035541195476575124,0.3311159256659852,1.0,3/20,1.36%,RBMS1;ATXN1;RBMS3
prerank,phospholipid transfer activity (GO:0120014),-0.5519479461554287,-1.587099280718612,0.03773584905660377,0.23812492802527513,0.986,7/21,8.99%,PITPNC1;CERT1;PLTP;PITPNA;TNFAIP8L3;PLEKHA3;OSBPL2
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.6128490468759732,-1.586368694220139,0.030232558139534883,0.2308708954241369,0.987,5/14,13.83%,SLC26A7;SLC26A2;SLC25A30;SLC26A6;SLC25A11
prerank,poly-pyrimidine tract binding (GO:0008187),0.6223596128908697,1.583818639595553,0.03686635944700461,0.3348751502360958,1.0,3/23,1.36%,RBMS1;ATXN1;RBMS3
prerank,anion:anion antiporter activity (GO:0015301),-0.5815513476774852,-1.5822965450463053,0.025510204081632654,0.22946955245149447,0.987,5/17,13.83%,SLC26A7;SLC26A2;SLC26A6;SLC25A4;SLC25A11
prerank,E-box binding (GO:0070888),0.5941971518105988,1.5787641932015943,0.021337126600284494,0.33839942327057454,1.0,6/34,6.05%,TCF4;MITF;ZEB1;ASCL1;NEUROD1;ATOH8
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.6473608883033392,-1.5756899370503195,0.041666666666666664,0.23240197640600732,0.989,8/12,13.22%,PDE4D;PDE3B;PDE4B;PDE8A;PDE2A;PDE8B;PDE7A;PDE4C
prerank,5'-nucleotidase activity (GO:0008253),-0.6101000850978828,-1.575005757128866,0.030373831775700934,0.22603455830237498,0.99,5/13,19.08%,NT5E;NT5C2;NT5C1A;NT5C;ACP3
prerank,voltage-gated chloride channel activity (GO:0005247),-0.6702008619438093,-1.5711640004077512,0.03736263736263736,0.22579102714830798,0.991,5/10,21.21%,ANO1;CLCN3;CLCN5;ANO6;CLCN4
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.6673934093210865,-1.5626848326474319,0.022332506203473945,0.23305977790358037,0.995,4/10,11.81%,DPP10;FAP;PRCP;DPP6
prerank,GABA-A receptor activity (GO:0004890),-0.5803291162592743,-1.5626771952707104,0.034574468085106384,0.22620507855347508,0.995,7/18,9.47%,GABRG3;GABRA2;GABRB3;GABRB1;GABRG2;GABRB2;GABRA3
prerank,GABA receptor activity (GO:0016917),-0.5531201745127613,-1.5613401803681188,0.0332409972299169,0.2220095211025678,0.995,7/21,9.47%,GABRG3;GABRA2;GABRB3;GABRB1;GABRG2;GABRB2;GABRA3
prerank,receptor ligand activity (GO:0048018),0.4542292791028411,1.5602463736812742,0.0010649627263045794,0.3820173601382597,1.0,28/245,7.07%,IGF1;GREM2;EPHA7;BMP6;IGF2;GDNF;AREG;TGFA;SEMA3D;IL34;IL17D;EPGN;WNT8B;INHBE;WNT4;GAS6;SEMA5A;WNT6;CSF1;APOA1;ENDOU;NTF3;VIP;FAM3B;CCL4;WNT5B;IL12B;TSLP
prerank,muscle alpha-actinin binding (GO:0051371),0.6776409966366718,1.5551919628299913,0.03951890034364261,0.38680181724516116,1.0,4/15,4.65%,PDLIM5;PDLIM2;PALLD;SYNPO2
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.532627150755938,1.5501703473741,0.030065359477124184,0.3915744320980658,1.0,18/60,8.61%,EPHA3;EPHA7;DDR2;FGFR1;EPHA4;EPHA8;FGFR2;KIT;FGFR4;PDGFRA;PDGFRB;ACVR1;AXL;MUSK;ROR1;NTRK3;EGFR;EPHB2
prerank,monocarboxylic acid binding (GO:0033293),0.6500951292600721,1.5498978272016555,0.03542673107890499,0.3816636660461994,1.0,4/18,15.02%,CYP26B1;NR2F2;NAPEPLD;RXRA
prerank,nuclear export signal receptor activity (GO:0005049),0.7004398744364657,1.5492634302360102,0.058925476603119586,0.373426736064434,1.0,5/11,14.43%,RANBP17;NUP42;XPO7;CSE1L;NUP214
prerank,alpha-actinin binding (GO:0051393),0.6178954225900111,1.5460488112937967,0.02865761689291101,0.3733082362615214,1.0,6/24,6.66%,PDLIM5;DAG1;PDLIM2;PALLD;SYNPO2;CACNA1C
prerank,translation elongation factor activity (GO:0003746),-0.6070664351407441,-1.537258865860991,0.040100250626566414,0.2570465448782546,0.998,7/14,14.00%,EEF2;GTPBP1;EIF5A;EIF5AL1;GFM2;EEF1A1;EEF1B2
prerank,protein tyrosine kinase activator activity (GO:0030296),-0.54810328421327,-1.5221049490661012,0.036414565826330535,0.2785820884578022,0.999,7/19,12.77%,EFNA5;AFAP1L2;NRG3;GRM5;DGKQ;PAK2;ERBB3
prerank,amino acid:sodium symporter activity (GO:0005283),0.7002762675076214,1.5204853231164779,0.07460035523978685,0.4420653345007194,1.0,2/11,3.80%,SLC1A3;SLC6A13
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.655715795529543,-1.52012284186537,0.04205607476635514,0.27453719632794293,0.999,4/10,3.99%,SLCO2A1;SLCO1C1;SLCO2B1;SLC22A6
prerank,nucleotidase activity (GO:0008252),-0.5623823309845201,-1.514607170640596,0.04589371980676329,0.27713356641549713,0.999,6/15,22.13%,NT5E;NT5C2;NT5C1A;NT5C;ACP3;BPNT2
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.6369490413335468,-1.5144267725340148,0.06744186046511629,0.27070123080368297,0.999,8/11,27.34%,SGMS1;SGMS2;PTDSS1;SAMD8;PIGO;GNPTAB;PIGN;AASDHPPT
prerank,transcription coactivator binding (GO:0001223),0.6270759490606804,1.5137099472483535,0.04251968503937008,0.45383113118305823,1.0,4/20,3.07%,RORA;SMAD3;AR;THRB
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.5952454642580325,-1.512465957156352,0.05542168674698795,0.26703066221897587,1.0,9/13,23.06%,GABRG3;GABRA2;GLRA1;GABRG2;GLRA2;GABRA3;GABRA4;GABRG1;GLRA3
prerank,inward rectifier potassium channel activity (GO:0005242),-0.5002181917765197,-1.5124005923024482,0.0326975476839237,0.2608395131908736,1.0,12/24,26.86%,KCNJ2;KCNJ3;ABCC9;KCNN2;KCNJ15;KCNJ10;KCNJ8;KCNJ6;ABCC8;KCNJ13;KCNJ16;KCNN1
prerank,ion channel activity (GO:0005216),-0.38722354100840983,-1.504253382515503,0.009345794392523364,0.2702167622213556,1.0,18/80,9.66%,TRPM3;PIEZO2;GRID2;GRIA4;PIEZO1;GRIK1;GRIK2;GRIN2A;ABCC9;MCUB;GABRB1;TRPC1;UNC80;GRIN2B;GRIN3A;TRPM7;GRIA2;GRID1
prerank,calcium-release channel activity (GO:0015278),0.6392055675525657,1.5038364357403025,0.06666666666666667,0.4760976205166525,1.0,3/17,4.72%,ITPR1;TRPA1;RASA3
prerank,acylglycerol lipase activity (GO:0047372),-0.6295235881099182,-1.4992942025421536,0.040380047505938245,0.2728284759692217,1.0,3/11,5.02%,MGLL;ABHD2;LIPE
prerank,gap junction channel activity (GO:0005243),0.6174103813111737,1.4989883864044236,0.05741626794258373,0.48154509431248005,1.0,4/22,6.99%,GJA1;GJB6;GJB2;PANX1
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.5645586259155192,-1.498768331544468,0.036939313984168866,0.2616260149814501,1.0,7/16,21.77%,ANO1;ANO4;TTYH2;ANO3;ANO2;ANO6;NMUR2
prerank,intracellular chloride channel activity (GO:0061778),-0.5645586259155192,-1.498768331544468,0.036939313984168866,0.2616260149814501,1.0,7/16,21.77%,ANO1;ANO4;TTYH2;ANO3;ANO2;ANO6;NMUR2
prerank,phosphatidylglycerol binding (GO:1901611),-0.6027676910006016,-1.4972912864046102,0.06132075471698113,0.25866678175156654,1.0,3/13,3.60%,PITPNC1;PLTP;PITPNA
prerank,semaphorin receptor activity (GO:0017154),0.7208472175837486,1.4939234013349336,0.07394957983193277,0.4867817760030316,1.0,2/11,0.18%,NRP1;PLXNA2
prerank,NAD binding (GO:0051287),0.5946649163811951,1.4911028538001319,0.045941807044410414,0.48451929505299857,1.0,5/26,8.58%,ALDH1A1;CRYL1;SIRT2;NNT;ALDH2
prerank,wide pore channel activity (GO:0022829),0.6121817783297511,1.490799692624644,0.0624,0.4748303886566375,1.0,4/23,6.99%,GJA1;GJB6;GJB2;PANX1
prerank,protein kinase C binding (GO:0005080),0.5370914034643929,1.4852278596067179,0.04878048780487805,0.4821402273749458,1.0,9/43,9.62%,NELL1;PDLIM5;PRKCSH;GRK5;DACT1;TOP2B;PARD6G;PARD6B;ITGAV
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.6503990122753431,1.4840982601987218,0.07859531772575251,0.476089069409448,1.0,2/15,1.08%,SLC1A3;SLC1A5
prerank,endopeptidase activity (GO:0004175),0.43452486480100116,1.4828045957551583,0.004228329809725159,0.47008025388300634,1.0,47/257,14.57%,ADAMTS6;ADAMTS12;ADAMTSL3;TRABD2B;THSD4;ADAMTS10;ADAMTS5;ADAM33;ADAMTS2;ADAMTSL2;MMP2;MMP19;USP11;RHBDL3;SFRP1;CTSH;MMP11;CTSF;USP47;USP20;MMEL1;ADAMTS9;SPRTN;PRSS48;USP35;USP24;USP48;PMPCB;ECE2;EEF1AKMT4-ECE2;APEH;MASP1;CAPN7;CLPP;CASP7;ADAMTSL4;F2;USP30;USP9Y;CTSZ;USP10;USP9X;CTSL;USP38;JMJD7;HPN;THOP1
prerank,insulin-like growth factor binding (GO:0005520),0.6491438354074064,1.4782309716860276,0.09027777777777778,0.4744613050737368,1.0,8/15,12.55%,IGFBP2;IGFBP4;IGFBP5;IGF2R;ITGB3;ITGAV;IGFBP3;INSR
prerank,aminoacyl-tRNA ligase activity (GO:0004812),-0.4421972082250971,-1.4750258382656727,0.056666666666666664,0.2947330890100457,1.0,14/37,22.19%,WARS1;WARS2;LARS1;TARS3;YARS1;YARS2;QARS1;TARS2;KARS1;FARS2;NARS2;MARS2;AARS2;TARS1
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.5139120717605951,1.466712168604662,0.05263157894736842,0.502541881541607,1.0,8/53,6.39%,SLC7A11;SLC1A3;SLC7A2;SLC1A5;SLC6A9;SLC22A2;SLC7A13;SLC38A6
prerank,neuropeptide receptor activity (GO:0008188),-0.4695071387601929,-1.466327333382965,0.06611570247933884,0.3053190631049454,1.0,18/29,40.36%,SORCS2;HCRTR2;NPY1R;SORCS1;GPR37;NPSR1;SORCS3;NPY5R;NMUR2;TACR1;SSTR2;GPR143;NPY2R;SSTR1;NMUR1;NTSR1;NPFFR1;GAL
prerank,endopeptidase regulator activity (GO:0061135),0.5310471812928718,1.4624526168627079,0.056686046511627904,0.5073531655498854,1.0,12/40,15.32%,AHSG;RECK;FETUB;CAST;SERPIND1;TFPI;CST3;RENBP;APH1B;ITIH2;ADRM1;NLRC4
prerank,"DNA binding, bending (GO:0008301)",-0.5622642861273939,-1.4597092840472203,0.05466970387243736,0.3118403486559348,1.0,6/14,20.17%,LEF1;FOXD1;HHEX;TOP2A;HMGB2;HMGA2
prerank,insulin-like growth factor I binding (GO:0031994),0.6535935793614918,1.4595889461018083,0.09824561403508772,0.5069796701117075,1.0,7/13,12.55%,IGFBP2;IGFBP4;IGFBP5;ITGB3;ITGAV;IGFBP3;INSR
prerank,growth factor receptor binding (GO:0070851),0.4615905326887243,1.45946200807111,0.0325,0.49791491902355,1.0,21/95,13.93%,ESM1;PDGFD;AREG;TGFA;IL6R;EPGN;KL;PDGFRA;PDGFRB;FRS2;PIBF1;SRC;IL12B;TSLP;ITGB3;FGF2;TRIP6;HBEGF;EGF;GLMN;ARF4
prerank,organic cation transmembrane transporter activity (GO:0015101),0.6494174567315213,1.4590887352405528,0.08360655737704918,0.4898131478034442,1.0,3/16,7.62%,SLC44A1;SLC22A2;SLC22A4
prerank,phospholipase binding (GO:0043274),0.6597286796936119,1.4556380353252663,0.08433734939759036,0.49235882057584174,1.0,4/13,9.32%,PDPK1;ARHGAP6;SRC;PRKN
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.6508860867837758,1.4555920161626867,0.09197324414715718,0.48382825407481356,1.0,5/14,7.13%,COL4A3;TIMP3;RECK;FETUB;TIMP2
prerank,leak channel activity (GO:0022840),0.6156875051520888,1.4533028401170582,0.07807308970099668,0.48266358735017645,1.0,4/18,6.99%,KCNK2;NALCN;KCNK7;PANX1
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.6808755231381501,1.4524231685600948,0.09306260575296109,0.4771354824860921,1.0,3/11,15.80%,SLC25A24;SLC35B3;LRRC8A
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.6455962682878627,1.4515333374877977,0.06836248012718601,0.47160857910233783,1.0,8/15,20.54%,SETD1A;WDR82;SETD4;KMT2A;WDR5;SETD1B;CXXC1;RBBP5
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.6096476228019602,-1.4502566539288875,0.08275862068965517,0.3242158374249504,1.0,6/10,20.75%,GABRG3;GABRA2;GABRG2;GABRA3;GABRA4;GABRG1
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.5332599606701188,1.4481565846969273,0.060781476121562955,0.47337585059961557,1.0,7/38,6.32%,SERPINE1;SERPING1;SERPIND1;WFDC3;TFPI;SERPINF1;SERPINH1
prerank,carboxypeptidase activity (GO:0004180),0.54905566027271,1.4453479944729275,0.05401459854014599,0.4743798370310415,1.0,9/35,12.70%,CPXM2;AEBP1;VASH2;CPXM1;AGBL2;NAALADL1;PEPD;CPA2;CTSZ
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.5759805744226008,-1.443877713725207,0.06845965770171149,0.3307737691797535,1.0,8/13,13.99%,KCNQ1;PRKAR1A;GSK3A;PRKAR2B;PRKAR1B;CSK;PRKAR2A;RYR2
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.43189720449963387,1.4359527860644907,0.015625,0.49532877711509293,1.0,42/188,15.06%,TCF7L2;ZBTB20;TBL1XR1;PBX1;SMAD3;AR;SOX5;RUNX1;ARID5B;NKX2-1;ARID4A;PRDM5;YAP1;IRF1;CREB3L2;KLF15;BCOR;TCF7;CEBPA;NFE2L2;RNF10;NR1D1;FOXC2;NCOR1;NONO;MZF1;GLIS2;FOXA1;TFAM;CEBPB;REST;PER3;GLI1;ZNF513;HDAC4;TAF9;ETS1;TCF12;GATA6;NR1H3;RXRA;FOXK2
prerank,metalloexopeptidase activity (GO:0008235),0.4981280376566384,1.4349511560862511,0.05312084993359894,0.4902854004193603,1.0,8/51,8.28%,CPXM2;CPQ;AEBP1;VASH2;CPXM1;AGBL2;DPEP1;PEPD
prerank,actin binding (GO:0003779),0.4399907295382038,1.4345298909133362,0.02011173184357542,0.48409798297275025,1.0,31/170,10.12%,PHACTR1;PLEKHH2;MTSS1;PDLIM5;MICAL3;NCALD;CALD1;GSN;SYNE2;DAG1;TLN2;TPM1;PDLIM2;PARVA;SHROOM2;MACF1;VASH2;MYH10;PHACTR2;SYNPO2;IQGAP2;LIMA1;SMTN;LRRK2;VCL;MYL4;CAPZB;ACTN4;PRKN;SYNPO2L;TNNT3
prerank,nuclease activity (GO:0004518),0.49286487590911987,1.434444489366064,0.04551724137931035,0.4768052429094204,1.0,10/52,11.56%,ENPP1;REXO5;SND1;OGG1;REXO4;RNASE12;RNASEL;PARN;DNASE1L1;RNASE7
prerank,cadherin binding (GO:0045296),-0.30669372052194455,-1.4294845317568212,0.0,0.35544902468676565,1.0,88/315,15.11%,PKP4;PTPRB;DOCK9;COBLL1;MRTFB;STXBP6;MPP7;FNBP1L;PTPRJ;CTNND2;ESYT2;CDH2;BAIAP2L1;ITGA6;NOTCH3;PROM1;F11R;CDH1;ANK3;KDR;BSG;TJP2;EPN2;CTNNA3;CEMIP2;TJP1;STK38;HSPA8;IQGAP1;RPL34;CBL;TRPC4;SPTBN1;CDH12;CDH6;RDX;PAICS;UBAP2;EEF2;CDH8;DIAPH3;LRRFIP1;TES;PTPRT;TMOD3;CDH9;FMNL2;HSP90AB1;TAGLN2;CLIC1;HNRNPK;EHD4;EPS8L2;CDH13;ANLN;WASF2;SNX1;PACSIN2;PFKP;LASP1;TRIM25;PCBP1;CLINT1;ABCF3;ALDOA;JUP;CDH10;SH3GLB2;SCRIB;RANGAP1;RPL6;RPL29;BZW2;GLOD4;CCT8;RPL7A;GAPVD1;PAK2;SLC3A2;PPME1;RPL14;PLEC;RUVBL1;EMD;NUMB;GIPC1;MB21D2;PDLIM1
prerank,poly-purine tract binding (GO:0070717),0.5478619164328903,1.4199466352079035,0.0736196319018405,0.5127177299219654,1.0,6/27,10.98%,RBMS1;ATXN1;RBMS3;RBMS2;RBPMS;DDX3X
prerank,rRNA binding (GO:0019843),-0.42177756878499384,-1.4181244237607804,0.03773584905660377,0.37255377648390753,1.0,16/42,21.54%,RPS14;RPS13;RPS3;RPL11;RPS9;CAVIN1;RPS5;MRPS18A;PPAN;RPL5;FASTKD2;RPLP0;MRPS7;RPL23;RRS1;RPF2
prerank,store-operated calcium channel activity (GO:0015279),-0.6012003245143034,-1.4141397579849744,0.10722100656455143,0.37424661331278736,1.0,5/10,13.40%,TRPC3;TRPC4;TRPC5;TRPC1;TRPC6
prerank,nucleotide diphosphatase activity (GO:0004551),0.6337250412818797,1.4136198659923727,0.11371237458193979,0.5255329042742104,1.0,3/14,6.81%,CILP;ENPP1;NUDT13
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.399777304031142,-1.413413494498821,0.03557312252964427,0.36900163155621674,1.0,10/48,7.91%,TRPM3;PIEZO2;SLC12A2;SLC12A7;PIEZO1;ABCC9;TRPC1;UNC80;SLC12A6;TRPM7
prerank,actinin binding (GO:0042805),0.578078012958511,1.4122744712092958,0.09292035398230089,0.52168165181913,1.0,6/21,9.65%,PDLIM5;DAG1;SYNPO2;CSRP2;CACNA1C;CSRP3
prerank,hormone activity (GO:0005179),0.49027057231121984,1.40714377378387,0.06455862977602109,0.5292192328052506,1.0,3/54,8.44%,IGF1;VIP;NPFF
prerank,cell adhesion mediator activity (GO:0098631),-0.46521052498039595,-1.4048938290417046,0.07853403141361257,0.38165144047081,1.0,9/24,10.50%,ESAM;BSG;CNTN4;NTNG1;SIRPA;CNTN6;LRRC4C;ROBO4;EMB
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.47648250712162665,1.4020729826768314,0.0701058201058201,0.5366853097468581,1.0,16/60,17.46%,LRRK1;PPM1H;PPM1E;CTDSPL;PPP3CA;LRRK2;MTMR3;RPAP2;CTDSP2;PPP1R3C;PHLPP2;PTEN;PPP1R3D;PPM1G;UBLCP1;DUSP4
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.4445823607273382,-1.3993401887754917,0.08282208588957055,0.38760715440837756,1.0,9/32,22.20%,KCNB2;KCNQ5;KCNQ1;KCNC2;KCNQ3;KCNA2;KCNS3;KCNC1;KCNC4
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.44892617231072807,-1.398634313616682,0.062111801242236024,0.3822046087949085,1.0,16/31,28.98%,SLC12A2;SLC12A7;KCNK5;ABCC9;SLC12A6;KCNK10;KCNA2;SLC12A5;SLC12A8;HCN1;TMEM38B;KCNC4;ABCC8;KCNK4;SLC12A9;AQP1
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.4587339913800328,-1.3919549382623602,0.06769230769230769,0.3902283604500601,1.0,12/26,28.27%,PPP1R1A;PPP1R14C;PTN;PPP1R14B;MGAT5;PPP1R14A;PPME1;LMTK2;CABIN1;PPP1R11;PPP1R1B;SET
prerank,transforming growth factor beta receptor binding (GO:0005160),0.5921143883869409,1.3902926971582201,0.11932773109243698,0.5668271629717273,1.0,4/18,5.69%,TGFBR3;SMAD3;TGFBR1;ENG
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.45852286334672326,1.3826023837916224,0.05172413793103448,0.5827560953281865,1.0,16/72,12.44%,FRMPD4;SVIL;ACTN2;GSN;MARK1;TULP1;PLCD1;MYO1B;ADAP2;TULP3;SNX18;PICALM;COMMD1;GSDME;SNX21;SYTL2
prerank,LRR domain binding (GO:0030275),0.6157538956942223,1.3789304014319974,0.12220309810671257,0.5874890219927994,1.0,2/14,7.36%,ROBO1;PMF1
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.6123496033688577,1.378535589725039,0.141156462585034,0.5807252127169127,1.0,4/14,8.24%,PYCR1;MTHFR;PYCR3;ALDH1L1
prerank,sulfuric ester hydrolase activity (GO:0008484),0.6314536189967308,1.3779480105623847,0.12411347517730496,0.5749107442555919,1.0,3/12,4.23%,SULF2;SULF1;GALNS
prerank,heme binding (GO:0020037),0.4614656929790099,1.3761129699427794,0.06940874035989718,0.5728869716324928,1.0,16/65,13.12%,PTGIS;CYP26B1;CYB5B;TDO2;FLVCR2;CYP1B1;SRC;HEBP1;CYP27A1;NR1D1;CYB5A;SDHC;PGRMC2;SLC48A1;CYB5R4;NOX4
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.44955734954920834,-1.3759341322810204,0.07567567567567568,0.4189771151477567,1.0,10/27,15.86%,SLC26A7;SLC26A2;ANO1;SLC22A8;SLC22A6;SLC39A8;SLC25A30;SLC26A6;SLC25A11;XPR1
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.63887776435313,1.3744443379145672,0.151618398637138,0.5703450984339575,1.0,3/12,15.80%,SLC25A24;SLC35B3;LRRC8A
prerank,copper ion binding (GO:0005507),0.4972040964008952,1.374102627815585,0.09590973201692525,0.5640657898751945,1.0,4/42,4.99%,PAM;MOXD1;MT3;HEPH
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.41799120307637433,-1.3724023474624296,0.0657439446366782,0.419974769344128,1.0,18/35,28.13%,TAF1B;RRN3;TAF1;BAZ2A;TBP;FOXP1;TAF1C;UBTF;H3-3A;AGO1;NPM1;GTF2B;TAF4;SMARCA4;RUVBL2;PIH1D1;FOS;TBPL1
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.4780458182676338,-1.3683858683921328,0.1,0.42201519477300464,1.0,12/21,15.16%,PDE5A;PDE4D;PDE3B;PDE4B;PDE8A;PDE2A;PDE1C;PDE8B;PDE9A;PDE7A;PDE4C;PDE6A
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.5571789228902521,-1.3656300827005667,0.12168141592920353,0.4213112494939838,1.0,4/12,16.69%,ENTPD1;ENTPD2;ENTPD6;ENTPD3
prerank,peptidase inhibitor activity (GO:0030414),0.5101441974114117,1.3656028003664515,0.09985315712187959,0.5827203659920067,1.0,10/33,12.57%,AHSG;RECK;FETUB;CAST;SERPIND1;TFPI;CST3;TIMP2;RENBP;ITIH2
prerank,protein heterodimerization activity (GO:0046982),0.4073202601002485,1.3650080111668634,0.039647577092511016,0.5771871471728053,1.0,39/178,13.51%,TCF4;BMP6;ADRA1B;ARNT2;ATP1A2;BCL2;TPM1;ITGA3;IRAK2;ZHX2;NEUROD1;MIGA2;EPAS1;ADRA2C;BDKRB2;BUD23;IL12B;AGTR1;ATP1B2;TLR6;TOP2B;IRAK3;ZBTB1;KATNB1;KRT10;ARNT;MICU2;EXT1;BHLHE41;ADRA2A;KATNA1;RRAGD;NR4A1;YWHAE;MTTP;TUBB2B;TPM2;TRMT112;P4HB
prerank,O-methyltransferase activity (GO:0008171),0.6495294931833847,1.3631427411936903,0.16206261510128914,0.5759269995942663,1.0,5/10,15.38%,COMT;FTSJ3;LRTOMT;BCDIN3D;CMTR2
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.5964480606722417,1.3603599346896231,0.11980033277870217,0.5694720537883737,1.0,1/16,0.20%,ATP6V0A4
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.5964480606722417,1.3603599346896231,0.11980033277870217,0.5694720537883737,1.0,1/16,0.20%,ATP6V0A4
prerank,cytokine receptor activity (GO:0004896),0.4408545217859261,1.3597695920074357,0.07954545454545454,0.564403632131196,1.0,14/83,10.10%,GHR;IL31RA;IL6R;LEPR;GFRA2;OSMR;XCR1;ACKR2;CCR9;IL12B;IL13RA1;IL15RA;CNTFR;GFRA4
prerank,P-type ion transporter activity (GO:0015662),-0.5580774124980151,-1.3579703633492752,0.1261061946902655,0.4328741919476009,1.0,5/12,11.81%,ATP2C1;ATP2A3;ATP2B2;ATP2B4;ATP7A
prerank,growth factor activity (GO:0008083),0.45593104714974264,1.357609849126985,0.08862433862433862,0.5643655527573698,1.0,16/74,14.20%,IGF2;GDNF;AREG;TGFA;EPGN;CSF1;ENDOU;NTF3;IL12B;CSPG5;FGF2;HBEGF;F2;EGF;NRTN;MDK
prerank,pseudouridine synthase activity (GO:0009982),0.6196119075863845,1.35732855229514,0.1400329489291598,0.5585695804501002,1.0,6/13,18.89%,PUS3;RPUSD4;RPUSD2;TRUB2;PUSL1;TRUB1
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.4870403582986436,-1.35485889637211,0.1341772151898734,0.4334239921240257,1.0,9/17,17.77%,PITPNC1;ATP8B1;PLTP;PITPNA;ABCG1;PCTP;PITPNB;ATP10A;ABCB4
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.4640300380185532,-1.3507023366454587,0.10541310541310542,0.43660505513568043,1.0,12/23,15.16%,PDE5A;PDE4D;PDE3B;PDE4B;PDE8A;PDE2A;PDE1C;PDE8B;PDE9A;PDE7A;PDE4C;PDE6A
prerank,lipoprotein particle receptor binding (GO:0070325),0.5377823399505877,1.3498892319948768,0.11290322580645161,0.5738989160938129,1.0,5/27,9.03%,LRP1;HSPG2;APOE;APOA1;PICALM
prerank,pyridoxal phosphate binding (GO:0030170),0.5526382008034232,1.3481232904491356,0.12709030100334448,0.5728908042310136,1.0,5/20,15.79%,ABAT;ACCS;PDXK;PYGM;PYGB
prerank,fatty acid synthase activity (GO:0004312),-0.5761531305572835,-1.3472419573343388,0.11697247706422019,0.43773600368030213,1.0,2/10,5.34%,ELOVL7;ELOVL5
prerank,poly(A) binding (GO:0008143),0.5507909437156338,1.3465127333574238,0.12871287128712872,0.5710516183293053,1.0,5/21,10.98%,RBMS1;RBMS3;RBMS2;RBPMS;DDX3X
prerank,cyclic nucleotide binding (GO:0030551),-0.46023220469793114,-1.3449233315149707,0.10863509749303621,0.4365846068464695,1.0,4/21,4.96%,PDE5A;PDE4D;PDE4B;PDE2A
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.5021727074249336,1.3375075082007861,0.13333333333333333,0.5913053207612422,1.0,16/34,21.72%,IGF2;PARP16;MAP2K1;CKS1B;ALS2;STK4;SPRY2;CCNK;DDX3X;STRADA;CCNT2;RICTOR;ETAA1;MLST8;TAOK1;CCNT1
prerank,CoA hydrolase activity (GO:0016289),0.5890533858872768,1.3333739434379057,0.14597315436241612,0.5973017553378238,1.0,4/16,5.14%,ACOT11;ACOT6;ACOT2;NUDT7
prerank,tRNA methyltransferase activity (GO:0008175),0.5752752092304995,1.330191477257183,0.14890016920473773,0.5996851670286427,1.0,6/16,15.13%,TRMT44;BCDIN3D;TRMT9B;TRMT13;THUMPD3;THUMPD2
prerank,fibroblast growth factor binding (GO:0017134),0.5439250133363526,1.328600507459424,0.1547049441786284,0.5980504005803716,1.0,9/21,15.81%,FGFR1;KL;FGFR2;FGFR4;GLG1;ITGB3;ITGAV;CXCL13;FIBP
prerank,lipid phosphatase activity (GO:0042577),0.5980672278524042,1.3285311072020685,0.13402061855670103,0.5919024150179485,1.0,3/14,3.03%,PLPP3;EPHX2;PLPP7
prerank,active ion transmembrane transporter activity (GO:0022853),-0.3995655039557123,-1.3236830266594948,0.09210526315789473,0.48073164099364973,1.0,18/37,25.88%,SLCO2A1;SLCO1C1;SLC22A8;SLCO2B1;SLC22A6;COX4I1;UQCRH;COX6A1;COX5B;SLCO4A1;COX5A;SLCO1B1;UQCR10;COX8A;UQCR11;UQCRQ;UQCRC1;UQCRFS1
prerank,GDP binding (GO:0019003),-0.3588023483721571,-1.323276940137173,0.08455882352941177,0.47479908866738413,1.0,16/63,14.30%,RAP1A;RIT2;RAB27A;KRAS;RAB21;RAP1B;RAB5B;RAB12;RAB8B;RAB27B;ARL3;RASL12;DIRAS2;RALB;RIT1;RAB4A
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.4482767631507429,-1.3200364214551539,0.13872832369942195,0.47579059350557495,1.0,8/26,9.96%,SLC6A6;ABCG2;SLC16A6;SLC5A6;SLC16A9;SLC16A1;SLC16A4;SLC26A6
prerank,mechanosensitive ion channel activity (GO:0008381),-0.5339741043233257,-1.3175203596870164,0.15594059405940594,0.4752041733373496,1.0,2/12,1.56%,PIEZO2;PIEZO1
prerank,amino acid transmembrane transporter activity (GO:0015171),0.46750096411814784,1.3170732204879374,0.1270718232044199,0.6192830952912475,1.0,11/47,9.72%,SLC7A11;SLC7A2;SLC1A5;SLC6A13;SLC22A2;SLC7A13;PDPN;SLC38A6;SLC22A4;SLC38A9;SLC43A1
prerank,protein kinase activator activity (GO:0030295),0.4479714241234535,1.3159336792284433,0.12980132450331125,0.6161411766500869,1.0,19/60,14.24%,IGF2;PRKAG2;GAS6;MT3;GPRC5D;PARP16;MAP2K1;ALS2;STK4;SPRY2;STK11;FGF13;DDX3X;RGCC;STRADA;DUSP19;WNK1;MARK2;GPRC5A
prerank,pre-mRNA binding (GO:0036002),0.500657307582959,1.3149504441571889,0.13808801213960548,0.6130640398365791,1.0,11/28,23.07%,CELF2;U2AF1L4;RBM22;HNRNPA1;ERI1;RNPC3;RBM41;HNRNPU;RBM4;ZRSR2;PRPF8
prerank,DNA-binding transcription factor binding (GO:0140297),0.3987468751359237,1.3148332382346415,0.04955947136563876,0.6070885221440809,1.0,28/189,10.62%,TCF7L2;LDB2;FHL2;RUNX1T1;SMAD3;AR;BCL2;DACT1;PRRX1;PRDM5;ASCL1;YAP1;TLE1;CRTC3;NEUROD1;TBX3;SKI;SIK1;NFE2L2;MTA2;RERE;RBPJ;NCOR1;MTA3;IFI27;CXXC5;RBL2;NEK6
prerank,ligand-gated calcium channel activity (GO:0099604),0.5565021031559914,1.3105737157863124,0.15481832543443919,0.6139019809643227,1.0,4/19,9.40%,ITPR1;TRPA1;RASA3;TRPM4
prerank,kinase activator activity (GO:0019209),0.49939457089520717,1.3091402959143832,0.15137614678899083,0.6123493332519606,1.0,12/30,16.24%,PRKAG2;MT3;GPRC5D;STK11;FGF13;RGCC;STRADA;DUSP19;WNK1;MARK2;GPRC5A;AGAP2
prerank,calcium channel inhibitor activity (GO:0019855),0.6209342777064536,1.3069965658036387,0.17264957264957265,0.6127489560771402,1.0,1/11,0.27%,ITPR1
prerank,metal ion:proton antiporter activity (GO:0051139),-0.5181521444201238,-1.3059966255276148,0.15048543689320387,0.4962085738874452,1.0,5/13,8.53%,SLC9A2;SLC9B2;SLC9A6;LETM1;SLC9A7
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.5133849250366967,1.3004720507914982,0.16717325227963525,0.6259659275507219,1.0,11/27,22.64%,POLR2D;POLR3A;POLR2C;POLRMT;PRIMPOL;POLR2L;POLR1F;MED21;POLR1H;POLR1D;POLR1C
prerank,neuropeptide binding (GO:0042923),-0.4689935477555054,-1.29415509426435,0.16137566137566137,0.5191114786008975,1.0,11/18,44.51%,SORL1;GPR37;NMUR2;SSTR2;MC4R;SSTR1;OPRD1;NMUR1;GPR149;OPRM1;SSTR3
prerank,calcium channel activity (GO:0005262),0.4221266573484318,1.293392420658413,0.11446540880503145,0.6411482091228541,1.0,13/84,10.48%,CACNA2D3;SLC24A3;SLC24A1;MCU;CACNB1;SLC24A5;CACNA1C;PANX1;CUL5;ORAI2;TRPM4;ITGAV;ANXA6
prerank,potassium channel activity (GO:0005267),-0.33336284073611866,-1.2924626900696137,0.04522613065326633,0.5161201011624433,1.0,18/89,9.58%,KCNB2;KCNK5;KCNQ5;KCND2;GRIK1;GRIK2;KCNMA1;KCND3;ABCC9;KCNK13;KCNN2;KCNQ1;KCNH7;KCNH5;KCNC2;KCNMB2;KCNK10;KCNQ3
prerank,glycine binding (GO:0016594),-0.5392971827871275,-1.2924443598534772,0.1550561797752809,0.5094475561388561,1.0,4/11,7.48%,GLRA1;GLRA2;GRIN2B;GRIN3A
prerank,transcription cis-regulatory region binding (GO:0000976),0.3727643277768674,1.2922016156706124,0.02063983488132095,0.6384690497930863,1.0,78/406,15.85%,TCF7L2;ZBTB20;RORA;TBL1XR1;TRPS1;TEAD1;PBX1;SMAD3;AR;SOX5;RUNX1;GLI3;AEBP1;ARID5B;NKX2-1;ARID4A;PRDM5;ASCL1;YAP1;MLXIP;MXI1;MSC;IRF1;RFX5;CREB3L2;KLF15;ETV6;EPAS1;CUX2;ZBTB8B;BCOR;TCF7;NR5A1;CEBPA;NFE2L2;RNF10;SREBF1;DR1;NR1D1;OSR1;BBX;FOXC2;NCOR1;ZBTB4;NONO;MZF1;ACTN4;GLIS2;ARNT;CREB3;FOXA1;TFAM;RBL2;ZBTB8A;ZNF177;CEBPB;POLRMT;NFE2;REST;PER3;GLI1;STAT6;ZNF513;HOXC8;HDAC4;TAF9;ETS1;TWIST2;TCF12;GATA6;NR1H3;ZNF25;RXRA;FOXK2;PSPC1;MTF1;TFCP2;ZBTB17
prerank,FMN binding (GO:0010181),-0.5278377246923519,-1.291891048173306,0.15348837209302327,0.5042179059840102,1.0,8/11,37.61%,NOS3;NOS1;MTRR;NOS2;PPCDC;NDOR1;HAO1;DUS2
prerank,steroid hydroxylase activity (GO:0008395),0.5579286587209297,1.2917689680811288,0.20261437908496732,0.6336351390820281,1.0,5/16,18.27%,CYP7B1;CYP1B1;CYP27A1;CYP2R1;CYP1A1
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.5248747733359026,-1.290949161102407,0.16626506024096385,0.49975589112984253,1.0,5/12,8.53%,SLC9A2;SLC9B2;SLC9A6;LETM1;SLC9A7
prerank,protein tyrosine kinase activity (GO:0004713),0.4069032869172817,1.288993304128642,0.10253317249698432,0.63554235423289,1.0,22/108,10.43%,EPHA3;EPHA7;DDR2;LYN;FGFR1;EPHA4;EPHA8;FGFR2;KIT;FGFR4;PDGFRA;PDGFRB;AXL;MUSK;ROR1;SRC;NTRK3;EGFR;EPHB2;RYK;BAZ1B;TTBK1
prerank,ligand-gated cation channel activity (GO:0099094),-0.33014532341637387,-1.2869883761543168,0.07352941176470588,0.5033414834242009,1.0,12/75,8.48%,KCNJ2;GRIA4;PTK2B;GRIK1;GRIK2;GRIN2A;KCNJ3;P2RX7;KCNN2;GRIN2B;GRIN3A;GRIA2
prerank,nucleoside monophosphate kinase activity (GO:0050145),-0.45493503401842694,-1.2866090246130573,0.14092140921409213,0.49781898639809286,1.0,5/20,10.53%,DLG2;TJP2;MAGI3;AK6;MPP1
prerank,receptor tyrosine kinase binding (GO:0030971),0.4420751257569171,1.286222101615911,0.145578231292517,0.6376106980841564,1.0,7/56,5.04%,ANGPT1;CBLB;PIK3R1;DOCK4;GAS6;ANGPT2;FRS2
prerank,voltage-gated calcium channel activity (GO:0005245),0.4789208149487032,1.2857119498171825,0.15223880597014924,0.6331393949257305,1.0,5/37,11.33%,CACNA2D3;CACNB1;CACNA1C;ITGAV;CACNA1G
prerank,bHLH transcription factor binding (GO:0043425),0.548844856896385,1.2855667320750492,0.18971061093247588,0.6277003134624229,1.0,3/19,3.20%,FHL2;SMAD3;ASCL1
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.5855251763250627,1.2818767068422476,0.2182741116751269,0.6321886590416693,1.0,2/12,5.04%,PIK3R1;FRS2
prerank,mRNA 3'-UTR binding (GO:0003730),0.42094244127753244,1.2813252585687689,0.1411042944785276,0.6280025104595609,1.0,13/79,12.75%,CELF2;RBMS1;RBMS3;CSDC2;IGF2BP2;CPEB1;ZFP36L1;CPEB3;RBMS2;PARN;SERBP1;LARP1;UTP23
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.6037728041872705,1.2766299164147146,0.2202797202797203,0.6361842133942467,1.0,5/11,18.25%,CASP12;CFLAR;CASP7;CASP9;CASP1
prerank,calcium activated cation channel activity (GO:0005227),-0.46473568196715215,-1.2765754988999531,0.17048346055979643,0.5158721555691824,1.0,7/17,16.55%,ANO1;KCNMA1;KCNN2;KCNMB2;TMEM63C;TMEM63B;ANO6
prerank,tau-protein kinase activity (GO:0050321),0.5341663665603099,1.2741578092327253,0.19601328903654486,0.6380236357258455,1.0,6/20,15.26%,ROCK2;MARK1;BRSK1;TTBK1;MARK2;DYRK1A
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.41164489120003517,1.273818884040336,0.12157330154946365,0.6334146525570588,1.0,22/91,15.76%,FRMPD4;SVIL;ACTN2;GSN;MARK1;TULP1;PLCD1;MYO1B;SH3PXD2B;ADAP2;TULP3;SNX18;PICALM;COMMD1;GSDME;SNX21;SYTL2;WIPI1;PIRT;PARD3;GSDMD;LAPTM4B
prerank,FAD binding (GO:0071949),0.5188456384721721,1.2737371994825972,0.20933734939759036,0.6281057085201257,1.0,5/24,8.94%,MICAL3;MTHFR;DDO;SQOR;AIFM1
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.6151409426148154,1.2731024922379153,0.22807017543859648,0.624324597336375,1.0,5/10,18.25%,CASP12;CFLAR;CASP7;CASP9;CASP1
prerank,kinase inhibitor activity (GO:0019210),0.48476947010688365,1.271027215459351,0.15963855421686746,0.6248488931348777,1.0,7/33,12.36%,RHOH;AHSG;PARVA;ITPRIP;DNAJC3;TAOK3;DUSP19
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.6174592449365959,1.270293258523438,0.2177858439201452,0.6218576883550928,1.0,3/10,11.21%,DSE;RENBP;GALM
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.6060673461863545,1.2702373130117288,0.2261682242990654,0.6167704639452436,1.0,2/11,9.92%,AKR1B1;AKR1B10
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.5910308193092163,1.2679279281037497,0.21525423728813559,0.618260046992768,1.0,6/10,23.03%,KAT2B;HEXIM2;INCA1;CDKN2C;CDKN1B;HEXIM1
prerank,sulfotransferase activity (GO:0008146),0.48835392357936597,1.2605648127379179,0.18666666666666668,0.6335323183090472,1.0,5/33,4.60%,UST;GAL3ST2;GAL3ST3;TPST1;HS6ST1
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.5621960202578883,1.2603209176386216,0.21453287197231835,0.62900725401457,1.0,2/14,7.28%,DHRS3;ADH1A
prerank,magnesium ion binding (GO:0000287),0.3836203462566181,1.2560945971464075,0.11744186046511627,0.6354517788258656,1.0,42/135,22.17%,EYA2;ADCY2;MARK1;CIB4;EPHX2;MVK;MAP3K20;PDXK;LRRK2;ADPRH;SIK1;BRSK1;DXO;OXSR1;MAST2;STK4;IRAK3;CLYBL;IDH2;STK11;NEK6;TDP2;RAP2A;MARK2;PSPH;CERK;FOXK2;NLRC4;RP2;DYRK3;GNAI1;ENDOV;RHEB;FAN1;EXD2;OPA1;NUDT5;NUDT12;PGM1;PPA1;PAPOLA;PPA2
prerank,glutathione transferase activity (GO:0004364),0.5208369780518711,1.2540928422436575,0.19534883720930232,0.6358862723828405,1.0,6/23,13.89%,PTGES;GSTM4;GSTM2;MGST1;GSTT1;GSTK1
prerank,ATPase binding (GO:0051117),0.4223448280717029,1.252931122398035,0.16559691912708602,0.6341313966616826,1.0,17/71,13.83%,ATP6V0A4;AR;ABCA1;TMTC4;PPP3CA;ANK1;DERL1;SRC;ATP1B2;SLC2A13;EGFR;ATP6V1E1;CLPP;TOR1AIP1;SELENOS;PTPN3;TAF9
prerank,5'-3' RNA polymerase activity (GO:0034062),0.4885860003718549,1.2502143228206404,0.21020092735703247,0.6367636310268515,1.0,10/27,22.64%,POLR2D;POLR3A;POLR2C;POLRMT;POLR2L;POLR1F;MED21;POLR1H;POLR1D;POLR1C
prerank,ubiquitin protein ligase activity (GO:0061630),0.37065112184878507,1.2457364465066225,0.0966702470461869,0.6445803700554337,1.0,60/228,18.73%,MYCBP2;RNF220;PDZRN3;HECW2;CBLB;SH3RF3;PELI2;SH3RF1;DCST1;MGRN1;UBR2;NEDD4;RFFL;SMURF2;BFAR;CDC42;ZNRF3;KCMF1;UBE4B;RNF10;TRIP12;DTX4;RNF185;RNF139;RNF145;UBR4;UBOX5;PRKN;ITCH;RNF181;ASB12;RNF6;RNF38;RNF152;RNFT1;RNF217;MUL1;RNF19A;RC3H2;AMFR;UBE2D1;ASB1;HACE1;HUWE1;RNF13;HLTF;RNF2;NHLRC3;UBR5;MSL2;UBR3;UBE3B;RNF138;UBE3A;RNF135;DTX3;RC3H1;RNF34;TRIM41;TRIM32
prerank,SH3 domain binding (GO:0017124),-0.33832633944761487,-1.244966844570989,0.11290322580645161,0.5884549541542309,1.0,14/62,10.26%,AFAP1L1;SHANK3;SGIP1;ELMO1;AFAP1L2;ENAH;ADAM12;ADAM15;CBL;ARHGAP27;PTPN12;WASF2;SHANK1;SKAP1
prerank,dynactin binding (GO:0034452),-0.5051092086289073,-1.2444471810362419,0.19759036144578312,0.5826999671473975,1.0,6/12,26.86%,BICD1;PAFAH1B1;BICDL1;BICD2;GSK3B;SPTBN5
prerank,channel activity (GO:0015267),0.4499739559435987,1.2422073419383421,0.17414965986394557,0.6488420592902261,1.0,8/41,13.13%,TRPA1;BCL2;PDPN;PANX1;AQP6;P2RX5;KCNK3;TMEM120B
prerank,gated channel activity (GO:0022836),-0.4828434846642115,-1.2417884398321895,0.20103092783505155,0.582723504636603,1.0,2/14,1.56%,PIEZO2;PIEZO1
prerank,protein serine/threonine kinase activity (GO:0004674),0.35396783129517884,1.2403737083624116,0.06645898234683281,0.6489714033891281,1.0,71/335,16.01%,STK17B;DAPK2;PDPK1;NRK;ROCK2;CDK14;CAMK1D;CDK8;DAPK1;GRK3;GRK5;BMPR1A;DMPK;MARK1;MYLK;TGFBR1;IRAK2;MAPK4;ACVR1;CDK16;SBK3;PRKAA2;MAP3K20;CASK;NUAK1;ULK2;LRRK2;AKT3;SIK1;EIF2AK3;BRSK1;MAP2K1;ARAF;OXSR1;MAST2;STK4;IRAK3;EGFR;MAP3K8;MAP4K4;CCNK;CAMK2B;VRK3;STK11;TTBK1;NEK6;BRAF;TAOK3;IKBKE;TBK1;TLK1;WNK1;MAP3K13;RIPK2;MAP3K15;MAP4K5;ACVR1B;STK16;MARK2;MOK;PIK3R4;CDK12;RIOK3;CLK4;PLK2;CLK3;DYRK1A;PIKFYVE;DYRK1B;MAPKAPK2;TRIO
prerank,outward rectifier potassium channel activity (GO:0015271),0.5740579834121187,1.2375257757185907,0.23978685612788633,0.6513028639298817,1.0,2/11,2.60%,KCNK2;KCNT2
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.5040458603234211,1.2346414232594096,0.2198473282442748,0.6542066959686242,1.0,4/22,6.70%,RBMS3;CPEB1;ZFP36L1;CPEB3
prerank,MHC class II protein complex binding (GO:0023026),-0.5185728117588371,-1.2334003189060536,0.2206896551724138,0.5970634234357665,1.0,4/11,12.70%,HSPA8;ATP1B1;HSP90AB1;CD81
prerank,carboxylic acid binding (GO:0031406),-0.36938711296660004,-1.2317033376683153,0.175,0.5948420650272782,1.0,15/38,25.36%,GRM7;NOS3;GLRA1;GLRA2;NOS1;GRIN2B;GRIN3A;GLUD1;MAG;GCLC;RTN4R;GRIN1;GLRA3;EPDR1;SHMT1
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.34783280373302594,1.2316032129876517,0.02834008097165992,0.6580235851542799,1.0,149/730,17.25%,TCF7L2;TCF4;ZBTB20;NFIA;RORA;ZFHX4;TEAD1;PBX1;SMAD3;ARNT2;PKNOX2;AR;ZKSCAN2;ZEB2;SOX5;MITF;GLIS3;NKX6-1;NR2F2;GLI2;RUNX1;PRRX1;SALL1;KCNIP3;ZIC1;SP7;IKZF2;MAF;GLI3;ZEB1;NKX2-1;THRB;PRDM5;FOXP2;NFIB;ASCL1;DNMT3A;JDP2;RUNX2;SIX5;MLXIP;RARB;ZIC4;NFIX;MXI1;MEOX2;IKZF4;MSC;IRF1;ZIC2;NEUROD4;RFX5;ZNF83;NEUROD1;CREB3L2;KLF15;RARG;TBX3;SP4;HLF;BCL6;SKI;TCF7;ATOH8;HES7;ZNF483;ZNF23;NR5A1;BATF;CEBPA;NFE2L2;SREBF1;ZBTB38;ZBTB24;MED8;NR1D1;RBPJ;TCF7L1;FOXC2;CHD2;HIVEP2;STAT5B;ZBTB4;HOXC5;ZBTB1;MZF1;SMAD1;GMEB1;GTF2IRD1;STAT2;GLIS2;NSD1;ARNT;CREB3L4;CREB3;FOXA1;ZKSCAN3;ZSCAN21;NR1D2;SP5;CEBPB;KLF9;BHLHE41;NFE2;NKX2-8;ZBTB37;ZFP30;REST;NR4A1;GLI1;STAT6;TEAD3;MYCN;NPAS2;EBF1;STAT4;ZNF182;HDAC4;HIVEP1;ETS1;ZNF148;ZNF383;ZNF219;TCF12;HOXD1;GATA6;NR1H3;HOXC4;RXRA;FOXK2;MYT1;MTF1;TFCP2;ZBTB17;ZNF585B;ZNF585A;MAFA;MXD4;EBF4;CREB5;PLAG1;ZNF423;FOXO6;SP1;ZFAT;MYBL1;IRF2;ZSCAN20;FOXJ3
prerank,GTPase regulator activity (GO:0030695),0.36981661623955264,1.230684659816593,0.09425785482123511,0.6556021129079145,1.0,36/212,9.80%,ALDH1A1;NRP1;ASAP1;RIN2;ERRFI1;RHOH;RABGAP1L;TBC1D4;SYDE2;DLC1;ARHGAP28;USP6NL;ARHGEF10L;ARHGAP18;NPRL3;ARHGAP29;ASAP3;RAPGEF2;IQGAP2;ARHGAP19;SMAP2;ARHGAP32;ARHGAP10;ACAP2;ARFGAP3;LRRK2;ADPRH;ARHGAP35;ALS2;ARHGAP9;ARRB1;ARL2;RUNDC3A;SYDE1;SEC23B;TBC1D2B
prerank,pentosyltransferase activity (GO:0016763),0.4631034913057901,1.2306049336824245,0.21304347826086956,0.6508803515303165,1.0,12/36,19.42%,ART4;PARP11;LARGE1;LARGE2;PARP16;SIRT2;PARP14;TNKS2;UPP2;LACC1;SIRT5;PPAT
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.4973395755644801,-1.2291240734613005,0.23284313725490197,0.5945411519395396,1.0,5/12,14.26%,PIK3R6;IPMK;PIK3R3;PIK3C2B;PIK3CA
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.34688920962272646,1.2290550903077915,0.029292929292929294,0.6502361505260409,1.0,148/731,17.25%,TCF7L2;TCF4;ZBTB20;NFIA;RORA;ZFHX4;TEAD1;PBX1;SMAD3;ARNT2;PKNOX2;AR;ZKSCAN2;ZEB2;SOX5;MITF;GLIS3;NKX6-1;NR2F2;GLI2;RUNX1;PRRX1;SALL1;KCNIP3;ZIC1;SP7;IKZF2;MAF;GLI3;ZEB1;NKX2-1;THRB;PRDM5;FOXP2;NFIB;ASCL1;DNMT3A;JDP2;RUNX2;SIX5;MLXIP;RARB;ZIC4;NFIX;MXI1;MEOX2;IKZF4;MSC;IRF1;ZIC2;NEUROD4;RFX5;ZNF83;NEUROD1;KLF15;RARG;TBX3;SP4;HLF;BCL6;SKI;TCF7;ATOH8;HES7;ZNF483;ZNF23;NR5A1;BATF;CEBPA;NFE2L2;SREBF1;ZBTB38;ZBTB24;MED8;NR1D1;RBPJ;TCF7L1;FOXC2;CHD2;HIVEP2;STAT5B;ZBTB4;HOXC5;ZBTB1;MZF1;SMAD1;GMEB1;GTF2IRD1;STAT2;GLIS2;NSD1;ARNT;CREB3L4;CREB3;FOXA1;ZKSCAN3;ZSCAN21;NR1D2;SP5;CEBPB;KLF9;BHLHE41;NFE2;NKX2-8;ZBTB37;ZFP30;REST;NR4A1;GLI1;STAT6;TEAD3;MYCN;NPAS2;EBF1;STAT4;ZNF182;HDAC4;HIVEP1;ETS1;ZNF148;ZNF383;ZNF219;TCF12;HOXD1;GATA6;NR1H3;HOXC4;RXRA;FOXK2;MYT1;MTF1;TFCP2;ZBTB17;ZNF585B;ZNF585A;MAFA;MXD4;EBF4;CREB5;PLAG1;ZNF423;FOXO6;SP1;ZFAT;MYBL1;IRF2;ZSCAN20;FOXJ3
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.5701370113228216,1.2290018316943108,0.2634228187919463,0.6456030888141775,1.0,7/12,24.05%,TENT5A;TENT5D;TENT4A;TENT4B;PAPOLG;PAPOLA;PAPOLB
prerank,cytokine activity (GO:0005125),0.37649521413575665,1.2286725277705073,0.1368909512761021,0.6418127831109355,1.0,19/131,11.11%,BMP6;IL34;IL17D;WNT8B;INHBE;WNT4;WNT6;CCL19;CSF1;CXCL16;FAM3B;CCL4;WNT5B;IL12B;TSLP;BMP2;FGF2;BMP15;IFNK
prerank,potassium channel regulator activity (GO:0015459),-0.34874528876437216,-1.2286314838948447,0.15725806451612903,0.588923076535974,1.0,10/49,11.81%,DPP10;KCNIP4;KCNAB1;NEDD4L;ABCC9;KCNMB2;SGK1;WNK2;ADRB2;DPP6
prerank,chemokine binding (GO:0019956),0.46491273851862913,1.2279439089860953,0.21609538002980627,0.6390459220970821,1.0,8/30,12.78%,XCR1;ACKR2;CCR9;PDPN;ITGB3;ITGAV;FGF2;CXCR6
prerank,histone demethylase activity (GO:0032452),0.49079400936641543,1.2270113361961976,0.2405446293494705,0.6368984334060932,1.0,13/27,23.22%,FBXL19;KDM5B;PHF2;KDM5C;KDM7A;PHF8;RIOX1;KDM3B;KDM4A;KDM5A;KDM4C;JARID2;KDM3A
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.36390871722518653,1.2268367225220351,0.11595744680851064,0.6328199584127081,1.0,59/232,18.73%,MYCBP2;RNF220;PDZRN3;HECW2;CBLB;SH3RF3;PELI2;SH3RF1;DCST1;MGRN1;UBR2;NEDD4;RFFL;SMURF2;BFAR;CDC42;ZNRF3;KCMF1;RNF10;TRIP12;DTX4;RNF185;RNF139;RNF145;UBR4;PRKN;ITCH;RNF181;ASB12;RNF6;RNF38;RNF152;UFL1;RNFT1;RNF217;MUL1;RNF19A;RC3H2;AMFR;UBE2D1;ASB1;HACE1;HUWE1;RNF13;HLTF;RNF2;NHLRC3;UBR5;MSL2;UBR3;UBE3B;RNF138;UBE3A;RNF135;DTX3;RC3H1;RNF34;TRIM41;TRIM32
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.5859862815331783,1.2264860558804473,0.27191413237924866,0.6292083620897304,1.0,5/10,21.12%,KDM7A;PHF8;RIOX1;KDM4A;KDM4C
prerank,DNA binding (GO:0003677),0.3456010392311191,1.2258520326499527,0.026078234704112337,0.6264857154277162,1.0,136/694,15.70%,TCF7L2;TCF4;POLR2D;RBMS1;RORA;TEAD1;PBX1;SMAD3;ZEB2;C1D;BCL2;NR2F2;GLI2;SP7;ARID5B;NKX2-1;ARID4A;THRB;PRDM5;FOXP2;NFIB;DNMT3A;PDS5B;NUPR1;RARB;ZIC4;OGG1;MEOX2;RLF;APLP2;IRF1;ZIC2;RFX5;NEUROD1;RARG;LIG4;DENND4A;TBX3;SP4;EPAS1;HLF;BCL6;CUX2;COLEC11;GTF3C1;HES7;SHOC1;INO80;SMARCA1;RAD51B;DMC1;CUL4B;NR5A1;SPRTN;BATF;CEBPA;NFE2L2;POLG;DDX60;SREBF1;SNAPC1;REXO4;DCLRE1C;TSHZ2;TET1;POLL;RBPJ;LIN9;TCF7L1;FOXC2;SAFB2;CHD2;KDM5B;HIVEP2;NHEJ1;EGFR;MLH1;ZBTB4;AIFM1;HNRNPA1;SPATA24;SMC6;ARNT;FOXA1;ZKSCAN3;PHF1;TFAM;CXXC5;DNASE1L1;MBD1;CENPC;DNASE2;DDX3X;CEBPB;POLRMT;NFE2;TDP2;CCDC25;SPDEF;NKX2-8;DCLRE1A;RAD18;NR4A1;MBD4;MCM2;GLI1;CAMTA1;ZNF513;MYCN;NPAS2;HDAC4;TAF9;RC3H2;ETS1;HMCES;ZNF148;RAD51D;ZNF219;POGK;YAF2;SNAPC4;NR1H3;FUBP3;RBM5;RXRA;FOXK2;HUWE1;RBM6;SAP30L;SMARCB1;TSHZ1;HDGFL3;CAMTA2;MTF1;TFCP2;RTF2
prerank,cGMP binding (GO:0030553),-0.5060115987611187,-1.2257799587425577,0.20293398533007334,0.5892522157050205,1.0,2/11,4.96%,PDE5A;PDE2A
prerank,lipase activity (GO:0016298),-0.3605678197043764,-1.223634185205501,0.16967509025270758,0.5881120808512865,1.0,16/43,27.50%,MGLL;ABHD2;LIPE;PLA1A;PNPLA8;PNPLA3;PNPLA2;ABHD6;PITPNM3;DAGLB;LYPLA1;LIPH;LIPC;LIPA;FAAH;LPL
prerank,transcription coregulator binding (GO:0001221),0.428035083112316,1.2214781091701317,0.20855614973262032,0.6339286419235155,1.0,11/50,12.00%,RORA;SMAD3;AR;THRB;CHD6;USP11;NR1D1;FAM89B;PHF1;NEK6;PER3
prerank,sequence-specific mRNA binding (GO:1990825),-0.515092757924694,-1.2212796102258012,0.2199546485260771,0.5873011838438807,1.0,5/10,25.42%,DHFR;TYMS;DHX9;RBM24;FMR1
prerank,cysteine-type endopeptidase activity (GO:0004197),0.40430172112780843,1.2208115714008625,0.19099756690997566,0.6315352496617944,1.0,27/78,21.18%,CASP12;CFLAR;USP11;SFRP1;CTSH;CTSF;USP47;USP20;USP35;USP24;USP48;CASP7;USP30;USP9Y;CTSZ;USP10;USP9X;CTSL;USP38;CASP9;CASP1;USP49;CAPN15;USP46;USP37;PIGK;UCHL1
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.34241476952705874,1.2158221572262822,0.027054108216432865,0.6407978458666672,1.0,165/830,17.25%,TCF7L2;TCF4;ZBTB20;NFIA;RORA;ZFHX4;TRPS1;TEAD1;PBX1;SMAD3;ARNT2;PKNOX2;AR;ZKSCAN2;ZEB2;SOX5;MITF;GLIS3;NKX6-1;NR2F2;GLI2;RUNX1;PRRX1;SALL1;KCNIP3;ZIC1;SP7;IKZF2;MAF;GLI3;AEBP1;ZEB1;NKX2-1;THRB;PRDM5;FOXP2;NFIB;ASCL1;DNMT3A;JDP2;RUNX2;SIX5;MLXIP;RARB;ZIC4;NFIX;MXI1;MEOX2;IKZF4;MSC;IRF1;ZIC2;NEUROD4;RFX5;ZNF83;NEUROD1;KLF15;RARG;ETV6;TBX3;SP4;EPAS1;HLF;BCL6;CUX2;ZBTB8B;SKI;TCF7;ATOH8;HES7;ZNF483;ZNF23;NR5A1;BATF;CEBPA;NFE2L2;SREBF1;ZBTB38;ZBTB24;MED8;NR1D1;OSR1;BBX;RBPJ;TCF7L1;FOXC2;CHD2;HIVEP2;STAT5B;ZBTB4;HOXC5;ZBTB1;MZF1;SMAD1;GMEB1;ACTN4;GTF2IRD1;STAT2;GLIS2;NSD1;ARNT;CREB3L4;CREB3;FOXA1;ZKSCAN3;ZSCAN21;NR1D2;RBL2;SP5;ZBTB8A;ZNF177;CEBPB;KLF9;BHLHE41;NFE2;NKX2-8;ZBTB37;ZFP30;REST;NR4A1;GLI1;STAT6;TEAD3;MYCN;NPAS2;HOXC8;EBF1;STAT4;ZNF182;HDAC4;HIVEP1;ETS1;ZNF148;ZNF383;ZNF219;TWIST2;TCF12;HOXD1;GATA6;NR1H3;ZNF25;HOXC4;RXRA;FOXK2;MYT1;MTF1;TFCP2;ZBTB17;ZNF585B;ZNF585A;MAFA;MXD4;EBF4;CREB5;PLAG1;ZNF423;ATF5;TFDP1;FOXO6;SP1;ZFAT;MYBL1;IRF2;ZSCAN20;FOXJ3
prerank,ATP binding (GO:0005524),0.35314988214273996,1.2106672047028944,0.10471204188481675,0.6500840410603596,1.0,48/266,14.37%,STK17B;DAPK2;ENPP1;DAPK1;KSR1;ABCA1;ATP1A2;BMPR1A;DMPK;MARK1;MLKL;PRKAG2;TGFBR1;MYO18A;MYH10;MYO1B;ACVR1;LIG4;MVK;OAS2;RHOBTB3;MAP3K20;PDXK;AKT3;SIK1;BRSK1;OXSR1;CLPX;MAST2;STK4;IRAK3;MAP4K4;ABCB9;STK11;NEK6;PEX6;ABCE1;P2RX5;TLK1;WNK1;INSR;MAP4K5;ACVR1B;MTREX;MARK2;HSPA9;ABCD2;RTEL1
prerank,phosphotyrosine residue binding (GO:0001784),-0.36709288160788384,-1.2058264680477662,0.19344262295081968,0.6220342541601224,1.0,12/37,19.03%,YES1;PLCG2;SHE;SHC3;BCAR3;SHB;PIK3R3;PTPN6;RASA1;NCK2;PTPN5;FGR
prerank,protein tyrosine kinase binding (GO:1990782),0.3994968952868151,1.2057075558578707,0.2092426187419769,0.6589636556462627,1.0,10/71,6.47%,ANGPT1;CBLB;DOCK4;NEDD9;EPHA4;GAS6;ANGPT2;ACVR1;CDH5;CD247
prerank,cytokine receptor binding (GO:0005126),0.39188859007718313,1.205055073746046,0.19035532994923857,0.6562802312855713,1.0,11/83,7.33%,TGFBR3;SMAD3;IL6R;IL34;OSMR;CCL19;CSF1;PIBF1;IL12B;TSLP;IL13RA1
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.34152962827589667,1.2040971119136943,0.05337361530715005,0.6544561108313354,1.0,101/597,15.06%,TCF7L2;TCF4;ZBTB20;TBL1XR1;TEAD1;PBX1;SMAD3;ARNT2;PKNOX2;AR;SOX5;GLI2;RUNX1;ZIC1;MAF;GLI3;ARID5B;NKX2-1;ARID4A;THRB;PRDM5;NFIB;ASCL1;YAP1;JDP2;RUNX2;RARB;ZIC4;NFIX;LBX2;MEOX2;MSC;TSPYL2;IRF1;RFX5;NEUROD1;CREB3L2;KLF15;RARG;TBX3;HLF;BCL6;CUX2;BCOR;TCF7;HES7;ZNF23;ZW10;NR5A1;BATF;CEBPA;NFE2L2;MBD2;RNF10;SREBF1;NR1D1;OSR1;BBX;TCF7L1;FOXC2;NCOR1;KDM5B;NONO;MZF1;GMEB1;GLIS2;ARNT;CREB3L4;CREB3;FOXA1;TFAM;NR1D2;CENPC;ZNF177;CEBPB;BHLHE41;NFE2;SPDEF;NKX2-8;ZBTB37;REST;NR4A1;PER3;MBD4;MCM2;GLI1;ZNF513;MYCN;NPAS2;HOXC8;HDAC4;TAF9;HIVEP1;ETS1;TCF12;HOXD1;GATA6;NR1H3;HOXC4;RXRA;FOXK2
prerank,calcium ion binding (GO:0005509),0.34919741574537466,1.2036315233646537,0.09885535900104059,0.6513441762533947,1.0,46/323,10.63%,ITPR1;FBN1;PAM;CLEC3B;ENPP1;CDH11;SLC8A1;GSN;PLSCR2;ADGRV1;SPARC;LRP1;GJB2;MAN1C1;PPP3CA;CIB4;ASPH;MCTP2;STIM1;FBLN1;RAPGEF2;SLC25A24;PLA2G4A;BAIAP3;SMOC2;CDH5;COLEC11;TNNC1;CABCOCO1;DCHS1;SCUBE1;RCN1;SYT9;NAALADL1;FKBP9;PLSCR4;ANXA3;TRPM4;S100A11;MICU2;MASP1;SLIT3;SLIT1;ANXA6;PCDHB8;BRAF
prerank,calcium-activated potassium channel activity (GO:0015269),-0.5039603836061676,-1.2035437145948977,0.24390243902439024,0.6216991662392215,1.0,3/11,7.52%,KCNMA1;KCNN2;KCNMB2
prerank,cation transmembrane transporter activity (GO:0008324),0.4288055116478341,1.2016213899933454,0.23140495867768596,0.6522989858785256,1.0,7/48,6.39%,SLC7A2;SLC1A5;SLC41A1;SLC6A9;SLC22A2;SFXN2;SLC38A6
prerank,solute:anion antiporter activity (GO:0140323),0.544242434737982,1.2009664585684707,0.2759226713532513,0.6498022963178292,1.0,1/14,0.10%,SLC7A11
prerank,TBP-class protein binding (GO:0017025),-0.4091387360913239,-1.1978265629714873,0.22408963585434175,0.6301548488932467,1.0,10/21,26.08%,ESR1;TAF1B;TAF1;HHEX;GTF2A2;RUVBL1;YEATS2;GTF2B;THRA;RUVBL2
prerank,MAP-kinase scaffold activity (GO:0005078),0.5768323147012328,1.1972416188075854,0.2882882882882883,0.655242170714064,1.0,6/11,16.84%,KSR1;SH3RF1;MAP2K1;DUSP19;AKAP13;MAPK8IP3
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.5171058632822135,1.1957840674610591,0.26776859504132233,0.6547977365163292,1.0,3/15,5.27%,XCR1;ACKR2;CCR9
prerank,GTPase activator activity (GO:0005096),0.34619931200097254,1.1925442187688533,0.12421711899791232,0.6595032389967133,1.0,53/313,9.80%,ALDH1A1;NRP1;ASAP1;RIN2;MYCBP2;ERRFI1;RABGAP1L;TBC1D4;FARP1;RAPGEF4;SYDE2;DLC1;DOCK4;ARHGAP28;DOCK10;RCBTB2;USP6NL;ARHGEF10L;DOCK11;ARHGAP18;IQSEC2;DENND2A;NPRL3;ARHGAP29;ASAP3;FGD1;RAPGEF2;IQGAP2;FGD4;ARHGAP19;DENND4A;SMAP2;ARHGAP32;ARHGAP10;ARFGEF2;ACAP2;ARFGAP3;LRRK2;ADPRH;ARHGEF17;DOCK5;DENND5A;ARHGEF18;ARHGAP35;ALS2;ARHGAP9;RGL1;ARRB1;ARHGEF11;SYDE1;RAPGEF1;SEC23B;TBC1D2B
prerank,R-SMAD binding (GO:0070412),0.4990254462373408,1.1923942348040235,0.28805237315875615,0.6557099029864585,1.0,3/18,3.16%,SMAD3;LDLRAD4;PMEPA1
prerank,RNA cap binding (GO:0000339),-0.44985880978506726,-1.1917766114395318,0.21428571428571427,0.6397108512125728,1.0,7/16,21.59%,EIF4E;EIF4A1;CYFIP2;EIF4E2;SNUPN;EIF3D;DCPS
prerank,myosin V binding (GO:0031489),-0.45489546116008467,-1.1901559765350687,0.23017902813299232,0.6373871192047659,1.0,8/15,25.56%,RAB6A;RAB3C;RAB11A;RAB27B;RAB6B;RAB3A;RAB14;RAB39B
prerank,secondary active transmembrane transporter activity (GO:0015291),-0.33841348910838026,-1.1900563989282105,0.18518518518518517,0.6312047079238403,1.0,11/51,9.35%,SLCO2A1;SLCO1C1;SLC7A5;SLC22A8;SLCO2B1;CLCN3;SLC5A6;SLC22A6;MFSD2A;SLC35E4;SLC25A30
prerank,disordered domain specific binding (GO:0097718),-0.4129544868823513,-1.1900409828960985,0.23076923076923078,0.6248996341371216,1.0,4/23,10.38%,FN1;HSP90AB1;CALM1;CALM3
prerank,voltage-gated potassium channel activity (GO:0005249),-0.3091385042687477,-1.1899912669074861,0.1388888888888889,0.6187089911544059,1.0,12/80,6.21%,KCNB2;KCNJ2;KCNQ5;KCND2;KCNJ3;KCNMA1;KCND3;KCNN2;KCNQ1;KCNH7;KCNH5;KCNC2
prerank,alkali metal ion binding (GO:0031420),0.5341011518906246,1.1869818576671383,0.2926829268292683,0.6661863341578804,1.0,4/13,13.78%,ATP1A2;PDXK;ADPRH;HDAC4
prerank,adenyl ribonucleotide binding (GO:0032559),0.3445436213862511,1.1835877482321833,0.13564668769716087,0.6708231150650718,1.0,52/291,14.37%,STK17B;DAPK2;ENPP1;DAPK1;KSR1;RAPGEF4;ABCA1;ATP1A2;BMPR1A;MPPED2;DMPK;MARK1;MLKL;PRKAG2;TGFBR1;MYO18A;MYH10;MYO1B;RAPGEF2;ACVR1;LIG4;MVK;OAS2;RHOBTB3;MAP3K20;PDXK;AKT3;SIK1;BRSK1;OXSR1;CLPX;MAST2;STK4;IRAK3;MAP4K4;ABCB9;STK11;NEK6;PEX6;ABCE1;P2RX5;TLK1;WNK1;INSR;MAP4K5;ACVR1B;MTREX;MARK2;HSPA9;ABCD2;ACSS2;RTEL1
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.4582329950036808,-1.181075877657458,0.24630541871921183,0.6353005265126911,1.0,5/14,15.80%,OTUD7B;MINDY2;MINDY1;YOD1;USP15
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",-0.4904582548650345,-1.1803014513730539,0.27292576419213976,0.6311888294589,1.0,10/11,50.99%,DDAH1;DDAH2;PADI2;ARG2;ARG1;PADI1;PADI4;AGMAT;PADI3;PADI6
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.46594850652510894,1.1764163483826315,0.26865671641791045,0.6854253904884842,1.0,4/27,3.89%,SLC8A1;SLC8A3;SLC41A1;SLC9A9
prerank,potassium ion leak channel activity (GO:0022841),0.5091178683240657,1.1764117423864082,0.285,0.6811472033200086,1.0,2/15,6.18%,KCNK2;KCNK7
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.45750929437828236,-1.1762766278904924,0.26246719160104987,0.635451079636436,1.0,4/14,6.54%,NOD1;MAL;BCL2L13;ATP2A3
prerank,metal ion binding (GO:0046872),0.33455121131663357,1.1735694783167716,0.10590631364562118,0.6846437285200083,1.0,69/477,10.63%,ITPR1;FBN1;PAM;CLEC3B;ENPP1;EYA2;ADCY2;CDH11;SLC8A1;GSN;PLSCR2;ADGRV1;SPARC;LRP1;GJB2;MARK1;MAN1C1;PPP3CA;CIB4;EPHX2;ASPH;HMGCLL1;APOE;MCTP2;STIM1;FBLN1;RAPGEF2;MT3;SLC25A24;MVK;PLA2G4A;BAIAP3;SMOC2;MAP3K20;CDH5;COLEC11;PDXK;TNNC1;LRRK2;ADPRH;SIK1;CABCOCO1;DCHS1;BRSK1;SCUBE1;RCN1;DXO;SYT9;OXSR1;NAALADL1;FKBP9;MAST2;STK4;IRAK3;PLSCR4;ANXA3;CLYBL;TRPM4;IDH2;S100A11;STK11;MICU2;MASP1;SLIT3;SLIT1;ANXA6;PCDHB8;NEK6;BRAF
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.5098048455060497,-1.1725714789424062,0.2785714285714286,0.6383745218933586,1.0,3/10,10.35%,MECOM;PRDM16;SUV39H1
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.40635974045594797,1.1707738605263165,0.2541208791208791,0.6874980928259741,1.0,7/55,7.30%,ITPR1;SLC24A3;SLC24A1;MCU;SLC24A5;PANX1;CUL5
prerank,semaphorin receptor binding (GO:0030215),-0.3985874278493211,-1.1698838488727572,0.22284122562674094,0.6392971675806745,1.0,8/23,12.61%,SEMA6D;SEMA6A;SEMA7A;RIT2;SEMA5B;SEMA3G;SEMA3C;SEMA4B
prerank,frizzled binding (GO:0005109),0.4384582302135981,1.1698149617837479,0.2776957163958641,0.685740216595063,1.0,8/34,10.17%,WNT8B;WNT4;WNT6;FZD1;SFRP1;ZNRF3;WNT5B;RYK
prerank,sodium:proton antiporter activity (GO:0015385),-0.48437901678621154,-1.1697365822907027,0.2672811059907834,0.6336954548653042,1.0,4/11,8.53%,SLC9A2;SLC9B2;SLC9A6;SLC9A7
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.4683894049771505,1.1651712662812,0.2754946727549467,0.6935824431327222,1.0,6/25,13.39%,ART4;PARP11;PARP16;SIRT2;PARP14;TNKS2
prerank,protein tyrosine phosphatase activity (GO:0004725),-0.30382279751799146,-1.1568963491435034,0.16666666666666666,0.6609199565870493,1.0,25/71,18.02%,PTPRB;PTPRG;PTPRJ;UBASH3B;PTPN14;PTPRE;PTPRD;PTPRK;PTPN12;DUSP22;PTPN2;ACP1;PTPRT;PTP4A2;CDC14A;PTPN22;MTMR6;HACD2;DUSP11;PTPN6;PTPRN;PTPRC;PALD1;DUSP23;PTPN5
prerank,adrenergic receptor binding (GO:0031690),0.5038163215161059,1.156424434556065,0.31686541737649065,0.7138129332752627,1.0,6/16,13.99%,GNAS;NEDD4;RAPGEF2;ADRA2C;ADRA2A;DLG4
prerank,sequence-specific DNA binding (GO:0043565),0.329688174009723,1.1563849203761138,0.10595358224016145,0.7096286644855336,1.0,80/590,11.67%,TCF7L2;TCF4;ZBTB20;RORA;TEAD1;PBX1;SMAD3;ARNT2;PKNOX2;ZEB2;BCL2;NR2F2;GLI2;ZIC1;MAF;GLI3;THRB;PRDM5;FOXP2;NFIB;ASCL1;JDP2;RUNX2;RARB;ZIC4;NFIX;LBX2;FBXL19;MEOX2;MSC;RFX5;NEUROD1;KLF15;RARG;TBX3;SP4;EPAS1;HLF;BCL6;CUX2;TCF7;HES7;ZNF23;NR5A1;BATF;NFE2L2;MBD2;SREBF1;SNAPC1;ZBTB38;NR1D1;OSR1;BBX;TET1;RBPJ;TCF7L1;FOXC2;SAFB2;KDM5B;ZBTB4;GMEB1;GLIS2;ARNT;TELO2;CREB3L4;CREB3;FOXA1;ZKSCAN3;TFAM;CXXC5;NR1D2;MBD1;ZNF177;CEBPB;POLRMT;BHLHE41;NFE2;SPDEF;NKX2-8;ZBTB37
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),-0.361090440798604,-1.1559369008411857,0.23964497041420119,0.6575991273393581,1.0,9/35,11.94%,TEC;YES1;PTK2B;BMX;CLK1;PKDCC;CSK;PEAK1;FES
prerank,death receptor activity (GO:0005035),-0.4779322920795243,-1.1541850207927797,0.2942477876106195,0.6556669034858087,1.0,2/11,3.04%,TNFRSF11A;TNFRSF19
prerank,transition metal ion binding (GO:0046914),0.330744226812586,1.1532689407601728,0.16462167689161555,0.7138321690511747,1.0,96/397,19.71%,PAPPA;MYCBP2;PAM;MOXD1;AGMO;ENPP1;ADAM33;ADCY2;CBLB;SEC24D;SMAD3;GLI2;MSRB3;MPPED2;ZEB1;SLC30A8;FBXL19;IKZF4;LARGE1;MT3;ENDOU;HPF1;HEPH;SKI;LARGE2;PDXK;SLC11A2;RBSN;B4GALT1;DPEP1;TIMP2;ADH1A;SIRT2;TRAF7;NAALADL1;TET1;KDM5B;COMMD1;BBOX1;PRKN;NSD1;TIMM9;BAZ1B;PHF2;CXXC5;MBD1;KDM5C;ABCE1;TDP2;CPA2;NAPEPLD;MNAT1;CDA;KMT2A;SEC23A;HDAC4;NFU1;KDM7A;PHF8;CXXC4;RXRA;SAP30L;CYP2R1;RASSF1;DPP3;MYT1;MELTF;RNF2;RIOX1;COA6;SORD;AOX1;ZDHHC20;SHH;PIM1;PRIMPOL;GLO1;LACC1;DUSP12;SEC24A;HHIP;DHX58;RC3H1;POLR2L;KPNB1;SOD3;RABIF;SMPDL3B;FDX1;SIRT5;KDM4A;SCD;TET3;MDM4;CDADC1;IDE
prerank,MAP kinase kinase kinase activity (GO:0004709),0.5323895113613364,1.1527171445241815,0.2987249544626594,0.711337768148668,1.0,4/11,12.69%,MAP3K20;EGFR;MAP3K13;MAP3K15
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.5233025527907874,1.1491637685315483,0.3086206896551724,0.7166785325241558,1.0,3/13,9.33%,HSD3B2;ECI1;IDI1
prerank,ubiquitin conjugating enzyme activity (GO:0061631),-0.36886189427149724,-1.1490300033114782,0.26666666666666666,0.6631381774646807,1.0,12/31,21.28%,UBE2G1;UBE2J1;UBE2H;TAF1;UBE2D3;UBE2K;UBE2B;UBE2G2;AKTIP;UBE2S;UBE2QL1;UBE2O
prerank,iron ion binding (GO:0005506),0.4048372662177237,1.1487475658808808,0.2569832402234637,0.7136528530425933,1.0,19/48,20.13%,AGMO;HEPH;TET1;PHF2;CDO1;ABCE1;NFU1;KDM7A;PHF8;EGLN1;CYP2R1;MELTF;RIOX1;AOX1;PHYH;ALKBH1;FDX1;SCD;FTO
prerank,Notch binding (GO:0005112),-0.3906926757715527,-1.14695964572517,0.2774869109947644,0.6623053636825891,1.0,12/22,21.91%,CCN3;DNER;JAG2;NOTCH4;SNW1;GALNT11;KCTD10;DLL4;CUL3;DLL1;MEGF10;DTX1
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.49853316781932416,1.14489875291648,0.32053422370617696,0.7194261935697319,1.0,3/16,10.38%,TDO2;ALOXE3;CDO1
prerank,SH2 domain binding (GO:0042169),0.4337291056037473,1.1436333190121715,0.29112081513828236,0.7185326930432678,1.0,5/31,6.31%,DAG1;AFAP1;DLC1;SH3PXD2B;SRC
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.4674247021172605,1.1418020809449778,0.30818619582664525,0.7191787889440527,1.0,1/22,0.20%,ATP6V0A4
prerank,I-SMAD binding (GO:0070411),0.5137203479521042,1.1412422128283455,0.3240901213171577,0.7165502720550865,1.0,3/13,9.23%,SMAD3;TGFBR1;SMAD1
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.4321096671198065,1.1393657231783083,0.3005952380952381,0.7170172234161737,1.0,15/32,21.12%,PHYHD1;TET1;BBOX1;P4HTM;JMJD7;KDM7A;PHF8;EGLN1;RIOX1;PHYH;ALKBH1;KDM4A;TET3;FTO;KDM4C
prerank,RNA methyltransferase activity (GO:0008173),0.4721888545494226,1.1346471097052802,0.3378151260504202,0.7251717150141062,1.0,9/19,28.00%,FTSJ3;BCDIN3D;TRMT9B;TRMT13;METTL4;METTL3;TRMT12;TYW3;MEPCE
prerank,metalloaminopeptidase activity (GO:0070006),-0.42482367624129524,-1.132056708737207,0.2824427480916031,0.6958742222115585,1.0,7/16,25.66%,XPNPEP3;MMP15;RNPEPL1;MMP16;TRHDE;LNPEP;NPEPPS
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.4064092274367983,1.1305166974538545,0.29508196721311475,0.7316617782671636,1.0,19/42,24.01%,CCNA2;CKS1B;KAT2B;CCNK;HEXIM2;INCA1;CCNL2;CCNL1;CNPPD1;CCNQ;CDKN2C;CCNT2;CDKN1B;CCND2;CCNT1;CCNG2;HEXIM1;CCNY;CCNE2
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.32816102885605913,-1.12893178787135,0.2679738562091503,0.6982056823362289,1.0,12/42,10.50%,STXBP6;BAIAP2L1;ESAM;BSG;CNTN4;NTNG1;TMOD3;SIRPA;CNTN6;LRRC4C;ROBO4;EMB
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.3643704355752584,-1.1287602022522765,0.2807570977917981,0.6924598560473602,1.0,6/27,10.96%,RNF144B;RNF144A;RNF125;SIAH1;SIAH3;DCUN1D4
prerank,epidermal growth factor receptor binding (GO:0005154),0.44873023580593013,1.1262050100888177,0.32216905901116427,0.7388555035813728,1.0,6/25,13.93%,AREG;TGFA;EPGN;HBEGF;EGF;ARF4
prerank,organic anion transmembrane transporter activity (GO:0008514),0.34978883095454955,1.1261924155856342,0.2485345838218054,0.7347636186715705,1.0,15/134,6.39%,SLC1A3;SLC7A2;GJA1;SLC1A5;SLC16A12;SLC13A3;SLC6A9;SLC6A13;SLC2A10;SLC25A24;SFXN2;PDPN;SLCO3A1;SLC35A3;SLC38A6
prerank,zinc ion binding (GO:0008270),0.32880403268001174,1.1253804229931077,0.23084994753410285,0.7330363227650464,1.0,72/293,19.71%,PAPPA;MYCBP2;PAM;ENPP1;ADAM33;CBLB;SEC24D;SMAD3;GLI2;MSRB3;ZEB1;SLC30A8;FBXL19;IKZF4;MT3;HPF1;SKI;PDXK;RBSN;DPEP1;TIMP2;ADH1A;SIRT2;TRAF7;NAALADL1;TET1;KDM5B;BBOX1;PRKN;NSD1;TIMM9;BAZ1B;PHF2;CXXC5;MBD1;KDM5C;CPA2;NAPEPLD;MNAT1;CDA;KMT2A;SEC23A;HDAC4;KDM7A;PHF8;CXXC4;RXRA;SAP30L;RASSF1;DPP3;MYT1;RNF2;SORD;ZDHHC20;SHH;PRIMPOL;GLO1;DUSP12;SEC24A;HHIP;DHX58;RC3H1;POLR2L;KPNB1;RABIF;SMPDL3B;SIRT5;KDM4A;TET3;MDM4;CDADC1;IDE
prerank,carboxylic ester hydrolase activity (GO:0052689),-0.28566223847171546,-1.1250818829861118,0.23979591836734693,0.6967593991691785,1.0,33/85,28.62%,ENPP2;MGLL;ABHD2;NDST3;PLA2G7;LIPE;PNPLA7;BCHE;PAFAH1B2;PLAAT3;PNPLA3;PLA2G4C;TARS2;PNPLA2;ABHD6;PNPLA6;LYPLA2;DAGLB;AARS2;PLA2G4F;LYPLA1;PLA2G4E;AOAH;GDPD1;ABHD4;PLAAT1;LIPC;PLA2G4B;LIPA;FAAH;LPL;PGAP1;PON3
prerank,sialyltransferase activity (GO:0008373),-0.38562421667192237,-1.1204409287200314,0.30971128608923887,0.7030573625618395,1.0,4/20,0.97%,ST6GALNAC3;ST3GAL6;ST8SIA4;ST6GAL1
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.4477631544457279,-1.1201244386583538,0.3125,0.6978961945887866,1.0,7/12,28.13%,TAF1;TBP;H3-3A;GTF2B;RUVBL2;FOS;TBPL1
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.4664949597105629,-1.1186701481956072,0.3333333333333333,0.6959280895674603,1.0,2/11,4.78%,LEF1;GATA2
prerank,ATP hydrolysis activity (GO:0140603),0.4057115292862316,1.1171290798425324,0.33655172413793105,0.7506080618711699,1.0,14/41,17.80%,MYO18A;RNF213;RHOBTB3;SHOC1;CLPX;DDX3X;MYO1E;ABCA3;ABCD2;TOR1B;SMCHD1;ABCB6;DDX4;TOR3A
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.37382003699751265,-1.1163719458630705,0.3002680965147453,0.6958368319292265,1.0,4/23,5.85%,PLCE1;EDNRA;PLCG2;CHRM3
prerank,adenylate cyclase binding (GO:0008179),0.5391372266792045,1.11341921405137,0.3527336860670194,0.7565637804263419,1.0,2/10,2.63%,ADCY2;ADCY5
prerank,solute:sodium symporter activity (GO:0015370),-0.3562939985237568,-1.1128520806887094,0.28212290502793297,0.6991413156134353,1.0,3/27,8.29%,SLC4A10;SLC5A6;SLC4A8
prerank,small GTPase binding (GO:0031267),0.340142386171938,1.1113833860553537,0.2799552071668533,0.7580822908699265,1.0,40/170,15.14%,MYCBP2;RHOH;RABGAP1L;RAPGEF4;ABCA1;DOCK4;USP6NL;OPTN;CDC42EP4;FGD1;IQGAP2;GOLGA4;FGD4;RHOBTB3;STRN3;NDRG1;RANBP9;LRRK2;SPHK2;AFDN;MYO1C;ALS2;TRIP11;PICALM;ARFIP2;FMNL1;GGA2;BRAF;RNF152;FGD3;GOLGA5;WASF1;TNFAIP1;RAB3GAP1;TSC2;FLNA;AKAP13;RAPGEF6;TBC1D20;HACE1
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.3108850581943419,-1.1106553025348518,0.25984251968503935,0.6989767848625149,1.0,27/57,28.83%,COX4I1;NDUFC1;UQCRH;COX6A1;COX5B;NDUFA6;NDUFA5;NDUFA7;NDUFA8;NDUFB7;NDUFA3;NDUFA10;COX5A;NDUFS7;NDUFS1;NDUFS5;UQCR10;NDUFB3;COX8A;UQCR11;UQCRQ;UQCRC1;CYB561D2;UQCRFS1;NDUFB4;NDUFV2;NDUFV3
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.336663495241346,1.11042435618781,0.289532293986637,0.7566389557044737,1.0,27/173,11.94%,ZBTB20;TRPS1;ZEB2;MITF;KCNIP3;AEBP1;ZEB1;PRDM5;FOXP2;ASCL1;JDP2;MXI1;ETV6;TBX3;BCL6;SKI;NR1D1;ZBTB4;ZBTB1;MZF1;GTF2IRD1;ZKSCAN3;ZNF177;CEBPB;BHLHE41;ZBTB37;REST
prerank,ubiquitin-specific protease binding (GO:1990381),0.46908478693606737,1.1096245498006923,0.36089030206677264,0.7548203050323828,1.0,8/19,22.34%,DERL1;DERL3;PRKN;SELENOS;PTEN;AMFR;SUMO1;BAG6
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.4740618874243378,-1.1093593195032285,0.3333333333333333,0.696413854120204,1.0,3/10,11.50%,OTUD4;YOD1;TNFAIP3
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.3332712359830156,1.105637898279468,0.2893289328932893,0.7614816798093516,1.0,32/181,15.36%,TCF7L2;LDB2;SMAD3;ARNT2;AR;DACT1;PRRX1;CDK5RAP3;NEUROD1;NCOA2;TBX3;TACC1;NFE2L2;MTA2;RERE;RBPJ;NCOR1;MTA3;ACTN4;ARNT;IFI27;RBL2;NCOR2;BHLHE41;TEAD3;TRIP4;NCOA3;HDAC4;TCERG1;TADA3;RXRA;SMARCB1
prerank,potassium ion antiporter activity (GO:0022821),0.4923554997705629,1.1041319293327696,0.37355371900826445,0.7614678884111866,1.0,5/15,9.11%,SLC24A3;SLC9A9;SLC24A1;SLC24A5;SLC9A5
prerank,carbohydrate:cation symporter activity (GO:0005402),0.52445309033025,1.1030618851274034,0.38782608695652177,0.7601102947143848,1.0,2/11,9.28%,SLC2A10;SLC5A3
prerank,galactosyltransferase activity (GO:0008378),-0.46027221876089136,-1.102538393533492,0.3583535108958838,0.7090739586499765,1.0,3/11,6.20%,B4GALT4;B4GALT5;B4GALT7
prerank,chemorepellent activity (GO:0045499),0.4412297998434906,1.102227223369337,0.3474842767295597,0.7581567714001879,1.0,4/25,4.30%,EPHA7;SEMA3D;SEMA5A;APOA1
prerank,phosphatase inhibitor activity (GO:0019212),-0.3917684697843896,-1.101443933309788,0.3304093567251462,0.7060285805734786,1.0,12/20,34.54%,PTN;MGAT5;PPME1;LMTK2;URI1;ANP32E;STYX;CABIN1;PPP1R1B;SET;SAG;ENSA
prerank,tumor necrosis factor receptor binding (GO:0005164),-0.4391122313823534,-1.0999196333193464,0.32075471698113206,0.7043483803174767,1.0,5/12,27.09%,TRAF5;TRAF1;TRAF2;BABAM2;TRAF6
prerank,estrogen receptor binding (GO:0030331),-0.347710697100866,-1.0991331735980214,0.32323232323232326,0.7005552267561002,1.0,12/32,23.07%,LEF1;ESR1;MED1;NRIP1;STRN;TAF10;PPARGC1B;ARID5A;SRARP;PPID;PADI2;DCAF1
prerank,cardiolipin binding (GO:1901612),0.5228883748447372,1.0983533996186774,0.375,0.7645639838817697,1.0,5/10,21.44%,GSDME;PLEKHN1;GSDMD;OPA1;STOML2
prerank,NADPH binding (GO:0070402),-0.43092029332173554,-1.097931044467017,0.3290155440414508,0.6983472657762952,1.0,10/13,37.61%,KCNAB1;DHFR;CBR3;HMGCR;GRHPR;MTRR;CBR4;LBR;NDOR1;DUS2
prerank,protein kinase regulator activity (GO:0019887),0.3517746201123679,1.097147326723129,0.3237139272271016,0.7637866514912862,1.0,37/95,24.18%,PARVA;CCNA2;PRKAG2;MT3;ITPRIP;GPRC5D;DNAJC3;CCNK;STK11;FGF13;TAOK3;CCNL2;RGCC;STRADA;CCNL1;DUSP19;WNK1;CNPPD1;MARK2;GPRC5A;CDKN1C;AGAP2;CCNQ;CCNT2;CDKN1B;PRKAG1;ELP4;MADD;CCND2;TRIB1;CCNT1;CCNG2;NCKAP1L;HEXIM1;CCNY;CCNE2;MBIP
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.444184784948763,1.0964397496333231,0.36809815950920244,0.7616871624301974,1.0,2/24,1.22%,CAMK1D;DAPK1
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.4542354580588031,1.095767324999285,0.36900958466453676,0.7553871964368799,1.0,2/21,1.12%,CDK14;CDK8
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.4542354580588031,1.095767324999285,0.36900958466453676,0.7553871964368799,1.0,2/21,1.12%,CDK14;CDK8
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.4475257976237702,-1.0951611859787915,0.3359375,0.7001764798820874,1.0,5/13,17.20%,LPCAT1;AGPAT1;PNPLA3;AGPAT5;LPCAT2
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.4714169877736688,1.0945533948209134,0.3482758620689655,0.7545179485614626,1.0,2/16,1.82%,SLC1A5;SLC13A3
prerank,sterol binding (GO:0032934),0.38751097077320074,1.0940244505620786,0.3292349726775956,0.7519200961028883,1.0,19/56,18.95%,RORA;ABCA1;INSIG2;APOA1;OSBPL8;STAR;SIDT1;ANXA6;TSPO;VDAC1;GRAMD1A;OSBPL9;NR1H3;OSBPL5;GRAMD1C;NPC1;INSIG1;ERLIN1;OSBP2
prerank,single-stranded DNA binding (GO:0003697),0.3534789918287796,1.0932226432857843,0.33209417596034696,0.7501757698051407,1.0,15/93,14.98%,POLR2D;RBMS1;SHOC1;RAD51B;DMC1;SPRTN;REXO4;MLH1;HNRNPA1;SMC6;TDP2;MCM2;HMCES;RAD51D;FUBP3
prerank,single-stranded RNA binding (GO:0003727),0.3938462519468522,1.0931527683466293,0.35,0.7465349537608548,1.0,5/43,10.98%,POLR2D;A1CF;DDX60;HNRNPA1;DDX3X
prerank,microtubule motor activity (GO:0003777),-0.3058196073815762,-1.0913161310950792,0.2987551867219917,0.7038862579050531,1.0,19/51,22.51%,STARD9;KIF26B;KIF6;KIF13A;KIF2A;KIF16B;KIF20B;KIF1A;DYNLRB1;KIF15;KIFC3;KIF21A;KIF23;KIF18A;KIF5A;KIF18B;KIF22;KIF4A;KIF14
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.35430749885772134,-1.0906560282363325,0.3025210084033613,0.7000697325120466,1.0,9/29,13.96%,SLC26A7;SLC26A2;SLC25A13;SLC25A12;SLC1A1;SLC25A30;SLC26A6;SLC25A11;SLC1A4
prerank,ubiquitin-protein transferase activity (GO:0004842),0.3151418649131584,1.0856413231397175,0.28526970954356845,0.762086039731476,1.0,83/346,18.73%,MYCBP2;RNF220;PDZRN3;HECW2;CBLB;SH3RF3;PELI2;SH3RF1;DCST1;MGRN1;UBR2;NEDD4;RFFL;SMURF2;RNF213;BFAR;BCOR;CDC42;ZNRF3;PML;CUL4B;RNF31;KCMF1;RNF10;TRIP12;CUL5;UBE2U;DTX4;FBXL3;TRAF7;RNF185;RNF139;RNF145;UBA7;UBR4;PRKN;ITCH;RNF181;ASB12;RNF6;RNF38;RNF152;MIB1;FBXO9;RSPRY1;FBXO11;ERCC8;FBXO4;BTRC;RNFT1;RNF217;MUL1;TNFAIP1;RNF19A;RC3H2;UBE2E2;AMFR;UBE2D1;ASB1;HACE1;HUWE1;RNF13;HLTF;DZIP3;RNF2;NHLRC3;UBR5;UBE2R2;MSL2;RNF214;UBR3;UBE3B;RNF138;UBE3A;RNF135;PJA2;DTX3;TRIM45;RC3H1;RNF34;TRIM47;TRIM41;TRIM32
prerank,N-methyltransferase activity (GO:0008170),0.46290836797627116,1.0854555567698347,0.36858475894245724,0.7587058679930427,1.0,4/20,9.49%,NNMT;HNMT;TRMO;DIMT1
prerank,acyl-CoA hydrolase activity (GO:0047617),0.46648780713401683,1.0854141051225856,0.3871499176276771,0.7550541819601149,1.0,3/17,4.50%,ACOT11;ACOT6;ACOT2
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.39743902805271614,1.0853469320525615,0.3530239099859353,0.7515020978158967,1.0,17/40,26.33%,NNMT;DNMT3A;COMT;HNMT;LRTOMT;TPMT;THUMPD3;THUMPD2;METTL4;DNMT3B;PEMT;N6AMT1;DNMT1;CARNMT1;ARMT1;SETD3;RRP8
prerank,microtubule binding (GO:0008017),-0.24108381326933556,-1.0831988507210133,0.1935483870967742,0.7140847495705478,1.0,58/222,20.44%,DNM3;MTUS1;SGIP1;MAP2;REEP1;NAV3;STARD9;CCDC88A;KIF26B;EML5;MID1;FMN1;KIF6;KIF13A;RPS3;KIF2A;ARHGEF2;FNTA;CDK5;KRIT1;SUN2;SYBU;RP1;RAB11A;PAFAH1B1;ARL3;CCDC61;KIF16B;NEFH;KIF20B;KIF1A;KIF15;POLB;DCTN1;GAS2L1;TRPV4;CCDC88C;CDK5RAP2;MAP1B;CEP57;KIF21A;CAPN6;DNM1;PRC1;GAS8;IRAG2;KIF23;KIF18A;REEP2;MTCL1;MAST1;CLASP1;KNSTRN;KIF5A;SPAG5;KIF18B;CCDC170;CLIP2
prerank,protein kinase C activity (GO:0004697),-0.42628296436319396,-1.082335669097334,0.3427230046948357,0.7109295782036796,1.0,4/14,17.55%,PRKCH;PKN1;PRKCZ;PRKCE
prerank,3'-5' DNA helicase activity (GO:0043138),0.46090568952942595,1.0806382581808438,0.37037037037037035,0.7599579286804851,1.0,4/16,12.24%,NAV2;RECQL5;ASCC3;MCM2
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.495490400747049,1.0803414938744247,0.40362438220757824,0.7569416647071389,1.0,2/12,7.99%,B3GALT1;B3GALNT1
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",-0.27980677304607465,-1.0801196756167466,0.2948717948717949,0.7115863027766569,1.0,26/74,24.15%,NADK2;DGKB;DGKH;HK2;PANK3;DGKK;RFK;IPMK;ETNK1;FAM20C;DGKG;DGKQ;PIK3C2B;PIK3CA;CLP1;NOL9;NADK;TKFC;DGKZ;DGKI;KHK;PIK3CG;CHKA;PGM2L1;PKM;IDNK
prerank,metal ion transmembrane transporter activity (GO:0046873),0.4177411720687579,1.0794436515332606,0.3601236476043277,0.7554195373512126,1.0,3/27,6.47%,ITPR1;SLC41A1;SLC11A2
prerank,phospholipase C activity (GO:0004629),-0.3552467472501367,-1.0781754019100867,0.3194444444444444,0.7110574488607067,1.0,4/25,5.85%,PLCE1;EDNRA;PLCG2;CHRM3
prerank,clathrin adaptor activity (GO:0035615),0.47329916042210973,1.0778871401953534,0.4098883572567783,0.7558675042135585,1.0,4/15,9.97%,STON1;DAB2;AP1G2;AP1M1
prerank,mannosyltransferase activity (GO:0000030),0.4368680039740984,1.0771240525418433,0.3660436137071651,0.7541662631196989,1.0,2/21,2.04%,TMTC1;TMTC4
prerank,beta-tubulin binding (GO:0048487),0.41300904205002037,1.0761940556946274,0.37300435413642963,0.7528290726087559,1.0,9/31,21.33%,GJB6;DLEC1;PDCD5;FGF13;EML4;IFT74;APPL1;HTT;TAOK1
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.43643672437720626,-1.0740848112014294,0.36895674300254455,0.7161556421325763,1.0,5/12,17.95%,CISD2;CISD1;ISCU;SDHB;CIAPIN1
prerank,exonuclease activity (GO:0004527),0.3762222477911475,1.0730072083678455,0.3651006711409396,0.7570674211751287,1.0,10/46,11.79%,ENPP1;REXO5;POLG;REXO4;DCLRE1C;DXO;EXOSC1;REXO2;ERI1;EXOSC7
prerank,ion gated channel activity (GO:0022839),-0.35941125999924467,-1.0716808396013155,0.3746397694524496,0.7171198709968988,1.0,8/24,16.55%,ANO1;ANO4;TTYH2;ANO3;TMEM63C;ANO2;TMEM63B;ANO6
prerank,chloride channel regulator activity (GO:0017081),-0.410007384397464,-1.0713863088863758,0.38386308068459657,0.7126521058478719,1.0,5/14,16.85%,VAMP8;SGK1;WNK2;CFTR;STX1A
prerank,protein phosphorylated amino acid binding (GO:0045309),-0.31847423875382946,-1.0686281090348022,0.3170731707317073,0.7141436258434696,1.0,6/42,3.46%,YES1;PLCG2;SHE;SHC3;BCAR3;SHB
prerank,Hsp70 protein binding (GO:0030544),-0.3296807682045098,-1.067815586366501,0.3527397260273973,0.7111721129285041,1.0,11/31,23.49%,RPS3;DNAJB14;SACS;ERN1;NOD2;GPR37;DNAJC8;HIKESHI;PPID;DNAJB1;PPEF2
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.4814012947804799,1.0660758297561888,0.41711229946524064,0.7704198398409744,1.0,4/13,9.58%,PDGFD;PDGFRA;PDGFRB;ITGB3
prerank,C-C chemokine receptor activity (GO:0016493),0.428872661667601,1.0659584467243983,0.3911042944785276,0.767020199485703,1.0,3/21,5.27%,XCR1;ACKR2;CCR9
prerank,DNA-directed DNA polymerase activity (GO:0003887),-0.3764617131101758,-1.0653954473901974,0.37254901960784315,0.7122610957511865,1.0,9/21,20.66%,REV3L;POLM;POLH;POLE4;POLB;POLN;POLD4;POLQ;POLK
prerank,UDP-glycosyltransferase activity (GO:0008194),0.35636935414352366,1.0580915654018008,0.38461538461538464,0.7834728473115036,1.0,8/70,10.09%,GXYLT2;B3GALT1;OGT;LARGE1;LARGE2;B4GALT1;B3GALNT1;EXT1
prerank,lipoprotein particle binding (GO:0071813),-0.3731193128712547,-1.0553160001994693,0.3671875,0.7322477418711669,1.0,7/20,11.57%,PLTP;THBS1;SORL1;SCARF1;CDH13;SCARB1;STAB1
prerank,adenyl nucleotide binding (GO:0030554),-0.43894749207090067,-1.054408177125601,0.41119221411192214,0.7242671972782306,1.0,6/11,28.51%,BAG4;GRPEL1;HSPBP1;HSPH1;GRPEL2;BAG2
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.43894749207090067,-1.054408177125601,0.41119221411192214,0.7242671972782306,1.0,6/11,28.51%,BAG4;GRPEL1;HSPBP1;HSPH1;GRPEL2;BAG2
prerank,triglyceride lipase activity (GO:0004806),-0.37027543117310924,-1.0540195884405106,0.3825136612021858,0.720080445811047,1.0,7/20,27.50%,LIPE;PNPLA3;PNPLA2;DAGLB;LIPH;LIPC;LPL
prerank,hyaluronic acid binding (GO:0005540),0.49528706436504477,1.0537116375842122,0.44014084507042256,0.7908400634191773,1.0,3/10,14.27%,CEMIP;LYVE1;CHODL
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.4123956270474369,1.0520092973291275,0.4159159159159159,0.7914180448464665,1.0,2/25,1.42%,MICAL3;CYP26B1
prerank,low-density lipoprotein particle binding (GO:0030169),-0.39660344817738424,-1.0519140696930305,0.41304347826086957,0.7204184928542937,1.0,7/16,11.57%,PLTP;THBS1;SORL1;SCARF1;CDH13;SCARB1;STAB1
prerank,glutamate receptor binding (GO:0035254),-0.39100534752542276,-1.0514828464765922,0.40414507772020725,0.7165712506809317,1.0,6/17,16.80%,SHANK3;SHANK1;NSF;HOMER1;IGSF11;HOMER3
prerank,RNA stem-loop binding (GO:0035613),0.4798443385099572,1.047415503123151,0.4377104377104377,0.7993056822076808,1.0,7/12,23.61%,MYH10;CPEB3;DDX3X;RC3H2;RC3H1;LARP6;METTL16
prerank,GTPase activity (GO:0003924),-0.23674817645933294,-1.0468433445102558,0.3673469387755102,0.7228194810132523,1.0,50/192,19.08%,DNM3;RAP1A;RIT2;RAB27A;KRAS;MFN1;GBP5;EEF2;RAB6A;GNA14;GBP4;RAB21;GBP7;GCH1;RAB3C;RAP1B;RAB5B;GNB2;RAB8B;GTPBP10;RHOB;RAB11A;EFTUD2;RAB27B;GTPBP1;ATL2;RASL12;ARHGDIB;GFM2;DIRAS2;GPN3;RALB;GNB1;RAB24;GNG5;RIT1;RAB6B;EEF1A1;RAB4A;GPN2;GNG11;GNA12;DNM1;GNA11;RAB3A;NKIRAS2;TBCC;RAB5C;GNAZ;GNA13
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.3257986363418898,-1.0468260392014745,0.3612040133779264,0.7179749935460381,1.0,7/33,10.96%,RNF144B;RNF144A;RNF125;SIAH1;RPS3;SIAH3;DCUN1D4
prerank,DNA polymerase activity (GO:0034061),-0.36238657293028287,-1.045751715224487,0.403899721448468,0.7158351410605267,1.0,9/22,20.66%,REV3L;POLM;POLH;POLE4;POLB;POLN;POLD4;POLQ;POLK
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),-0.33269275279183463,-1.0454815437501104,0.38080495356037153,0.7118720733601485,1.0,12/34,21.28%,UBE2G1;UBE2J1;UBE2H;TAF1;UBE2D3;UBE2K;UBE2B;UBE2G2;AKTIP;UBE2S;UBE2QL1;UBE2O
prerank,methyl-CpG binding (GO:0008327),0.42095813845968255,1.0451658169230535,0.4089506172839506,0.8010385198295241,1.0,7/22,14.93%,MBD2;ZBTB38;TET1;ZBTB4;CXXC5;MBD1;CXXC4
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.4451161211795693,-1.045069385735902,0.3953488372093023,0.7082474667247106,1.0,6/10,27.29%,USP22;NAA60;EP300;BRCA2;ATF2;HAT1
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.29655107886653714,1.0444714965495832,0.3652085452695829,0.7991315801722524,1.0,83/431,17.43%,STK17B;DAPK2;ENPP1;RHOH;DAPK1;KSR1;ABCA1;ATP1A2;RHOD;BMPR1A;DMPK;RANBP17;MARK1;MLKL;PRKAG2;RHOBTB1;RRAS2;TGFBR1;MYO18A;MYH10;MYO1B;ACVR1;LIG4;MVK;OAS2;MRAS;RHOBTB3;MAP3K20;PDXK;CDC42;LRRK2;AKT3;RHOBTB2;SIK1;BRSK1;RAB22A;OXSR1;CLPX;MAST2;STK4;IRAK3;ARL2;MAP4K4;ARFIP2;ABCB9;STK11;RHOT1;ARL1;ANXA6;NEK6;PEX6;ABCE1;P2RX5;RRAGD;RHOQ;TLK1;WNK1;TUBB2B;INSR;RAP2A;MAP4K5;ACVR1B;MTREX;MARK2;HSPA9;ARF4;ABCD2;RTEL1;GNL2;NLRC4;RND3;ARF6;TUBB2A;ARL5A;AGAP2;AKT1;RHOG;LONP1;PIM1;PTPA;ABCB6;RHOU;GCK
prerank,phosphatidylinositol binding (GO:0035091),-0.2657245755072331,-1.0442107679613741,0.3595505617977528,0.7058069071609284,1.0,22/91,16.15%,PITPNC1;ESYT2;MCF2L;EPB41;DENND1B;CCDC88A;SNX13;PITPNA;WDFY3;TNFAIP8L3;SNX27;HIP1R;SNX1;ITPR3;SCARB1;EXOC8;FES;PHF12;PLEKHF2;GAP43;PIGU;PITPNB
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.40597164282120923,-1.0415787892786015,0.4112903225806452,0.7077537755381617,1.0,5/15,17.20%,LPCAT1;AGPAT1;PNPLA3;AGPAT5;LPCAT2
prerank,G protein-coupled receptor binding (GO:0001664),0.3232236290145517,1.0412391461366384,0.41531322505800466,0.8035872508670817,1.0,25/132,14.68%,GRK3;WNT8B;WNT4;GNAS;WNT6;CCL19;INSL3;FZD1;SFRP1;USP20;ZNRF3;WNT5B;AGTR1;TULP3;NPFF;ARRB1;ARHGEF11;PRKN;RYK;ADM;PTCH2;GNAO1;GPRASP2;FLNA;RSPO1
prerank,chloride channel inhibitor activity (GO:0019869),-0.43714379624117766,-1.0366586951853014,0.41784037558685444,0.7148513786068371,1.0,5/10,23.73%,VAMP8;WNK2;CFTR;STX1A;WNK4
prerank,ATPase activator activity (GO:0001671),0.43213093637655786,1.0361700641709628,0.41639871382636656,0.8125710879523869,1.0,4/20,16.36%,DNAJC1;ATP1B2;TOR1AIP1;TOR1AIP2
prerank,transcription corepressor binding (GO:0001222),0.40294400433459304,1.035140305423491,0.4236006051437216,0.8115698192137726,1.0,7/27,12.00%,RORA;USP11;NR1D1;FAM89B;PHF1;NEK6;PER3
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.41562053259447485,-1.034665008164785,0.42409638554216866,0.7150432333025765,1.0,5/12,21.44%,CNOT6L;PAN3;PNLDC1;CNOT7;CNOT8
prerank,cysteine-type peptidase activity (GO:0008234),0.3494516634721106,1.0343021958927312,0.40074906367041196,0.8101261033821565,1.0,26/73,21.18%,USP11;SFRP1;CTSH;CTSF;USP47;USP20;USP35;USP24;USP48;ATG4A;CASP7;OTULINL;USP30;USP9Y;CTSZ;USP10;USP9X;CTSL;USP38;CASP9;CASP1;USP49;USP46;ATG4B;USP37;UCHL1
prerank,GTPase binding (GO:0051020),0.31264795562579506,1.0340494141639018,0.4154696132596685,0.8071201713446381,1.0,43/195,15.14%,MYCBP2;RHOH;RABGAP1L;RAPGEF4;ABCA1;DOCK4;USP6NL;OPTN;CDC42EP4;FGD1;IQGAP2;GOLGA4;FGD4;GNB3;RHOBTB3;STRN3;NDRG1;RANBP9;LRRK2;SPHK2;AFDN;MYO1C;ALS2;TRIP11;PICALM;ARFIP2;FMNL1;GGA2;BRAF;RNF152;RRAGD;FGD3;GOLGA5;WASF1;TNFAIP1;RAB3GAP1;TSC2;FLNA;AKAP13;RADIL;RAPGEF6;TBC1D20;HACE1
prerank,protein phosphatase 2A binding (GO:0051721),-0.3519554967053351,-1.0319397121268377,0.40226628895184136,0.7170580410806762,1.0,8/23,15.80%,CTTNBP2NL;GRIN3A;ADCY8;STRN;PPME1;FOXO1;SMG7;STRN4
prerank,double-stranded RNA binding (GO:0003725),-0.2703221648824693,-1.0313138087407565,0.3879310344827586,0.713791663464206,1.0,17/70,15.52%,STRBP;IFIH1;MBNL1;TFRC;LRRFIP1;VIM;HSP90AB1;TUBB4B;ELAVL1;EIF4A1;MSN;ADAR;SLC3A2;SUPV3L1;APTX;ADARB2;MRPL44
prerank,phosphatase activity (GO:0016791),0.33765414955532125,1.026201615414903,0.42366412213740456,0.82267995615176,1.0,5/73,3.00%,CILP;PLPP3;ATP1A2;PXYLP1;EPHX2
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.31199082338260475,1.026173519219046,0.42790697674418604,0.8190931006072443,1.0,41/147,16.63%,RIN2;MYCBP2;FARP1;RAPGEF4;DOCK4;DOCK10;RCBTB2;DOCK11;IQSEC2;DENND2A;FGD1;RAPGEF2;FGD4;DENND4A;ARFGEF2;ARHGEF17;DOCK5;DENND5A;ARHGEF18;ALS2;RGL1;ARHGEF11;RAPGEF1;EIF2B4;SBF2;LAMTOR2;ARHGEF10;FGD3;DENND1A;EGF;RAB3GAP1;EPS8L1;SERGEF;CCZ1;AKAP13;RAPGEF6;EIF2B3;RAB3IL1;ARFGEF1;FNIP1;DENND6A
prerank,WW domain binding (GO:0050699),0.40509276690638985,1.0219571451148521,0.4446085672082718,0.8258399194409691,1.0,5/26,11.35%,PMEPA1;RAPGEF2;TCEAL8;TCEAL1;NFE2
prerank,C-C chemokine binding (GO:0019957),0.4077173247088404,1.0211710996997192,0.43681747269890797,0.8241179134476495,1.0,3/22,5.27%,XCR1;ACKR2;CCR9
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.48595030607424483,1.0208847525538831,0.4664371772805508,0.8211609141369083,1.0,3/10,10.78%,ASH1L;NSD1;SETD5
prerank,ubiquitin binding (GO:0043130),0.3432913652429472,1.0203761429168907,0.4592875318066158,0.8187518168342036,1.0,16/73,14.10%,SMAD3;NEDD4;FAF2;SPRTN;RNF31;SIRT2;UBXN2B;RNF185;CKS1B;UBXN11;PRKN;USPL1;OTULINL;RAE1;RNFT1;ADRM1
prerank,calcium-dependent phospholipid binding (GO:0005544),-0.28211855184907747,-1.0192463484124301,0.4214876033057851,0.7382069194997851,1.0,19/49,25.31%,CPNE8;ESYT2;MCTP1;DYSF;CPNE3;SYT1;PCLO;PLA2G4C;SYT6;CPNE5;SYT4;ANXA1;SYT15;PLA2G4F;PLA2G4E;SYT5;ANXA8;ESYT3;CPNE9
prerank,Hsp90 protein binding (GO:0051879),-0.3176596879973806,-1.0128994298746292,0.42388059701492536,0.7491690445975181,1.0,9/33,20.49%,SLC12A2;KDR;RPS3;UNC45B;ERN1;NOD2;HIF1A;PPID;USP19
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.47544964606426704,1.010937063893152,0.46113989637305697,0.8381385235294974,1.0,1/11,0.27%,ITPR1
prerank,phosphoric ester hydrolase activity (GO:0042578),0.3506549762166286,1.010688133520638,0.4599728629579376,0.8350954515723736,1.0,4/49,3.00%,ATP1A2;PXYLP1;MPPED2;EPHX2
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.43487560472039055,-1.01066908169027,0.47544642857142855,0.7498698354047699,1.0,4/10,12.94%,SHANK3;SHANK1;NSF;IGSF11
prerank,voltage-gated cation channel activity (GO:0022843),-0.25274696392617624,-1.0093815416653429,0.4114285714285714,0.7484307545939478,1.0,28/97,21.32%,KCNB2;PTK2B;KCNQ5;KCND2;GRIN2A;KCNMA1;KCND3;KCNQ1;KCNH7;KCNH5;KCNC2;GRIN2B;GRIN3A;CACNA2D2;KCNQ3;KCNA2;CACNA2D1;CACNA1D;KCNS3;CACNG3;CACHD1;CACNG4;CACNA1A;GRIN1;HCN1;CACNB3;HVCN1;KCNC1
prerank,enoyl-CoA hydratase activity (GO:0004300),0.488264938080179,1.008420150831644,0.46296296296296297,0.8370562030810421,1.0,3/10,11.92%,ECHDC2;ECI1;ECHS1
prerank,mRNA binding (GO:0003729),0.29559106528135526,1.0068002891349204,0.46971307120085015,0.8373664583594199,1.0,30/249,11.34%,CELF2;SAMD4A;RBMS1;RBMS3;A1CF;CSDC2;RBFOX1;RBMXL2;HNRNPLL;RBFOX2;MYH10;IGF2BP2;SNRNP70;CPEB1;ZFP36L1;THOC2;ACO1;SF1;CPEB3;DXO;RBMS2;HNRNPR;RBPMS;METTL14;PARN;EIF3A;NUP98;DDX3X;EIF2S2;SERBP1
prerank,hexosaminidase activity (GO:0015929),0.4581789336037512,1.0051845930504713,0.4642857142857143,0.8378626397279181,1.0,1/12,0.72%,CEMIP
prerank,histone acetyltransferase binding (GO:0035035),0.4017734267348475,1.004710760660329,0.45950155763239875,0.8353383111553444,1.0,5/21,12.94%,GLI3;EPAS1;SIRT2;KANSL1L;TRIP4
prerank,androgen receptor binding (GO:0050681),-0.3445403727213693,-1.0044072959510677,0.4457831325301205,0.7562451199408614,1.0,10/25,19.13%,KDM1A;SNW1;FOXP1;PKN1;TMF1;TRIM68;ARID5A;EP300;RNF14;DDX5
prerank,peptidoglycan binding (GO:0042834),-0.4336168575963208,-1.002784844092664,0.47804878048780486,0.7554719368337476,1.0,6/10,32.00%,NOD1;PGLYRP1;NOD2;JCHAIN;NLRP3;TLR2
prerank,microtubule minus-end binding (GO:0051011),0.46743378986923534,1.002125562391769,0.48914858096828046,0.838082710647777,1.0,4/13,19.33%,MACF1;HAUS7;CAMSAP1;NUMA1
prerank,ankyrin binding (GO:0030506),-0.35798410063733915,-1.0017398726467377,0.45194805194805193,0.753263581349025,1.0,8/19,15.93%,CDH1;NRCAM;SPTBN1;SPTB;PLEC;CACNA1D;KCTD6;PTPRC
prerank,AMP binding (GO:0016208),0.46915304903492755,1.0014720534068748,0.4539130434782609,0.835939589002058,1.0,2/11,3.24%,MPPED2;PRKAG2
prerank,double-stranded DNA binding (GO:0003690),0.2864227133647571,1.000283448569416,0.49897750511247446,0.8351935120160655,1.0,65/531,12.17%,TCF4;ZBTB20;RBMS1;TEAD1;PBX1;ARNT2;PKNOX2;GLI2;ZIC1;MAF;GLI3;THRB;NFIB;ASCL1;JDP2;RUNX2;RARB;ZIC4;NFIX;LBX2;MEOX2;MSC;RFX5;NEUROD1;KLF15;RARG;TBX3;HLF;BCL6;CUX2;TCF7;HES7;ZNF23;RAD51B;DMC1;NR5A1;SPRTN;BATF;DDX60;SREBF1;REXO4;NR1D1;OSR1;BBX;TCF7L1;FOXC2;KDM5B;EGFR;GMEB1;GLIS2;ARNT;CREB3L4;CREB3;FOXA1;NR1D2;MBD1;ZNF177;CEBPB;BHLHE41;NFE2;SPDEF;NKX2-8;ZBTB37;NR4A1;TERF2
prerank,serine-type peptidase activity (GO:0008236),0.3211013974850669,0.9986973123585875,0.4625,0.8355306969756259,1.0,11/96,11.76%,GZMK;MMP2;ENDOU;RHBDL3;CTSH;PRSS48;APEH;HTRA1;MASP1;CLPP;F2
prerank,manganese ion binding (GO:0030145),0.3567668517836474,0.9980484003742218,0.46785225718194257,0.8335783666265805,1.0,6/48,6.86%,ADCY2;MPPED2;LARGE1;ENDOU;LARGE2;B4GALT1
prerank,fibroblast growth factor receptor binding (GO:0005104),0.40720682418154847,0.9969674487420883,0.46742671009771986,0.8325577492295018,1.0,3/21,10.16%,KL;FRS2;FGF2
prerank,cAMP binding (GO:0030552),-0.40919212062101723,-0.9942234220821615,0.47285067873303166,0.7666499625854681,1.0,3/11,4.96%,PDE4D;PDE4B;PDE2A
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.374440436502518,0.9930177183787705,0.48425787106446777,0.8384817008155805,1.0,12/33,21.25%,AR;RECQL5;WDR43;PAF1;NCOA3;PCF11;ELOF1;WAC;CDC73;ELP4;HNRNPU;SCAF8
prerank,titin binding (GO:0031432),0.4469228597173966,0.9926741090978461,0.4724689165186501,0.8358075107224162,1.0,1/13,0.87%,ACTN2
prerank,motor activity (GO:0003774),-0.265966939415165,-0.9925690925096843,0.4721030042918455,0.7657929202663734,1.0,19/60,22.51%,STARD9;KIF26B;KIF6;KIF13A;KIF2A;KIF16B;KIF20B;KIF1A;DYNLRB1;KIF15;KIFC3;KIF21A;KIF23;KIF18A;KIF5A;KIF18B;KIF22;KIF4A;KIF14
prerank,proton transmembrane transporter activity (GO:0015078),-0.29868407751513343,-0.9918942367370918,0.4562043795620438,0.7627657529570198,1.0,15/39,25.88%,CLCN3;COX4I1;CLCN5;UQCRH;COX6A1;COX5B;COX5A;CLCN4;UQCR10;COX8A;UQCR11;ATP6V1F;UQCRQ;UQCRC1;UQCRFS1
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.30338660199537626,-0.991317592076678,0.4652567975830816,0.7595940058150337,1.0,4/35,2.95%,PLCE1;GPCPD1;ENPP2;APEX2
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.3366878955447319,-0.9904548184102687,0.45042492917847027,0.7484040058602935,1.0,11/22,36.14%,CHRM3;HTR2A;HRH1;CHRM2;CHRM1;HTR6;HTR5A;HRH3;CHRM5;HTR2B;HTR1D
prerank,serotonin receptor activity (GO:0099589),-0.3366878955447319,-0.9904548184102687,0.45042492917847027,0.7484040058602935,1.0,11/22,36.14%,CHRM3;HTR2A;HRH1;CHRM2;CHRM1;HTR6;HTR5A;HRH3;CHRM5;HTR2B;HTR1D
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.3366878955447319,-0.9904548184102687,0.45042492917847027,0.7484040058602935,1.0,11/22,36.14%,CHRM3;HTR2A;HRH1;CHRM2;CHRM1;HTR6;HTR5A;HRH3;CHRM5;HTR2B;HTR1D
prerank,filamin binding (GO:0031005),-0.41553269114612207,-0.9896035663916728,0.4812206572769953,0.7459798376702003,1.0,1/11,0.02%,NEBL
prerank,chemoattractant activity (GO:0042056),0.3857993349361663,0.9892526708344036,0.46635367762128327,0.8404186025660295,1.0,6/26,20.01%,GDNF;NTF3;FGF2;BMP4;CX3CL1;PGF
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.44856759171245303,0.9862780814512128,0.49493243243243246,0.8439976668695983,1.0,1/13,0.60%,SLC7A2
prerank,transaminase activity (GO:0008483),0.4669829092835803,0.9860516666359141,0.48596491228070177,0.8410347874769816,1.0,1/11,2.21%,ABAT
prerank,NAD+ binding (GO:0070403),0.4548915211813571,0.9849860292521251,0.47442680776014107,0.8401315559339719,1.0,2/12,7.37%,CRYL1;SIRT2
prerank,phosphatidic acid binding (GO:0070300),-0.3429129097899483,-0.9835348345183045,0.4810810810810811,0.7553757952314516,1.0,2/19,0.74%,PITPNC1;PLTP
prerank,potassium:proton antiporter activity (GO:0015386),-0.4165124047982367,-0.9818570255993625,0.49774774774774777,0.7548845352437258,1.0,3/10,8.53%,SLC9A2;SLC9A6;SLC9A7
prerank,protein phosphatase binding (GO:0019903),-0.24116810705515618,-0.9808895996600798,0.5,0.7528716988978997,1.0,31/117,17.28%,PPP1R16B;CTTNBP2NL;ITGA1;IQGAP1;MET;KIFAP3;PXN;KCNQ1;ERBB2;PTPRT;FLT4;SIRPA;AP3B1;GRIN3A;ATP2B4;AKAP11;ANAPC7;GTF2F1;JUP;MTMR9;SKAP1;ADCY8;STRN;PPP1R3B;PPME1;CEACAM1;FOXO1;SMG7;STRN4;JAK3;RACK1
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.4073814686689795,0.9799122605415553,0.5111111111111111,0.8487088107548431,1.0,3/22,9.03%,HSPG2;APOE;PICALM
prerank,pyrophosphatase activity (GO:0016462),0.34255348469735414,0.9758119745002226,0.5,0.854618215751338,1.0,7/50,10.98%,CILP;ENPP1;NUDT7;DXO;DOLPP1;PLPP5;DDX3X
prerank,histone deacetylase activity (GO:0004407),0.41097217131922886,0.975769297217316,0.4943089430894309,0.8512889555230474,1.0,10/19,28.88%,SIRT2;HDAC8;HDAC4;SUDS3;MIER3;HDAC6;HDAC5;HDAC1;MIER1;SIRT7
prerank,exopeptidase activity (GO:0008238),-0.27577007826134203,-0.975099233597374,0.5245283018867924,0.7624131550903469,1.0,19/50,26.91%,DPP10;FAP;PRCP;XPNPEP3;ACE2;DPP6;MME;METAP2;BLMH;GGH;DPEP3;CPE;DPP4;NUDT16;RCE1;TRHDE;LNPEP;NPEPPS;CPB1
prerank,mitogen-activated protein kinase binding (GO:0051019),-0.3157149676157956,-0.9734811377430741,0.5169491525423728,0.7615014400568052,1.0,6/29,14.91%,PTPRJ;GCH1;NFATC1;SIRT1;DUSP7;DUSP8
prerank,nuclear receptor coactivator activity (GO:0030374),0.3434374327192068,0.9707636889965888,0.5108108108108108,0.8596307711086021,1.0,21/52,21.35%,NCOA2;BRD8;ATXN7L3;TACC1;MED14;ZMIZ1;ACTN4;FGF2;PSMC3IP;HELZ2;NCOA3;ETS1;SS18;NCOA7;CARM1;NCOA6;MED30;DCAF6;ACTN1;MED12;PRKCB
prerank,sodium channel regulator activity (GO:0017080),-0.29256494544676787,-0.9704513372907497,0.5075075075075075,0.7639503697172416,1.0,8/37,10.27%,NEDD4L;YWHAH;CAMK2D;FGF12;NOS1;ATP2B4;SGK1;GPLD1
prerank,nucleoside-triphosphatase activity (GO:0017111),-0.20834312373804342,-0.9704067442379052,0.6,0.7597607296969069,1.0,62/248,19.71%,DNM3;RAP1A;RIT2;RAB27A;KRAS;MFN1;VWA8;GBP5;EEF2;RAB6A;KIF2A;GNA14;GBP4;RAB21;GBP7;GCH1;RAB3C;RAP1B;RAB5B;GNB2;RAB8B;GTPBP10;RHOB;RAB11A;EFTUD2;RAB27B;GTPBP1;ATL2;RASL12;ARHGDIB;GFM2;KIF20B;DIRAS2;KIF1A;GPN3;RALB;GNB1;RAB24;GNG5;RIT1;KIF15;CFTR;RAB6B;EEF1A1;RAB4A;RUVBL1;GPN2;GNG11;GNA12;DNM1;GNA11;RAB3A;NKIRAS2;TBCC;CHD3;RAB5C;GNAZ;GNA13;KIF5A;CLU;DHX9;KIF18B
prerank,methyltransferase activity (GO:0008168),0.34868458934629043,0.9703015390182682,0.5046480743691899,0.8573438691603852,1.0,13/46,21.25%,NNMT;COMT;BUD23;NSUN2;FTSJ3;LRTOMT;BCDIN3D;NSUN4;METTL4;DNMT3B;METTL3;N6AMT1;DNMT1
prerank,N-acetyltransferase activity (GO:0008080),0.4112453694293642,0.9701954545189581,0.5045731707317073,0.8542177970941206,1.0,9/19,24.13%,KAT2B;SAT2;NAA80;NAT2;NAA50;SAT1;SMARCE1;NAT14;ESCO1
prerank,phospholipase A2 activity (GO:0004623),-0.3153590668369102,-0.9688229691185043,0.49557522123893805,0.7590669730995563,1.0,14/26,37.21%,PLA2G7;PLAAT3;PNPLA8;PNPLA3;PLA2G4C;PLA2G4F;PLA2G4E;PLAAT1;PLA2G4B;PLA2G5;PLB1;PLA2G6;PLA2G3;PLAAT5
prerank,GTPase inhibitor activity (GO:0005095),0.443597090859661,0.9665036264386822,0.5008665511265165,0.8591926029267901,1.0,4/13,12.60%,RHOH;IQGAP2;ARL2;GPS1
prerank,high voltage-gated calcium channel activity (GO:0008331),0.46496702003692025,0.9657738521940493,0.5088652482269503,0.8574281995532348,1.0,2/10,6.66%,CACNB1;CACNA1C
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.28487373177326114,0.9656517519392518,0.5527156549520766,0.8543744738443424,1.0,53/254,18.20%,TCF4;NFIA;SMAD3;AR;MITF;RUNX1;PRRX1;SP7;NFIB;MLXIP;MEOX2;RLF;IRF1;RFX5;NEUROD1;KLF15;HLF;CEBPA;RBPJ;FOXC2;MZF1;SMAD1;GMEB1;GLIS2;CREB3;FOXA1;ZSCAN21;NKX2-8;NR4A1;STAT6;MYCN;SMARCD2;ETS1;TCF12;HOXC4;FOXK2;MTF1;TFCP2;ZBTB17;ZNF585B;ZNF585A;PLAG1;ATF5;TFDP1;SP1;MYBL1;GTF2I;IRF2;FOXJ3;ELF1;FOXO3;RFXANK;SOX11
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.4537838559632605,0.9631517574547013,0.5053003533568905,0.8564689435781636,1.0,2/10,6.97%,DPYSL3;DPEP1
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.33330693845934256,0.9631409817087198,0.5223880597014925,0.8531613138550064,1.0,14/55,16.47%,SLC7A2;SLC16A12;SLC13A3;SLC6A13;PDPN;SLC38A6;SLC22A4;SLC38A9;SLC16A3;SLC38A3;SLC7A6;SLC38A10;SLC38A2;SLC16A2
prerank,ephrin receptor binding (GO:0046875),0.3939919503213503,0.956886313520534,0.5318818040435459,0.8634974342743478,1.0,5/21,9.02%,LYN;EFNB2;SRC;EFNA2;EFNB1
prerank,tubulin binding (GO:0015631),-0.20911944554173345,-0.9544429852760284,0.7142857142857143,0.7885956711232259,1.0,73/296,19.71%,DNM3;MTUS1;SGIP1;TTLL7;MAP2;UNC5C;TTLL5;REEP1;NAV3;STARD9;DIP2B;RABGAP1;CCDC88A;KIF26B;EML5;MID1;DIXDC1;FMN1;KIF6;KIF13A;RPS3;KIF2A;ARHGEF2;TBCE;FNTA;CDK5;KRIT1;SUN2;PAK1;SYBU;RP1;EFHC2;RAB11A;PAFAH1B1;ARL3;AGBL4;CCDC61;ALDOA;KIF16B;NEFH;KIF20B;KIF1A;PHF6;GIT1;KIF15;POLB;DCTN1;GAS2L1;TPPP3;TRPV4;CCDC88C;CDK5RAP2;EMD;MAP1B;CEP57;KIF21A;CAPN6;DNM1;PRC1;GAS8;CDK5R1;IRAG2;KIF23;BRCA2;KIF18A;REEP2;MTCL1;RAB11FIP5;MAST1;CLASP1;KIF5A;SPAG5;KIF18B
prerank,voltage-gated anion channel activity (GO:0008308),-0.36026014933771877,-0.9542412078455703,0.5275779376498801,0.7847693119779111,1.0,3/15,8.88%,ANO1;CLCN3;CLCN5
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.36703042400935215,0.9526757622721737,0.5507692307692308,0.8695723889035049,1.0,5/30,6.97%,GAS6;CAST;MT3;CST3;DPEP1
prerank,actin monomer binding (GO:0003785),0.3880471612888256,0.9497094506361525,0.5519877675840978,0.8727310497320567,1.0,3/22,7.31%,MTSS1;LIMA1;MYL4
prerank,tropomyosin binding (GO:0005523),0.4212069540149369,0.9495310705070349,0.5466237942122186,0.8697379972550723,1.0,3/16,2.82%,CALD1;TMOD4;TNNT1
prerank,phosphate ion binding (GO:0042301),-0.4095010319533327,-0.949301324660727,0.513126491646778,0.7919156624118712,1.0,5/10,31.95%,PDE2A;PNP;MTHFD2;CHST14;ADSS2
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.3792774260413499,-0.946536855720787,0.5405405405405406,0.793941843805107,1.0,3/12,6.54%,NOD1;BCL2L13;ATP2A3
prerank,glucuronosyltransferase activity (GO:0015020),0.4027210703748245,0.9458224195292604,0.5380794701986755,0.874280019967384,1.0,7/19,23.80%,LARGE1;LARGE2;EXT1;CHSY1;EXT2;B3GAT3;B4GAT1
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.4260367613043796,0.9439217768230972,0.5241935483870968,0.8750039013673988,1.0,5/14,14.62%,ACO1;EXO5;NUBPL;NFU1;ETFDH
prerank,protein phosphatase 1 binding (GO:0008157),-0.32590373586456894,-0.9435001080509253,0.5437158469945356,0.796444489759908,1.0,9/21,31.21%,PPP1R16B;KCNQ1;AKAP11;PPP1R3B;PPP1R11;PPP1R16A;LILRB1;PPP1R3F;PHACTR4
prerank,tau protein binding (GO:0048156),0.34119956306955507,0.9427982292826346,0.5654008438818565,0.8741584161162447,1.0,6/40,10.43%,ROCK2;MARK1;APOE;BRSK1;PICALM;TTBK1
prerank,retinoid X receptor binding (GO:0046965),0.4432995114727486,0.94023373657378,0.5370051635111877,0.8765078189816928,1.0,3/11,9.67%,RARG;TACC1;NSD1
prerank,death domain binding (GO:0070513),-0.3922059565422469,-0.934723592634307,0.5253456221198156,0.8118207099943422,1.0,6/11,17.28%,CRADD;DAPL1;BCL2L1;MCL1;DAP;RACK1
prerank,endopeptidase activator activity (GO:0061133),0.44250936781069655,0.9327955523224308,0.5476190476190477,0.8887924244409198,1.0,4/10,19.69%,APH1B;ADRM1;NLRC4;PSME3
prerank,vinculin binding (GO:0017166),-0.38660386499442906,-0.9327261375825886,0.5475638051044084,0.8120228714490604,1.0,3/11,9.00%,UTRN;PXN;SORBS3
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.3938310701035351,-0.932672549113875,0.5367483296213809,0.8078277569384924,1.0,5/10,21.89%,SIRPA;JUP;CXADR;DSG2;DSP
prerank,symporter activity (GO:0015293),-0.3908479365737902,-0.9308705297262548,0.5343680709534369,0.8077957325521988,1.0,2/10,7.78%,SLC5A6;MFSD2A
prerank,UDP-galactosyltransferase activity (GO:0035250),0.44630481001952327,0.9301972321532305,0.5520282186948854,0.8909219887822167,1.0,2/10,6.86%,B3GALT1;B4GALT1
prerank,protein kinase binding (GO:0019901),0.2659042494937947,0.9283319039466328,0.7070193285859614,0.8916898222263314,1.0,94/480,17.03%,TCF7L2;NELL1;PDLIM5;ERRFI1;RHOH;GHR;SMAD3;SASH1;PRKCSH;IL31RA;GRK5;DACT1;RHOD;KIF13B;NEDD9;EPHA4;NBEAL1;CCNA2;CEP152;PRKAG2;RHOBTB1;PDGFRB;KIF20A;RFFL;CDK5RAP3;MAPK4;ACVR1;TOM1L2;PKIA;RHOBTB3;CDH5;SKI;CDC42;CD247;RHOBTB2;SIK1;NISCH;ERCC6L2;CENPJ;IL15RA;CKS1B;TOP2B;PARD6G;OXSR1;PARD6B;IRAK3;DNAJC3;KAT2B;ZBTB4;SPRY2;CCNK;SMAD1;PRKN;ITGAV;TELO2;PARN;SPRED3;KIZ;NEK6;ADRA2A;UFL1;RGCC;TNIP2;DUSP19;WNK1;MAP3K13;MAP2K6;TRIP4;DACT2;VDAC1;NOX4;MVP;FAM83F;LLGL1;PTPN23;IBTK;GATA6;CEP192;SUFU;BAG5;RNF13;SPRED1;RND3;TPCN2;MAPKAPK2;STX1B;CASP9;TBL2;AGAP2;RHOG;MAPK8IP3;CDKN2C;RNF138;ZC3HC1
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.28949713431490554,-0.9268411619449619,0.5976331360946746,0.8081420798367653,1.0,15/34,28.83%,NDUFC1;NDUFA6;NDUFA5;NDUFA7;NDUFA8;NDUFB7;NDUFA3;NDUFA10;NDUFS7;NDUFS1;NDUFS5;NDUFB3;NDUFB4;NDUFV2;NDUFV3
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.28949713431490554,-0.9268411619449619,0.5976331360946746,0.8081420798367653,1.0,15/34,28.83%,NDUFC1;NDUFA6;NDUFA5;NDUFA7;NDUFA8;NDUFB7;NDUFA3;NDUFA10;NDUFS7;NDUFS1;NDUFS5;NDUFB3;NDUFB4;NDUFV2;NDUFV3
prerank,phosphatase binding (GO:0019902),0.2920483935437963,0.9250676138694236,0.5966386554621849,0.8953173872220644,1.0,25/105,15.73%,PIK3R1;SMAD3;ANK1;CDH5;EIF2AK3;MAST2;MTMR3;EGFR;ANAPC5;VRK3;PPP1R3C;IKBKE;TBK1;CD33;RCAN3;WNK1;SYTL2;STAT6;TSC2;MVP;DLG4;CEP192;SPRED1;DZIP3;PIK3R2
prerank,chemokine receptor activity (GO:0004950),0.36350251071139855,0.921952146136828,0.5564142194744977,0.8985654660794264,1.0,3/24,5.27%,XCR1;ACKR2;CCR9
prerank,leucine zipper domain binding (GO:0043522),0.43453062515011626,0.921911105704417,0.5602189781021898,0.8953578230054675,1.0,4/10,20.99%,PMF1;PAWR;AATF;DDIT3
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.3303844173792827,0.9206834412693479,0.5941828254847645,0.894704697661311,1.0,6/46,11.81%,B3GALT1;OGT;LARGE1;B3GALNT1;EXT1;MGAT3
prerank,MAP kinase activity (GO:0004707),-0.35887372493397757,-0.9198084543865486,0.5724465558194775,0.8197431196150544,1.0,7/14,24.26%,NLK;MAPK10;MAPK8;MAPK3;MAPK1;MAPK11;MAPK7
prerank,1-phosphatidylinositol binding (GO:0005545),-0.34609815843394764,-0.9172682695653824,0.5785714285714286,0.8209259341323648,1.0,3/15,11.16%,EPB41;WDFY3;SCARB1
prerank,calcium channel regulator activity (GO:0005246),0.3373268390979767,0.9171625245412413,0.5555555555555556,0.8987509393356026,1.0,2/37,4.12%,ITPR1;STIM1
prerank,flavin adenine dinucleotide binding (GO:0050660),0.3206012491648262,0.9146197618711054,0.5931972789115646,0.9006460893076418,1.0,16/53,23.13%,MICAL3;DPYD;MTHFR;DDO;SQOR;AIFM1;FOXRED2;NOX4;ETFDH;AOX1;CYB5R3;ETFA;PRODH;SDHA;LDHD;DLD
prerank,phospholipase activity (GO:0004620),-0.24092844687574325,-0.9130773963615756,0.6088709677419355,0.8257722146998696,1.0,25/67,27.50%,PLCE1;ENPP2;MGLL;PNPLA7;PLAAT3;GPLD1;PNPLA8;PNPLA3;PLA2G4C;SMPDL3A;ABHD6;PITPNM3;PLD3;PNPLA6;LYPLA2;PLA2G4F;LYPLA1;PLA2G4E;GDPD1;LIPH;ABHD4;PLAAT1;LIPC;PLA2G4B;LPL
prerank,ribosomal small subunit binding (GO:0043024),0.38882667463726867,0.9116434016869215,0.5818181818181818,0.9035660686693613,1.0,6/17,20.06%,ERAL1;DDX3X;ABCE1;LARP1;PIM1;PTCD3
prerank,MAP kinase phosphatase activity (GO:0033549),-0.3692986175018159,-0.9109898995276859,0.5926773455377574,0.8260980248086525,1.0,5/12,36.20%,DUSP7;DUSP8;DUSP3;DUSP5;DUSP2
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.3919138529528999,0.9088014060005859,0.5792880258899676,0.9064980570042708,1.0,7/18,21.93%,PIK3R1;WDR81;WDR91;PIK3R2;AGAP2;SOCS4;SOCS7
prerank,hexosyltransferase activity (GO:0016758),0.2890859379738314,0.9079909911175676,0.6239419588875453,0.9049241938946857,1.0,9/101,8.29%,TMTC1;TMTC4;B3GALT1;OGT;LARGE1;LARGE2;B4GALT1;B3GALNT1;ALG5
prerank,protein phosphatase regulator activity (GO:0019888),0.3145300405518801,0.9057398966792798,0.5906735751295337,0.9063055618792629,1.0,8/53,13.47%,RCAN2;DMPK;RCAN1;PPP4R4;RCAN3;PPP2R5D;BOD1L1;IGBP1
prerank,regulatory RNA binding (GO:0061980),0.33233177489021437,0.9050206077163222,0.5814606741573034,0.9044975839181181,1.0,12/38,24.47%,ZC3H7B;TUT7;PIWIL4;HNRNPA1;TUT4;ZNF346;RC3H1;DICER1;AGO4;RBM4;SOX2;AGO3
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.3897036153367194,0.9027315707175948,0.5958188153310104,0.9062760193027808,1.0,7/18,22.79%,GAS6;MT3;DPEP1;NOL3;BIRC2;BIRC3;XIAP
prerank,syntaxin binding (GO:0019905),0.30669011448714417,0.9012691460251979,0.6177248677248677,0.9061881050764113,1.0,8/61,7.84%,DAPK1;ABCA1;UNC13C;BAIAP3;STXBP3;STX16;LRRK2;SYT9
prerank,adenylyltransferase activity (GO:0070566),0.37222024452822156,0.898665604434995,0.607085346215781,0.9083277443666139,1.0,10/21,25.79%,OAS2;TENT4A;TENT4B;PAPOLG;NMNAT2;COASY;PAPOLA;NMNAT1;PAPOLB;ABL1
prerank,thioesterase binding (GO:0031996),0.42335687260832733,0.8974207731213056,0.579734219269103,0.9075118449659176,1.0,4/11,15.36%,CDC42;ADRA2A;HAUS7;ARF6
prerank,sodium channel activity (GO:0005272),0.3323686997536692,0.8963216525612551,0.604135893648449,0.9066211065176571,1.0,3/37,5.57%,SCN7A;SHROOM2;GRIK5
prerank,amyloid-beta binding (GO:0001540),0.2908251973294998,0.8927226239749156,0.63625,0.910541894389937,1.0,12/79,9.03%,LRP1;HSPG2;EPHA4;APOE;APOA1;LDLR;CST3;APBB2;TLR6;APBA1;EPHB2;PICALM
prerank,kinase binding (GO:0019900),0.25768692839258256,0.8926418848101235,0.7661538461538462,0.9075182240480828,1.0,90/435,17.03%,TCF7L2;ERRFI1;RHOH;GHR;GSN;SMAD3;SASH1;IL31RA;RHOD;KIF13B;WWC2;NBEAL1;CCNA2;SP100;CEP152;PRKAG2;RHOBTB1;PDGFRB;KIF20A;RFFL;CDK5RAP3;MAPK4;TOM1L2;RHOBTB3;SKI;CDC42;SRC;RHOBTB2;PARP16;SIK1;CEBPA;NISCH;ERCC6L2;CENPJ;IL15RA;CKS1B;OXSR1;TTC28;IRAK3;DNAJC3;EGFR;KAT2B;ZBTB4;SPRY2;CCNK;SMAD1;PRKN;TELO2;PARN;SPRED3;KIZ;NEK6;TRIP6;ADRA2A;UFL1;RGCC;TNIP2;STRADA;WNK1;MAP3K13;MAP2K6;TRIP4;VDAC1;MYCN;MVP;FAM83F;LLGL1;DLG4;PTPN23;FLNA;IBTK;GATA6;CEP192;SUFU;BAG5;SPRED1;RND3;LAPTM4B;TPCN2;STX1B;CASP9;TBL2;AGAP2;SGO1;RHOG;ATF5;TNS2;CDKN2C;RNF138;ZC3HC1
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.38286948885717625,0.8925979083623651,0.5771144278606966,0.9044454512078698,1.0,2/18,3.64%,PDLIM5;CNN3
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.36636694327812,0.8925883925521021,0.5974643423137876,0.9013240873536562,1.0,8/21,18.49%,AKAP7;ARFGEF2;PRRC1;WASF1;AKAP8L;ARFGEF1;PJA2;PRKACA
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.32865836596040165,-0.8893844535607168,0.6187214611872146,0.8688576926856115,1.0,6/16,18.61%,MTMR2;INPP5F;MTMR9;SACM1L;MTMR6;SYNJ1
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.37623749047706234,-0.8882902203582089,0.6087962962962963,0.8668880174705716,1.0,5/10,29.65%,PIK3R3;PIK3C2B;PIK3CA;PIK3CG;PIK3CD
prerank,hormone receptor binding (GO:0051427),-0.3496340566837669,-0.8879518931668797,0.6324582338902148,0.8631228001399315,1.0,3/14,12.82%,SOCS2;JAK2;TYK2
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.416934850710534,0.8878861012218592,0.59375,0.9073407484611417,1.0,1/10,3.80%,SLC6A13
prerank,cation channel activity (GO:0005261),0.28680215113097707,0.8878669377124423,0.6560196560196561,0.9042467109797455,1.0,13/94,10.48%,SLC24A3;NALCN;TRPA1;CALHM5;SLC24A1;MCU;KCNK7;SLC24A5;PANX1;CUL5;KCNQ4;TRPM4;ANXA6
prerank,lysophospholipase activity (GO:0004622),0.35954573936608675,0.8876747750068107,0.6232339089481946,0.901538857432096,1.0,3/20,6.13%,ASPG;PLA2G4A;LYPLAL1
prerank,PDZ domain binding (GO:0030165),0.3028354521146824,0.8858932857124472,0.6421052631578947,0.9020912241570083,1.0,10/61,9.32%,TGFBR3;DOCK4;FZD2;ARHGAP29;SYNJ2;RAPGEF2;FZD1;PLEKHA2;SLC22A4;PRKN
prerank,syntaxin-1 binding (GO:0017075),0.3598798321763103,0.8858720046018989,0.6022727272727273,0.8990374095635001,1.0,4/22,6.60%,DAPK1;UNC13C;STXBP3;LRRK2
prerank,hydro-lyase activity (GO:0016836),0.32483302553731536,0.8854004908766491,0.6291012838801712,0.8968481964205536,1.0,5/41,8.02%,GMDS;ECHDC2;ACO1;ECI1;ENO2
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.3207707972464803,0.8841187809208881,0.6398929049531459,0.8962812821795212,1.0,17/44,20.88%,SETD7;ASH1L;KMT5B;SETD1A;NSD1;WDR82;SETD5;SETD4;SMYD3;KMT2E;KMT2A;SETDB1;WDR5;SETD1B;CXXC1;RBBP5;N6AMT1
prerank,voltage-gated sodium channel activity (GO:0005248),0.35844919384675755,0.8836463069082414,0.6065318818040435,0.894156377548706,1.0,1/22,0.69%,SCN7A
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.37517247295686695,-0.8828693579392889,0.6013986013986014,0.8694885026062241,1.0,5/10,10.68%,PRKAR1A;PKIB;PRKAR2B;PRKAR1B;PRKAR2A
prerank,histone deacetylase binding (GO:0042826),0.290135019522802,0.8818670607926279,0.6499388004895961,0.8945455285206895,1.0,23/88,17.75%,DACT1;GLI3;BCOR;BEX4;SIRT2;TOP2B;MTA2;NCOR1;ZMYND15;MTA3;KAT2B;BRMS1L;PRKN;NCOR2;BHLHE41;YWHAE;HDAC4;AKAP8L;SUDS3;CAMTA2;SP1;KPNA2;NIPBL
prerank,ferrous iron binding (GO:0008198),-0.3028970805849315,-0.8813802753168405,0.6153846153846154,0.8682221174302129,1.0,5/21,12.33%,EGLN3;FTL;FTH1;EGLN2;ISCU
prerank,cytochrome-c oxidase activity (GO:0004129),-0.33056770933042123,-0.877481370261425,0.6520681265206812,0.8722056196198753,1.0,5/15,22.63%,COX4I1;COX6A1;COX5B;COX5A;COX8A
prerank,general transcription initiation factor binding (GO:0140296),-0.2902602418025682,-0.8774489615038,0.6528189910979229,0.867939768060163,1.0,11/25,23.25%,ESR1;TAF1B;TAF1;TBP;HHEX;GTF2A2;RUVBL1;YEATS2;THAP7;GTF2B;THRA
prerank,ribosomal large subunit binding (GO:0043023),-0.36425650368718365,-0.8773255242516166,0.6221198156682027,0.8639056648740084,1.0,6/11,26.42%,MRRF;MALSU1;NPM1;CPEB2;LTN1;CPSF6
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.3328394667059116,0.8748566389306559,0.6152694610778443,0.9050019465974889,1.0,6/32,9.72%,SLC1A5;SLC6A9;SFXN2;SLC38A6;SLC38A9;SLC43A1
prerank,peptidase activator activity (GO:0016504),0.3585760987765244,0.8738742709664994,0.6293823038397329,0.9036989123571507,1.0,7/22,15.32%,PCOLCE;PSME4;CLPX;APH1B;ADRM1;CASP8AP2;NLRC4
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.4059611557476194,0.87196586639341,0.6402027027027027,0.9043117390375637,1.0,4/11,16.25%,UBE4B;UBOX5;AMFR;UBR5
prerank,nucleotidyltransferase activity (GO:0016779),0.37004081756004364,0.8718482527041902,0.6332236842105263,0.9015385229891391,1.0,8/19,21.39%,TUT7;TENT4A;TUT4;CRPPA;TENT4B;YRDC;PAPSS2;NUDT5
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.40650183844049215,0.8686545500858905,0.6196721311475409,0.9048462125595216,1.0,7/12,23.22%,PHF2;KDM7A;PHF8;KDM3B;KDM4A;KDM4C;KDM3A
prerank,DNA replication origin binding (GO:0003688),-0.29213295734151407,-0.8670325497406774,0.6587926509186351,0.8814503661640535,1.0,11/23,36.19%,ORC4;MCM8;MCM3;DHX9;MCM5;ORC5;GRWD1;CDC6;POLA1;MCM7;KAT7
prerank,MAP kinase kinase activity (GO:0004708),0.3786938291519842,0.8656028685871794,0.64,0.907739304643595,1.0,3/15,12.84%,LRRK2;MAP2K1;MAP2K6
prerank,ADP binding (GO:0043531),0.3412588331810886,0.8648319884697895,0.6604651162790698,0.906135519369661,1.0,3/25,3.85%,PRKAG2;MYO18A;MYH10
prerank,chemokine activity (GO:0008009),0.32110318821544553,0.8628287039688991,0.6521739130434783,0.906949416992533,1.0,3/31,6.11%,CCL19;CXCL16;CCL4
prerank,acetylcholine receptor activity (GO:0015464),-0.29576195664895544,-0.860091077239909,0.6627906976744186,0.8916507062799369,1.0,13/22,46.85%,CHRM3;CHRM2;CHRM1;CHRNB1;HRH3;CHRM5;CHRNA5;CHRNG;CHRNA3;CHRNE;CHRNB4;CHRNB3;HRH4
prerank,endonuclease activity (GO:0004519),0.2984603109809887,0.8596471734546097,0.6757493188010899,0.9098970215775426,1.0,17/49,26.09%,SND1;OGG1;ENDOU;REXO4;PIWIL4;RNASEL;MBD4;TSNAX;DICER1;NOB1;APLF;RCL1;MRE11;AGO3;LACTB2;ANG;N4BP2
prerank,myosin binding (GO:0017022),0.29537061848769597,0.8579839603297675,0.6706827309236948,0.9100462920213183,1.0,3/55,1.20%,KIRREL1;CALD1;GSN
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.29778778936135203,-0.8579337812276873,0.6627218934911243,0.8916903086303766,1.0,2/21,4.34%,GRIK2;P2RX7
prerank,endoribonuclease activity (GO:0004521),0.32152591550226317,0.8563636797093617,0.6642547033285094,0.909980593389705,1.0,11/32,24.87%,SND1;ENDOU;PIWIL4;RNASEL;TSNAX;ENDOV;DICER1;NOB1;RCL1;AGO3;LACTB2
prerank,water transmembrane transporter activity (GO:0005372),0.4012053900800396,0.8562103835248541,0.6307420494699647,0.9073556332217716,1.0,2/11,8.37%,PDPN;AQP6
prerank,cholesterol transfer activity (GO:0120020),0.37677048925421136,0.8552828460394093,0.6510500807754442,0.9060439944443406,1.0,5/16,15.43%,ABCA1;APOA1;MTTP;GRAMD1A;GRAMD1C
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.33942318023819745,-0.8534792911983803,0.6642335766423357,0.8963977970418654,1.0,3/13,14.26%,PIP5K1B;PIK3C2B;PIK3CA
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.2720153998679975,0.8525293277526991,0.7261761158021713,0.908058169617263,1.0,27/100,16.32%,MYO10;OGT;MYO1B;SH3PXD2B;IQGAP2;OSBPL8;PLA2G4A;ADAP2;PLEKHA8;ARHGAP9;ARFIP2;COMMD1;SNX12;GOLPH3L;SNX21;DENND1A;WIPI1;PLEKHN1;PIRT;PARD3;SAP30L;OSBPL5;GSDMD;LAPTM4B;GOLPH3;FCHSD2;AKT1
prerank,peptide hormone receptor binding (GO:0051428),0.3972971169846967,0.8509656680356791,0.6486988847583643,0.9080143560324208,1.0,1/11,5.56%,VIP
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.3475118729086436,-0.8505873148956296,0.700507614213198,0.897912306314221,1.0,3/12,12.53%,EIF4E;CYFIP2;EIF4E2
prerank,cholesterol binding (GO:0015485),0.3091237509930406,0.8486477006762567,0.6861924686192469,0.9092109120479096,1.0,13/47,15.75%,ABCA1;APOA1;OSBPL8;STAR;SIDT1;ANXA6;TSPO;VDAC1;GRAMD1A;NR1H3;OSBPL5;GRAMD1C;NPC1
prerank,miRNA binding (GO:0035198),0.3280650405371546,0.8477262297535488,0.6592261904761905,0.908000451696554,1.0,10/30,24.47%,ZC3H7B;TUT7;HNRNPA1;TUT4;ZNF346;RC3H1;AGO4;RBM4;SOX2;AGO3
prerank,chemokine receptor binding (GO:0042379),0.308008750096047,0.8445399010050167,0.672883787661406,0.9109040949387598,1.0,5/35,13.53%,CCL19;CXCL16;CCL4;ITCH;CXCL13
prerank,solute:proton symporter activity (GO:0015295),0.3633737186412885,0.8441127416773573,0.6554054054054054,0.9088587122992736,1.0,3/16,8.00%,SLC2A10;SLC11A2;SLC2A13
prerank,Wnt-activated receptor activity (GO:0042813),0.3762230662022171,0.8435853778919686,0.6357388316151202,0.9069042058132686,1.0,4/15,10.17%,FZD2;FZD1;ROR1;RYK
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.27758412664330184,0.8417230331659762,0.7068527918781726,0.9074665071453535,1.0,16/75,18.12%,CRYL1;DHRS3;H6PD;MDH2;HSD3B2;MDH1B;ADH1A;DCXR;AKR1B10;KDSR;BDH1;SORD;PHGDH;PGD;DHDH;ME3
prerank,G protein-coupled receptor activity (GO:0004930),0.24404642044586755,0.8408838185398289,0.8002136752136753,0.9060107333601877,1.0,19/239,8.33%,ADRA1B;PDGFRL;ADGRV1;LGR4;PDGFRB;ADGRL1;NPR3;LTB4R;GPR63;ADRA2C;LHCGR;ADRB3;BDKRB2;MTNR1A;AGTR1;GRM2;LPAR1;DRD3;MAS1
prerank,protein homodimerization activity (GO:0042803),0.23795571140510952,0.8403817500933474,0.8941532258064516,0.9040405388910928,1.0,96/590,15.73%,ENPP1;FBLN5;GHR;GDNF;SMAD3;CPQ;BCL2;NR2F2;CRYL1;TPM1;FGFR1;IL6R;BMPR1A;SLC30A8;IL17D;EPHX2;FGFR2;KIT;TPST1;FOXP2;PDGFRA;APOE;NPR3;IRAK2;CSF1;APPL2;MAPK4;DPYD;ACVR1;ZHX2;GSTM4;MIGA2;GSTM2;ADRA2C;ADRB3;PDXK;HOGA1;TNNC1;PML;LRRK2;KYNU;CEBPA;GUCY2D;ZBTB38;NAALADL1;MMUT;ALS2;STK4;IRAK3;RBPMS;ZBTB4;CBY1;COMMD1;ZBTB1;MZF1;ACTN4;CAMK2B;S100A11;ARNT;ABCB9;TIMM9;MASP1;EXT1;CARD9;SMIM1;SLC39A13;CEBPB;GALM;BHLHE41;ADRA2A;FBXO4;TERF2;CIP2A;PANK1;CDA;MAP3K13;RIPK2;ZNF318;TPM2;GOLGA5;KMT2A;TSC2;PSPH;ABCD2;FLNA;SNX9;DGAT2;NUDT16L1;CRPPA;PEX11B;GLIPR2;NLRC4;PRKRA;CYP2R1;CASR;HMGCS1
prerank,thyroid hormone receptor binding (GO:0046966),0.33573620434979456,0.8384789785066112,0.7043090638930164,0.9046236172453591,1.0,10/28,18.81%,BRD8;TACC1;TRIP12;MED16;NCOR1;NSD1;TRIP6;NCOA3;NCOA6;MED30
prerank,hexose transmembrane transporter activity (GO:0015149),-0.3417860784064415,-0.8383185135631029,0.6798029556650246,0.9176721774886654,1.0,1/12,0.75%,SLC2A1
prerank,antiporter activity (GO:0015297),-0.2948371153274416,-0.8372449456977697,0.7020725388601037,0.9155475249193757,1.0,10/20,31.76%,CLCN3;SLC35E4;SLC25A30;ATP1A3;SLC25A11;CLCN4;SLC35D1;SLC25A10;SLC25A14;SLC35D2
prerank,snRNA binding (GO:0017069),0.3033571994159182,0.8311831095349637,0.6978021978021978,0.9142693765564198,1.0,15/42,23.67%,RBMXL2;SNRNP70;RBM22;HEXIM2;RNPC3;LSM8;RBM41;CCNT2;LSM10;HNRNPU;CCNT1;NCBP2;HEXIM1;PRPF8;TOE1
prerank,NADP binding (GO:0050661),-0.26022032899602304,-0.8300797348318258,0.7452229299363057,0.9246988486648947,1.0,18/32,28.95%,KCNAB1;NOS3;NOS1;ME1;DHFR;SPR;CBR3;HSD11B1;DHCR7;TM7SF2;HMGCR;CAT;GRHPR;NOX1;MTRR;CBR4;CRYZL1;NOS2
prerank,aspartic-type endopeptidase activity (GO:0004190),-0.34270302904446903,-0.8284658209599296,0.6790697674418604,0.923496951064434,1.0,2/12,9.25%,SPPL3;BACE2
prerank,CARD domain binding (GO:0050700),-0.322918204544967,-0.8281857829558255,0.7085427135678392,0.9196872867337036,1.0,4/14,15.21%,NOD1;CARD14;NOD2;CARD16
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",-0.2666559283063654,-0.8278352309421767,0.7914110429447853,0.9161095557996722,1.0,13/28,30.46%,EDC3;RPP14;POP4;RPP21;MRPL44;ELAC2;RNASEH1;NUDT16;EXO1;POP7;APEX1;FEN1;RPP40
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.3682608088790906,0.8265374814400809,0.6776859504132231,0.919405730714302,1.0,1/15,1.19%,PIK3R1
prerank,ion channel inhibitor activity (GO:0008200),0.30302066947368794,0.8261932483819128,0.7274011299435028,0.917215085153201,1.0,2/35,4.26%,ITPR1;NEDD4
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.34782288581273346,-0.8243775808491094,0.6952595936794582,0.9184004419491995,1.0,3/10,22.95%,ANKRD13A;USP15;FAAP20
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.33459583332729875,-0.8237412123980327,0.711217183770883,0.9154021046446307,1.0,9/12,51.62%,RRH;OPN1MW3;OPN1MW;OPN3;RHO;OPN5;OPN1SW;GNAT2;OPN4
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.39024799294718787,0.8234369677936305,0.678373382624769,0.9188856000732354,1.0,2/11,19.33%,SLC22A4;SLC25A29
prerank,phosphatidate phosphatase activity (GO:0008195),0.3705137227229356,0.8197084366434636,0.6661045531197302,0.9223823697182512,1.0,6/13,26.42%,PLPP3;PLPP5;LPIN3;LPIN2;PLPPR2;LPIN1
prerank,protein kinase inhibitor activity (GO:0004860),0.2963373043309635,0.8186996545190285,0.7406876790830945,0.9212217447793822,1.0,9/42,15.34%,PARVA;ITPRIP;DNAJC3;SPRY2;TAOK3;DUSP19;IBTK;CDKN1C;SPRED1
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.3049597450612764,0.8161770875976636,0.7047477744807121,0.9226442772498886,1.0,7/34,9.06%,MYO10;OGT;MYO1B;IQGAP2;ADAP2;ARHGAP9;COMMD1
prerank,carboxy-lyase activity (GO:0016831),-0.27797065309693325,-0.8155999900538116,0.7555555555555555,0.9260059526835995,1.0,10/23,41.01%,ECHDC1;DDC;GAD1;BCKDHA;MLYCD;PPCDC;UXS1;AZIN1;PCK2;MVD
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.3132913398744915,0.8148147531023354,0.711764705882353,0.9220519773441175,1.0,6/30,10.81%,SLC30A8;SLC25A37;SLC30A2;SLC11A2;SLC30A10;SLC39A13
prerank,sterol transfer activity (GO:0120015),0.3544796556326913,0.8141257742108565,0.7135922330097088,0.9203786052524267,1.0,5/17,15.43%,ABCA1;APOA1;MTTP;GRAMD1A;GRAMD1C
prerank,nuclear localization sequence binding (GO:0008139),-0.29485657371220414,-0.8127942461277421,0.7192982456140351,0.926683456566998,1.0,4/18,10.31%,NUP153;NFKBIA;IPO5;CABP1
prerank,acetyltransferase activity (GO:0016407),0.311144938276447,0.8081261359319434,0.7159763313609467,0.9272806874326383,1.0,11/31,24.13%,DBT;KAT2B;LCAT;SAT2;NAA80;NAA50;SAT1;PAFAH2;SMARCE1;NAT14;ESCO1
prerank,kinesin binding (GO:0019894),-0.2600624193828626,-0.8073282535099047,0.7560975609756098,0.9317938917172309,1.0,10/27,27.94%,ACTB;SPAG9;KIFAP3;NEFH;PRC1;KIF18B;KIF1B;SPTBN5;RAB29;FAM83D
prerank,Tat protein binding (GO:0030957),-0.34127563057209404,-0.8069345794277089,0.7139423076923077,0.9281738276279761,1.0,5/10,31.61%,ACTB;NPM1;DLL1;SMARCA4;MDFIC
prerank,myosin II binding (GO:0045159),0.3783844566246335,0.8057137839885838,0.6920222634508348,0.9283424626460437,1.0,2/10,7.31%,GSN;MYL4
prerank,NF-kappaB binding (GO:0051059),-0.2692409700214695,-0.8056480157795698,0.7415730337078652,0.9262605527787915,1.0,8/24,21.96%,FAF1;NFKBIA;EP300;NPM1;HDAC3;PSMA6;COMMD7;GSK3B
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.37585561215406077,0.8051245983546282,0.6742957746478874,0.9264975817720623,1.0,3/12,13.77%,CDK8;CCNK;CDK12
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.35855407260868377,0.8047711564326311,0.6816666666666666,0.924334846221018,1.0,6/15,22.52%,SH3PXD2B;PLA2G4A;SAP30L;SESTD1;RUBCNL;LANCL2
prerank,nuclear receptor binding (GO:0016922),0.2578207018547525,0.8010279106381155,0.808235294117647,0.9273361003107496,1.0,21/111,15.02%,TCF7L2;SMAD3;NCOA2;BRD8;TACC1;MED14;TRIP12;MED16;NCOR1;STAT5B;ACTN4;NSD1;RNF6;NCOR2;TRIP6;NR4A1;WIPI1;TRIP4;NCOA3;TADA3;RXRA
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.3369987325759378,-0.7965631770921834,0.731764705882353,0.9377910441901037,1.0,4/10,22.28%,APOBEC1;GDA;ADARB2;DCTD
prerank,histone methyltransferase binding (GO:1990226),-0.3250966870937534,-0.7898206524136597,0.7259615384615384,0.9448900309602164,1.0,2/11,6.88%,LCORL;HSP90AB1
prerank,GABA receptor binding (GO:0050811),-0.3304514645012425,-0.789489395473315,0.7334905660377359,0.9411979941455924,1.0,5/11,25.59%,PLCL2;TRAK2;JAKMIP1;GABARAP;AKAP5
prerank,serine-type endopeptidase activity (GO:0004252),0.25938881752742504,0.7861692097565223,0.79296875,0.9481433933312118,1.0,8/80,11.76%,MMP2;RHBDL3;CTSH;PRSS48;APEH;MASP1;CLPP;F2
prerank,alpha-tubulin binding (GO:0043014),0.302100162685416,0.7855362240347519,0.7293577981651376,0.9463893268157858,1.0,4/31,6.61%,DLEC1;EFHC1;INO80;BEX4
prerank,deubiquitinase activity (GO:0101005),-0.19234996111417016,-0.7849405719414564,0.9371428571428572,0.9441210342923477,1.0,20/88,20.73%,USP53;OTUD7B;MINDY2;USP29;MINDY1;OTUD7A;OTUD4;USP31;YOD1;OTULIN;TNFAIP3;USP14;USP22;USP15;USP4;UFD1;EIF3F;OTUB1;USP19;TANK
prerank,vitamin D receptor binding (GO:0042809),-0.3031936351642167,-0.7841419532429916,0.7525773195876289,0.9413068072985848,1.0,4/14,12.59%,MED1;MED4;SNW1;THRAP3
prerank,mRNA 5'-UTR binding (GO:0048027),-0.267817896121099,-0.7828577663875206,0.7988826815642458,0.9391548921262038,1.0,6/24,14.43%,RPL41;RPS14;RPS13;RPS7;RPL26;RPL5
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.3320603167181282,-0.7794993291566799,0.7532751091703057,0.9360948964642787,1.0,2/10,14.91%,DUSP7;DUSP8
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.3320603167181282,-0.7794993291566799,0.7532751091703057,0.9360948964642787,1.0,2/10,14.91%,DUSP7;DUSP8
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.3353991194486383,0.7773402860313752,0.7225042301184433,0.9565816146798863,1.0,4/14,16.10%,AIFM1;CYB5R4;NOX4;NOX3
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.32188501385144064,0.7740607904789513,0.7649842271293376,0.9588528385365542,1.0,9/20,24.06%,SLC30A8;SLC30A2;SLC30A10;SLC39A13;SLC39A1;SLC39A12;SLC39A6;SLC30A5;SLC30A4
prerank,ribonuclease P RNA binding (GO:0033204),-0.32053200222126327,-0.7730851104629547,0.7413394919168591,0.9419957316760343,1.0,5/10,30.46%,RPP14;POP4;RPP21;POP7;RPP40
prerank,5'-3' exonuclease activity (GO:0008409),0.3332413059747251,0.7699459299996771,0.7161936560934892,0.9623573209455275,1.0,6/14,24.39%,DCLRE1C;DXO;DCLRE1A;FAN1;XRN1;MRE11
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.22547074978690948,0.7698525869106697,0.911983032873807,0.9597042875777713,1.0,75/269,23.79%,TXNIP;SMAD3;BCL2;MOAP1;RFFL;CDK5RAP3;AXIN2;FAF2;SKI;DERL1;PML;CUL4B;RNF31;VCL;SNCAIP;CUL5;DBT;ARRB1;EGFR;UBOX5;PRKN;LTBR;STAT2;SMC6;ITCH;CKB;NEK6;SLC22A18;IKBKE;RAD18;YWHAE;ACVR1B;TRIP4;MUL1;SYT11;GLMN;DIO2;HSPA9;SNX9;UBE2D1;BAG5;TMBIM6;HLTF;LAPTM4B;AUP1;SPART;SPOP;MAP1LC3A;BECN1;RNF34;PSMD1;PRKACA;KDM4A;SUMO1;UBE2T;PSMA3;PRDX6;UCHL1;CBS;TRIB1;SMAD2;JKAMP;TSG101;RNF20;BAG6;HDAC6;WFS1;AMBRA1;BRCA1;HSPA5;ATXN3;ERLIN2;UBXN7;CASC3;DET1
prerank,histone methyltransferase activity (GO:0042054),-0.23920054444298533,-0.7696687973016081,0.8616352201257862,0.9428488131880809,1.0,8/32,17.17%,EED;EZH2;PRMT7;SMYD2;SUV39H1;SMYD1;PRMT6;KMT5A
prerank,neurexin family protein binding (GO:0042043),0.36744135229629715,0.7671756639397367,0.7425925925925926,0.9608623799283385,1.0,2/10,12.44%,SYTL5;SYTL2
prerank,methylation-dependent protein binding (GO:0140034),0.2645621425177503,0.7654018855912471,0.8083441981747066,0.96067658483159,1.0,18/57,21.01%,ING3;ING5;PHF1;PHF2;L3MBTL1;L3MBTL2;KMT2E;JMJD7;WDR5;KDM7A;PHF8;CBX5;SPIN4;ATRX;KDM4A;CXXC1;RBBP5;KDM5A
prerank,histone acetyltransferase activity (GO:0004402),-0.24535455313969162,-0.7649832934466859,0.8306709265175719,0.9458878219607025,1.0,10/30,19.17%,TAF1;KAT2A;TAF10;TADA2A;USP22;KAT6A;NAA60;EP300;BRCA2;MCM3AP
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.29978229189315353,-0.7642506357821967,0.7978723404255319,0.9427748943802637,1.0,6/14,25.03%,RPP14;POP4;RPP21;ELAC2;TSEN34;POP7
prerank,telomeric DNA binding (GO:0042162),-0.24412786845744822,-0.7622217975538652,0.8492307692307692,0.9418880457677905,1.0,18/32,42.44%,KDM1A;HNRNPD;CTC1;HNRNPA2B1;ZBTB48;SMG7;TEN1;HMBOX1;APEX1;PIF1;TERT;STN1;PURA;TERF2IP;ACD;TINF2;UPF3A;XRCC6
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.25469557800346637,0.7620579947957736,0.8031088082901554,0.9628975703844792,1.0,11/69,16.69%,ASPG;PLA2G4A;DBT;LPGAT1;KAT2B;CERS6;CERS5;MOGAT3;DGAT2;CERS2;ZDHHC20
prerank,neuropeptide hormone activity (GO:0005184),0.3115902118861079,0.760568762328656,0.7553846153846154,0.9622823997357154,1.0,3/22,15.65%,VIP;NPFF;NPY
prerank,3'-5' exonuclease activity (GO:0008408),-0.21743641245458348,-0.7598991775393193,0.9061371841155235,0.9413315506169229,1.0,12/45,21.44%,REV3L;CNOT6L;ANGEL2;PNPT1;PNLDC1;RAD1;TATDN1;DIS3L2;EXOSC5;CNOT7;USB1;CNOT8
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.31761277735735005,-0.7594797497688984,0.7598152424942263,0.9379313363922771,1.0,2/11,5.49%,APEX2;RPS3
prerank,ribonuclease activity (GO:0004540),0.26305161418750944,0.7579952685565988,0.8322411533420708,0.9631894687658251,1.0,18/56,25.49%,SND1;ENDOU;RNASE12;EXOSC1;PIWIL4;RNASEL;RNASE7;EXOSC7;TSNAX;DICER1;NOB1;EXOSC2;RCL1;AGO3;LACTB2;EXOSC8;ANG;RNASE4
prerank,transferrin receptor binding (GO:1990459),-0.31884748511563793,-0.7566069159035026,0.7927107061503417,0.9381004121504072,1.0,3/10,21.79%,SNX1;CD81;CHUK
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.25596909359141884,-0.7555772728129936,0.8103448275862069,0.9356348104989651,1.0,7/23,21.94%,PLEKHA5;HIP1R;KIF16B;WDR45B;WIPI2;CLVS2;PLA2G4E
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.35800650609886536,0.7546124889494015,0.7578397212543554,0.9655765970774224,1.0,1/11,1.34%,SASH1
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.30814604255426686,0.7540529914153751,0.778125,0.9635727130484375,1.0,5/22,11.60%,OPTN;SPRTN;WDR81;ZBTB1;IKBKE
prerank,SUMO binding (GO:0032183),0.3362706186757728,0.7523095163035672,0.7540106951871658,0.9633561156655471,1.0,4/13,14.32%,PML;USPL1;SERBP1;CASP8AP2
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",-0.2541005790946313,-0.751893170085751,0.8419540229885057,0.936774056162871,1.0,9/24,28.89%,AK5;IP6K1;AK7;PMVK;PPIP5K1;ITPKB;AK3;ITPKC;NME2
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.28945036731299345,0.7513800875063046,0.8128491620111732,0.9619585260487277,1.0,7/34,16.47%,SETD7;KMT5B;SETD4;SMYD3;KMT2E;SETDB1;EEF2KMT
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.2985689399662607,0.7503028787223602,0.7912087912087912,0.9607462507892766,1.0,1/24,1.26%,GLUL
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.28787623850755634,0.7501018154063709,0.8049490538573508,0.9582639237574241,1.0,6/29,9.96%,PRKAG2;PKIA;KAT2B;SPRY2;HEXIM2;INCA1
prerank,nucleosomal DNA binding (GO:0031492),0.315787963034684,0.74773069086036,0.7917981072555205,0.9588920902999032,1.0,6/21,16.84%,MBD2;SMARCC2;MTA2;SMARCD2;SMARCB1;HNRNPC
prerank,ubiquitin protein ligase binding (GO:0031625),0.2195969384183609,0.7473643965411916,0.9264392324093816,0.9566824533266028,1.0,71/254,23.79%,TXNIP;SMAD3;BCL2;MOAP1;RFFL;AXIN2;FAF2;SKI;DERL1;PML;CUL4B;RNF31;VCL;SNCAIP;CUL5;DBT;ARRB1;EGFR;UBOX5;PRKN;LTBR;SMC6;CKB;NEK6;SLC22A18;IKBKE;RAD18;YWHAE;ACVR1B;MUL1;SYT11;GLMN;DIO2;HSPA9;SNX9;UBE2D1;BAG5;TMBIM6;HLTF;LAPTM4B;AUP1;SPART;SPOP;MAP1LC3A;BECN1;RNF34;PSMD1;PRKACA;KDM4A;SUMO1;UBE2T;PSMA3;PRDX6;UCHL1;CBS;TRIB1;SMAD2;JKAMP;TSG101;RNF20;BAG6;HDAC6;WFS1;AMBRA1;BRCA1;HSPA5;ATXN3;ERLIN2;UBXN7;CASC3;DET1
prerank,tRNA binding (GO:0000049),-0.21569682625154787,-0.7467228638520447,0.8861209964412812,0.939576604394374,1.0,20/43,35.65%,TRMT10A;PSTK;PTCD1;YARS2;EEF1A1;KARS1;FARS2;AIMP1;AARS2;EIF2AK4;NSUN6;TRMT10C;CTU1;TERT;HSD17B10;DALRD3;THG1L;TRMT10B;DARS2;ELP1
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.2768601705821421,0.7457750657598519,0.8055555555555556,0.9561330633706115,1.0,13/35,28.27%,BCDIN3D;QRSL1;TRMT9B;TRMT13;DTWD1;ALKBH1;DUS3L;FTO;TRMT12;TYW3;PTRH2;TRIT1;QTRT2
prerank,lysine-acetylated histone binding (GO:0070577),0.31330927240455286,0.7454281118727373,0.8076923076923077,0.9512381437882285,1.0,4/20,6.93%,PSME4;PHIP;MLLT3;ATAD2B
prerank,acetylation-dependent protein binding (GO:0140033),0.31330927240455286,0.7454281118727373,0.8076923076923077,0.9512381437882285,1.0,4/20,6.93%,PSME4;PHIP;MLLT3;ATAD2B
prerank,microtubule plus-end binding (GO:0051010),0.31030355414131194,0.7421464448880847,0.7893939393939394,0.9530687729936999,1.0,3/20,9.50%,STIM1;CLIP4;MAPRE2
prerank,voltage-gated ion channel activity (GO:0005244),-0.28603352987936914,-0.7397784131157801,0.8502415458937198,0.9444527417939066,1.0,5/14,21.23%,KCND2;CACNA1H;ANO6;HCN1;HVCN1
prerank,RNA polymerase II complex binding (GO:0000993),0.28334052697088097,0.7397467351889829,0.8021472392638037,0.9537213119589311,1.0,11/32,21.25%,RECQL5;WDR43;PAF1;NCOA3;PCF11;ELOF1;WAC;CDC73;ELP4;HNRNPU;SCAF8
prerank,retinoic acid receptor binding (GO:0042974),0.31766864450162213,0.7341531108713175,0.8230647709320695,0.958540579577472,1.0,4/17,9.67%,RARG;TACC1;ACTN4;NSD1
prerank,CCR chemokine receptor binding (GO:0048020),0.2826055844213927,0.7339751445555102,0.8198473282442749,0.9561084977250425,1.0,4/28,17.51%,CCL19;CCL4;CXCL13;CX3CL1
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.29324964580521556,0.7275331728432584,0.806697108066971,0.9617467674137843,1.0,3/26,7.99%,B3GALT1;GBGT1;B3GALNT1
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.25691277110836463,0.7260061141836183,0.8493723849372385,0.9610744835624927,1.0,19/49,23.75%,OPTN;SPRTN;EPS15;WDR81;ZBTB1;TNIP2;IKBKE;RAD18;DZIP3;TNIP1;PSMD4;UIMC1;BRCC3;ZFAND6;ABRAXAS2;BAG6;HDAC6;PRPF8;PARP10
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",-0.23699238425781616,-0.7250168549416844,0.8753894080996885,0.95835023019956,1.0,9/29,23.98%,ACER3;ACER2;GANC;OVGP1;CTBS;NEU1;PARG;GLA;HPSE
prerank,GTP binding (GO:0005525),0.21502631719481236,0.7232186974012231,0.9362416107382551,0.9618771421127162,1.0,29/172,16.62%,RHOH;RHOD;RANBP17;RHOBTB1;RRAS2;MRAS;RHOBTB3;CDC42;LRRK2;RHOBTB2;RAB22A;ARL2;ARFIP2;RHOT1;ARL1;ANXA6;RRAGD;RHOQ;TUBB2B;INSR;RAP2A;ARF4;GNL2;RND3;ARF6;TUBB2A;ARL5A;AGAP2;RHOG
prerank,receptor antagonist activity (GO:0048019),0.30514200386128726,0.7213655404827708,0.7794871794871795,0.9615843944884447,1.0,4/17,23.24%,DKK3;IL18BP;FST;PXDN
prerank,signal sequence binding (GO:0005048),0.2699215274477097,0.7203814225773765,0.8579545454545454,0.960162698827582,1.0,11/35,24.73%,CEMIP;KPNA6;KDELR3;NUP214;KPNA2;KPNA1;KPNB1;SEC61A1;AP2B1;KDELR2;KPNA4
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.2849205876773017,0.7198622004842172,0.8268330733229329,0.9581500956559502,1.0,11/24,22.52%,OSBPL8;PLA2G4A;PLEKHA8;ARFIP2;GOLPH3L;OSBPL5;GSDMD;GOLPH3;SESTD1;RUBCNL;LANCL2
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),-0.28548093005518804,-0.71760311754685,0.8427518427518428,0.9632386511919724,1.0,9/14,51.46%,CAPNS1;CAPN6;CAPN3;CAPN11;CAPN2;CAPN12;CAPN8;CAPNS2;CAPN9
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.3215616862637647,0.7165237634365563,0.7795992714025501,0.9597629399270032,1.0,5/13,20.56%,DNASE1L1;ENDOV;DICER1;ZGRF1;FAN1
prerank,phosphatase activator activity (GO:0019211),-0.27428042348863446,-0.7104051316286106,0.8405063291139241,0.967412591391787,1.0,4/14,10.38%,PPP2R5A;GTF2F1;CALM1;CALM3
prerank,gamma-tubulin binding (GO:0043015),0.2935477403844283,0.7074047863314575,0.8518518518518519,0.9682539564402693,1.0,5/22,14.11%,NDRG1;CENPJ;BRSK1;DDX3X;RAD51D
prerank,RNA polymerase binding (GO:0070063),0.3015214010142647,0.7065266105644823,0.8035426731078905,0.9666762059731454,1.0,7/18,22.99%,NEDD4;TCERG1;CCNT2;PKN2;SCAF8;CCNT1;BRCA1
prerank,mRNA methyltransferase activity (GO:0008174),0.3282867535492202,0.7064011689461636,0.8053097345132744,0.9641520373224601,1.0,6/12,24.75%,NSUN2;METTL14;CMTR2;METTL3;METTL16;PCIF1
prerank,3'-5'-exoribonuclease activity (GO:0000175),-0.21750042374780254,-0.7061282476254591,0.8885017421602788,0.9681179466437876,1.0,10/34,21.44%,CNOT6L;ANGEL2;PAN3;PNPT1;PNLDC1;DIS3L2;EXOSC5;CNOT7;USB1;CNOT8
prerank,O-acyltransferase activity (GO:0008374),-0.217734583785192,-0.7053656279571371,0.9145569620253164,0.964927343389865,1.0,6/30,17.20%,LPCAT1;MBOAT1;PLA2G4C;MBOAT7;LPCAT3;LPCAT2
prerank,signaling receptor complex adaptor activity (GO:0030159),0.2590668461663272,0.7022360284738502,0.8723098995695839,0.9662383440906153,1.0,3/38,6.60%,PIK3R1;FRS2;LRRK2
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.24452364060689563,-0.7022093642999787,0.9025787965616046,0.9645644811892387,1.0,13/21,51.68%,GRM5;GRM1;GRIA1;CHRNB1;CHRNA5;CHRNG;CHRNA3;CHRNE;CHRNB4;CHRNB3;DRD5;CHRNA1;DRD1
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.33101067168863785,0.7018603494476761,0.7953410981697171,0.964101933123864,1.0,11/11,66.92%,CHRNB2;CHRNA7;CHRNA4;CHRNA9;CHRNA2;CHRNA10;CHRNA1;CHRNB4;CHRNA3;CHRNA5;CHRNB1
prerank,lysine N-methyltransferase activity (GO:0016278),0.2994539356345349,0.7013622753465176,0.8307926829268293,0.9621360479633666,1.0,3/20,16.47%,SETD7;SETD4;EEF2KMT
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.23092708158426728,0.6979197305610196,0.9009247027741083,0.9635299502609014,1.0,6/73,8.33%,LGR4;NPR3;LTB4R;LHCGR;BDKRB2;MAS1
prerank,RNA binding (GO:0003723),0.19683357110391483,0.6979132950123447,0.999,0.9609819787474265,1.0,276/1321,21.47%,POLR2D;CELF2;SAMD4A;RBMS1;BICC1;ROCK2;RBMS3;C1D;LRP1;DCN;TENT5A;A1CF;CSDC2;RBFOX1;RRBP1;SON;ADK;RBMXL2;MACF1;HNRNPLL;RBFOX2;FNDC3B;SPATS2L;SND1;RFTN1;MYO18A;MYH10;CDC42EP4;POLR1G;CAST;ZC3H7B;ENDOU;IGF2BP2;TNS1;GOLGB1;MDH2;NUDT7;OAS2;MAP3K20;SIDT1;SNRNP70;DYNC1H1;ZFP36L1;NPM3;TNRC6B;THOC2;ERI3;SERPINH1;RPUSD4;ACO1;SF1;CPEB3;BUD23;PNN;NPM2;DDX60;NUP42;SNTB2;DDX17;REXO4;RPP25L;TOP3B;DXO;HELZ;DNTTIP2;TUT7;EXOSC1;ERAL1;SAFB2;ZNF106;RBMS2;CHD2;TNRC6A;IBA57;RBM22;ALDH18A1;HNRNPR;NSUN2;RBPMS;METTL14;HNRNPA1;FLYWCH2;APEH;NONO;DDX39A;GFM1;ACTN4;EIF4A2;HEXIM2;DIMT1;RAVER2;ASCC3;ADAT1;PRRC2B;DDX19A;FTSJ3;RNASEL;WDR33;PARN;PPHLN1;TFAM;EIF3A;BYSL;RPUSD2;MANF;TRIP6;ERI1;NUP98;DDX3X;DDX31;EIF2S2;POLRMT;DDX23;PPP1R10;SERBP1;SUGP1;RBM19;RAE1;EIF5B;SUGP2;EXOSC7;MAGOHB;STXBP1;DDX50;WDR43;YWHAE;RCAN3;TUT4;LARP1;TRMT9B;HMGN5;SLC16A3;NMD3;GANAB;UTP23;DDX10;MTREX;TEFM;NOL3;ALDH6A1;USP10;USO1;IFIT2;RBM34;STAU1;HELZ2;ESF1;P4HB;GTF2E2;TIAL1;MARK2;SNRPD2;TEP1;HSPA9;RC3H2;NELFE;FLNA;NSUN5;TCERG1;SRP72;SRSF5;AKAP8L;NUDT16L1;RBM39;FASN;PCF11;GPKOW;GNL2;FUBP3;RBM5;RPP30;PRRC2C;HUWE1;CLK3;RRP7A;MRPL23;RBM6;HLTF;PRKRA;RBM4B;DDX52;DZIP3;PSPC1;RPP38;MRPL40;ELP5;EPPK1;COA6;EIF3I;DNAJC21;TBL2;LSM8;KTN1;TENT4B;SRRM2;DCP1A;SYNCRIP;HNRNPC;LONP1;NGDN;KPNA2;TRMT2A;TSNAX;PRPF6;PATL1;DDX4;NAF1;ZNF346;SF3B2;SF3B1;LSM10;RRP9;DARS1;SRSF10;ALKBH1;KHDC4;R3HDM2;PRRC2A;PPIE;CPSF2;DHX58;CKAP4;TRUB2;RC3H1;METTL3;EIF3C;DDX1;PARP12;TPR;ENDOV;TRIM32;KPNB1;FIP1L1;DICER1;SAP18;PSMD4;RSRC2;SUMO1;FASTKD3;DUS3L;NCOA5;ZGRF1;CCDC47;LARP6;YTHDF2;GPATCH8;PTCD3;AATF;UTP3;HNRNPU;AGO4;YRDC;HDLBP;ZFP36L2;GSPT1;FSCN1;ACTN1;DDX49;HNRNPH1;ZC3H15;MRPS28;MRPS35;DDX24;CEBPZ;PKN2;SCG3;BMS1;EIF4G2;SCAF8;UBFD1;SRSF3;RARS2;NOCT;NUDT5;SARS1;SARS2
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",-0.23473114347650026,-0.6943496502548686,0.8939393939393939,0.9690186973857751,1.0,5/25,10.69%,ARAP3;HIP1R;PLEKHA1;KIF16B;PLEK
prerank,death receptor binding (GO:0005123),0.3004699580071148,0.6935880252461366,0.8189655172413793,0.9632335699537673,1.0,8/15,27.01%,NTF3;CASP8AP2;BDNF;FEM1B;MADD;MYD88;FADD;RIPK1
prerank,MHC class I protein binding (GO:0042288),0.31671458127712027,0.6934891568148432,0.8275862068965517,0.9607846271359743,1.0,4/13,20.90%,DERL1;ABCB9;TAPBP;TAP1
prerank,guanyl ribonucleotide binding (GO:0032561),0.20411306025634599,0.6892046235469511,0.9747530186608123,0.9630562577489638,1.0,31/196,16.62%,RHOH;RHOD;MPPED2;RANBP17;RHOBTB1;RRAS2;RAPGEF2;MRAS;RHOBTB3;CDC42;LRRK2;RHOBTB2;RAB22A;ARL2;ARFIP2;RHOT1;ARL1;ANXA6;RRAGD;RHOQ;TUBB2B;INSR;RAP2A;ARF4;GNL2;RND3;ARF6;TUBB2A;ARL5A;AGAP2;RHOG
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.28204495675281027,0.6792969451682772,0.8403614457831325,0.9712494519384115,1.0,4/20,16.49%,USP47;OTULINL;USP9X;COPS2
prerank,nucleobase-containing compound kinase activity (GO:0019205),-0.25093330194777425,-0.6768754275362274,0.8987012987012987,0.9818456448119204,1.0,4/17,16.13%,AK5;CLP1;NOL9;AK7
prerank,ATPase regulator activity (GO:0060590),0.2524182541182488,0.675210873654462,0.89,0.972974713335225,1.0,7/38,16.40%,DNAJC1;ATP1B2;KATNB1;TOR1AIP1;BAG5;TOR1AIP2;FNIP1
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),-0.23051505647968443,-0.6748984585217429,0.9326145552560647,0.979771564903577,1.0,10/22,36.20%,MTMR2;DUSP7;DUSP8;DUSP23;CDKN3;DUSP3;SBF1;PPM1F;DUSP5;DUSP2
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",-0.20778221095454844,-0.6744194860931644,0.9297658862876255,0.9762819131645473,1.0,10/33,21.44%,CNOT6L;ANGEL2;PNPT1;PNLDC1;DIS3L2;EXOSC5;CNOT7;DCP2;USB1;CNOT8
prerank,protein phosphatase activator activity (GO:0072542),-0.26379412515278766,-0.6714541411544835,0.8787878787878788,0.9751865099530536,1.0,3/13,10.38%,PPP2R5A;CALM1;CALM3
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.2580921160981333,0.6702000648643229,0.882800608828006,0.9754074802121209,1.0,7/28,21.21%,PRKAA2;LRRK2;MAP2K1;MAP2K6;AKT1;PRKACA;AURKA
prerank,RNA polymerase core enzyme binding (GO:0043175),0.24528068567175698,0.6549150653080473,0.9071117561683599,0.9876846951146787,1.0,12/33,21.52%,RECQL5;WDR43;PAF1;NCOA3;PCF11;ELOF1;WAC;CDC73;ELP4;HNRNPU;SCAF8;MAF1
prerank,methylated histone binding (GO:0035064),0.22302809163222956,0.6537198233739796,0.9439374185136897,0.9861806170089409,1.0,18/62,21.01%,ING3;ING5;PHF1;PHF2;L3MBTL1;L3MBTL2;KMT2E;JMJD7;WDR5;KDM7A;PHF8;CBX5;SPIN4;ATRX;KDM4A;CXXC1;RBBP5;KDM5A
prerank,palmitoyltransferase activity (GO:0016409),0.2526832052471537,0.6535556641690001,0.8801213960546282,0.9838045753947009,1.0,1/28,1.26%,GLUL
prerank,neuropeptide receptor binding (GO:0071855),-0.24937671631342367,-0.6502072771462905,0.9090909090909091,0.9889256707763813,1.0,2/14,18.38%,SHANK1;PPY
prerank,translation initiation factor activity (GO:0003743),0.24245113898384446,0.6464113352928886,0.9300699300699301,0.9874149439911409,1.0,9/36,18.42%,EIF4A2;EIF3A;EIF2B4;EIF2S2;EIF5B;EIF4E3;EIF2B3;EIF3I;EIF3C
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.2339666550246746,0.6416395544313591,0.9291666666666667,0.9888445990842254,1.0,12/38,22.52%,SH3PXD2B;PLA2G4A;SNX12;SNX21;DENND1A;WIPI1;PARD3;ATG2B;WDR45;SESTD1;RUBCNL;LANCL2
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.26790191457544593,0.6404721280054338,0.8950617283950617,0.9873082090747194,1.0,4/20,14.60%,AGPAT3;LPGAT1;MOGAT3;DGAT2
prerank,aminopeptidase activity (GO:0004177),-0.20712994046305455,-0.6394706183190234,0.9606741573033708,0.9929352371818101,1.0,9/26,25.66%,XPNPEP3;MMP15;RNPEPL1;METAP2;BLMH;MMP16;TRHDE;LNPEP;NPEPPS
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",-0.2673665705520094,-0.6359582521971201,0.883495145631068,0.9915219633412049,1.0,6/12,28.52%,DHRS4;NDUFS7;CBR1;CBR4;CRYZL1;NQO1
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),-0.26988642604381236,-0.6356727759599965,0.9021479713603818,0.9878539791984273,1.0,6/11,46.30%,HCN1;HCN4;AQP1;CNGA2;CNGA4;CNGA3
prerank,DNA secondary structure binding (GO:0000217),-0.20036842375081926,-0.6260865641564958,0.9601226993865031,0.990240602475911,1.0,9/31,25.46%,MEF2C;YY1;RAD51C;HMGB2;HMGA2;MSH2;LIN54;RAD51AP1;GEN1
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.2545970557642451,-0.6219507745643921,0.9278846153846154,0.9891753760210378,1.0,7/11,30.24%,NUDT4;DCP2;NUDT11;DCPS;NUDT16;NUDT10;NUDT1
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.2573723357630708,-0.621407831801385,0.9048723897911833,0.985716650143926,1.0,5/12,22.00%,CCDC88A;VEGFA;VEGFC;DAB2IP;VEGFD
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.300435720376969,0.6206217975138582,0.8945454545454545,1.0,1.0,4/11,19.20%,NAA40;NAA20;NAA80;NAA50
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.214165422694229,0.6178966167729153,0.9525801952580195,1.0,1.0,17/54,25.21%,ASPG;ASPA;SIRT2;NGLY1;HDAC8;HDAC4;VNN1;SUDS3;AGA;DARS1;SIRT5;MIER3;HDAC6;HDAC5;ACER1;HDAC1;ACY1
prerank,nuclear import signal receptor activity (GO:0061608),0.2744418761964613,0.6167264091091372,0.8877721943048577,0.9983696052143913,1.0,4/15,18.83%,KPNA6;KPNA2;KPNA1;KPNB1
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.2951234598559076,0.611699089707309,0.8897058823529411,0.9994214645975568,1.0,4/10,23.66%,PML;IDE;FAN1;ANKRD13D
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.2685932847248502,0.6116219353353207,0.9165275459098498,0.9969086892828583,1.0,1/15,5.18%,PLA2G4A
prerank,CXCR chemokine receptor binding (GO:0045236),0.2781820752294022,0.6055128380505764,0.890625,0.9986048392730542,1.0,2/11,13.53%,ITCH;CXCL13
prerank,thiol-dependent deubiquitinase (GO:0004843),0.19541879953434754,0.6034299681316241,0.9776674937965261,0.9974209213224566,1.0,13/83,13.42%,USP11;USP47;USP20;USP35;USP24;USP48;USP30;USP9Y;USP32;USP10;USP9X;MINDY3;USP38
prerank,kinase activity (GO:0016301),0.1887952517410139,0.6032808698070994,0.9865030674846625,0.9950154562006504,1.0,24/109,21.35%,LYN;EPHA4;MVK;PDXK;LRRK2;SPHK2;MAP4K4;FN3KRP;CHKB;CKB;PI4KA;PANK1;CERK;AKT1;ITPKA;GK;CDC7;FN3K;NMRK1;COASY;BCKDK;PKN2;TAOK1;PAPSS2
prerank,glucose transmembrane transporter activity (GO:0005355),0.25980827350317165,0.5998693211552883,0.9384116693679092,0.9947297047283389,1.0,4/17,17.56%,SLC2A10;SLC5A3;SLC2A4;SLC2A8
prerank,damaged DNA binding (GO:0003684),0.21616243426048337,0.5993726625930954,0.9513212795549374,0.9925431987375773,1.0,6/44,11.91%,OGG1;CUL4B;DCLRE1C;SMC6;DCLRE1A;RAD18
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.2555117022632164,0.5988081167340896,0.9105263157894737,0.9903837130894431,1.0,2/16,6.68%,NEIL1;ADPRH
prerank,omega peptidase activity (GO:0008242),0.19030064506478364,0.5976106002224975,0.9879227053140096,0.9886584175032804,1.0,14/89,13.42%,USP11;USP47;USP20;USP35;USP24;USP48;APEH;USP30;USP9Y;USP32;USP10;USP9X;MINDY3;USP38
prerank,exoribonuclease activity (GO:0004532),0.2751682693010483,0.596068102162734,0.9218241042345277,0.987147188024568,1.0,5/12,27.34%,EXOSC1;EXOSC7;EXOSC2;EXOSC8;EXOSC9
prerank,cAMP response element binding (GO:0035497),-0.2516483366595291,-0.5861082388782681,0.946236559139785,1.0,1.0,6/10,32.86%,CREB1;JUN;HMGA2;ATF2;NR4A3;E4F1
prerank,ribonuclease P activity (GO:0004526),-0.23966530582467346,-0.5846473927650196,0.9473684210526315,0.9984505599681721,1.0,3/11,15.48%,RPP14;POP4;RPP21
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),-0.1873940573423807,-0.5843199598391899,0.9823529411764705,0.9947644047043513,1.0,6/28,21.50%,TMBIM1;TRAF5;TRAF1;TRAF2;DAB2IP;BABAM2
prerank,single-stranded DNA helicase activity (GO:0017116),-0.20817804269385976,-0.5839268160823263,0.961439588688946,0.9911950313948651,1.0,9/19,29.48%,RAD51;DHX9;POLQ;WRNIP1;HELB;MCM5;DSCC1;CHTF18;PIF1
prerank,telomerase RNA binding (GO:0070034),0.23618419648332734,0.5817482658392804,0.9459041731066461,0.9929989064776511,1.0,6/22,20.15%,PARN;TEP1;TENT4B;HNRNPC;NAF1;HNRNPU
prerank,carbohydrate kinase activity (GO:0019200),-0.23394048094178807,-0.5735943811850562,0.944954128440367,0.9920026764375102,1.0,1/11,5.77%,HK2
prerank,phospholipase inhibitor activity (GO:0004859),0.26616520510079267,0.5590437459357276,0.9151624548736462,1.0,1.0,5/10,33.87%,ANXA5;ANXA2;ANXA4;ANXA9;ANGPTL3
prerank,ribosome binding (GO:0043022),0.1986425547688357,0.5530120353439469,0.9780821917808219,1.0,1.0,11/46,22.34%,CPEB1;CPEB3;EIF6;ERI1;SERBP1;SRP72;EIF3C;CCDC47;SEC61A1;CPEB4;BAG6
prerank,DNA polymerase binding (GO:0070182),0.22813942065379408,0.540726051077308,0.9592169657422512,1.0,1.0,9/18,30.29%,FANCI;RTEL1;CDK2AP1;LONP1;NABP2;HMGB1;HSP90AA1;SMG6;PCNA
prerank,endodeoxyribonuclease activity (GO:0004520),-0.1898651903590358,-0.5392034126931039,0.9763157894736842,1.0,1.0,8/20,32.68%,RPS3;ZRANB3;EXO1;EXOG;APEX1;ENDOG;FEN1;ERCC5
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.21483136444162773,-0.5389772105654639,0.9662650602409638,0.997179924955149,1.0,6/13,36.37%,TRMT10A;TRMT1L;TRMT10C;TRMT10B;FTSJ1;TARBP1
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.2354654868379819,0.5380858626979511,0.9610619469026549,1.0,1.0,3/14,13.79%,MTMR3;MTMR7;PTEN
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.2350030194551928,0.5374876532560867,0.9458128078817734,1.0,1.0,3/17,17.01%,DPYD;DECR1;DECR2
prerank,MHC protein binding (GO:0042287),-0.19381629830205532,-0.5336370196304201,0.9727520435967303,0.9949925161698572,1.0,4/20,17.40%,ATP5F1A;TUBB4B;CD81;LAG3
prerank,four-way junction DNA binding (GO:0000400),0.2304986600689925,0.532839188278995,0.9662162162162162,1.0,1.0,7/17,26.38%,RAD51B;RAD51D;XRCC2;MSH6;HMGB3;ABL1;HMGB1
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.2040126207166252,-0.5321944513911546,0.9796954314720813,0.9916587188858683,1.0,6/15,29.65%,PIK3R3;PIK3C2B;PIK3CA;PIK3CG;PI4K2B;PIK3CD
prerank,aspartic-type peptidase activity (GO:0070001),-0.23051825917836696,-0.5309838498166984,0.972972972972973,0.9882933071829855,1.0,2/10,24.07%,BACE2;CTSE
prerank,single-stranded telomeric DNA binding (GO:0043047),0.24998785930138104,0.5290133798212746,0.9499105545617174,0.9992636909355199,1.0,2/11,12.17%,HNRNPA1;TERF2
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.22893264629069604,0.5143851393642711,0.9820261437908496,1.0,1.0,2/14,11.77%,AK8;NME6
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.24405547014811058,0.513944728193794,0.9685863874345549,0.9995061950580749,1.0,3/11,18.69%,FBXO11;PRMT9;CARM1
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.2448807423136234,0.5114224573889318,0.9654545454545455,0.9978467820086017,1.0,2/10,11.72%,DCLRE1C;DCLRE1A
prerank,snoRNA binding (GO:0030515),0.19039251649638586,0.5037946167257497,0.9910846953937593,0.9975519458790375,1.0,9/30,27.03%,NUDT7;BYSL;NUDT16L1;RRP9;BMS1;NUDT5;NOP14;HEATR1;TBL3
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.20858958116132958,0.4901439075471019,0.9761904761904762,0.9986869797837342,1.0,1/18,5.28%,HSD3B2
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.2039311907565535,-0.4794930656064195,0.9796380090497737,0.9956682300932664,1.0,6/10,40.76%,NCF2;NOX1;NCF1;NCF4;DUOX1;CYBA
prerank,peptide N-acetyltransferase activity (GO:0034212),0.22546956961517947,0.4613044555698976,0.9854545454545455,1.0,1.0,3/10,19.20%,NAA20;NAA80;NAA50
prerank,U6 snRNA binding (GO:0017070),0.20189610909881206,0.4432491001137496,0.9900332225913622,1.0,1.0,4/14,23.61%,RBM22;LSM8;PRPF8;METTL16
prerank,Toll-like receptor binding (GO:0035325),0.20301515956201854,0.44079166023337457,0.9896907216494846,1.0,1.0,3/11,21.72%,TLR6;TIRAP;MYD88
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.16928854654540101,-0.43854679488560194,1.0,0.9968390136344453,1.0,9/15,45.93%,P2RX7;P2RY14;PTAFR;P2RX3;P2RX6;GPR171;P2RX1;GPR87;P2RY13
prerank,deoxyribonuclease activity (GO:0004536),0.18591665899537405,0.42494224202717856,0.9893048128342246,0.9999490446901428,1.0,5/14,26.00%,DNASE1L1;MBD4;APLF;MRE11;MAP1S
prerank,SUMO transferase activity (GO:0019789),0.1736263736263734,0.39821534888489746,0.998324958123953,0.9998085361140289,1.0,16/16,82.65%,MUL1;HDAC4;NSMCE2;PIAS3;MDM2;RNF212;PIAS4;UBE2I;PIAS1;EGR2;RNF212B;PIAS2;TOPORS;TRIM28;CBX4;RANBP2
prerank,N-acyltransferase activity (GO:0016410),0.15059919622035228,0.3955791453118481,0.9970282317979198,0.99761112830595,1.0,10/32,24.13%,CERS6;CERS5;CERS2;SAT2;NAA80;NAA50;SAT1;SMARCE1;NAT14;ESCO1
